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ii 
This thesis demonstrated the effects of exogenous stimuli on engineered articular 
cartilage constructs and elucidated mechanisms underlying the responses to 
these agents. In particular, a series of studies detailed the effects of 
chondroitinase-ABC (C-ABC), hyaluronic acid (HA), and TGF-~1 on the 
biochemical and biomechanical properties of self-assembled articular cartilage. 
Work with C-ABC showed that this catabolic agent can be employed to improve 
the tensile properties of constructs. When constructs were cultured for 6 weeks, 
treating with C-ABC at 2 weeks enhanced the tensile stiffness. Furthermore, 
treating at 2 and 4 weeks synergistically increased tensile properties and allowed 
compressive stiffness to recover to control levels. Another study showed that 
combining C-ABC and TGF-~1 synergistically enhanced the biochemical and 
biomechanical properties of neotissue. Microarray analysis demonstrated that 
TGF-~1 increased MAPK signaling in self-assembled neocartilage whereas C-
ABC had minimal effects on gene expression. SEM analysis showed that C-ABC 
increased collagen fibril diameter and fibril density, indicating that C-ABC 
potentially acts via a biophysical mechanism. Constructs treated with C-ABC and 
TGF-~1 also showed stability and maturation in vivo, exhibiting a tensile stiffness 
of 3.15±0.47 MPa compared to a pre-implantation stiffness of 1.95±0.62 MPa. To 
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assess the response to HA application, studies were conducted to optimize HA 
administration and examine its effects in conjunction with TGF-~1. Applying HA 
increased the compressive stiffness 1-fold and increased GAG content by 35%, 
with these improvements depending on HA molecular weight, application 
commencement time, and concentration. Microarray and PCR analyses showed 
that HA also influenced genetic signaling, up-regulating multiple genes 
associated with the TGF-~1 pathway. In addition to genetic effects, the enhanced 
GAG retention due to HA treatment could increase the fixed charge density of the 
matrix and thereby increase resistance to compressive loading. Additive effects 
were observed when HA was applied in conjunction with TGF-~ 1, with the 
combined treatment increasing compressive stiffness and GAG content by 150% 
and 65%, respectively. In general, results demonstrated mechanisms underlying 
C-ABC, HA, and TGF-~1 treatments and showed how these agents can be 
applied to improve cartilage regeneration efforts. 
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Introduction and background 
Articular cartilage: basic biology 
---------------
1 
Articular cartilage is a hyaline cartilage that lines the articulating surface of bones 
that is devoid of vasculature, nerves, and lymphatics.1 Articular cartilage consists 
of a solid phase and a fluid phase. Water, along with dissolved solutes, forms the 
fluid phase that accounts for 60-85% of the total cartilage weight. 2 The solid 
phase primarily includes collagen, proteoglycans, and chondrocytes. 
Chondrocytes, the only cell type within cartilage, comprise only 1-5% of the 
tissue by volume.1 Because cartilage lacks vasculature, chondrocytes receive 
nutrients by diffusion or imbibition and exudation during loading. The organization 
and presence of cells and matrix components exhibit depth-dependence within 
cartilage. 
Although chondrocytes represent a small fraction of articular cartilage, 
they are crucial because they synthesize the matrix that imparts mechanical 
integrity to the tissue. After chondrogenic differentiation of mesenchymal stem 
cells, chondrocytes produce the matrix that forms the bulk of cartilage. 
Hypertrophic chondrocytes near the bone contribute to matrix calcification 
whereas cells in other zones produce the collagen and proteoglycan matrix. As 
the chondrocytes mature, they cease proliferation. This results in a largely 
acellular tissue with a substantial extracellular matrix. 
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One key component of articular cartilage matrix is an extensive fibrillar 
collagen network. Collagen molecules are comprised of three polypeptide chains 
that form a unique triple helical structure. These polypeptides contain high 
numbers of the repeating peptide sequence glycine-X-Y, where X and Y are 
frequently proline and hydroxyproline. This sequence helps stabilize the triple 
helix structure. Additionally, there are two short extrahelical telopeptides on each 
polypeptide chain which have neither the repeating peptide sequence nor a triple 
helical conformation. The most common types of collagen are the fibrillar 
molecules that assemble into fibrils; examples of fibrillar collagens include 
collagens I, II, and XI. The major collagen source within articular cartilage is a 
heteromer of collagen types II, IX, and XI, which is over 90% collagen 11.3.4 This 
heteromer forms the fibrillar network that provides articular cartilage with is 
tensile strength and stiffness. Both the orientations and sizes of the fibrils change 
as the tissue matures. Collagen VI is localized around the chondrocytes and 
contributes to the mechanical properties of the pericellular matrix, as well as cell 
signaling. Several types of collagen, namely collagens I and X, are rarely 
expressed in normal articular cartilage but are present during development and 
certain pathologies. 
The other major components of cartilage matrix are proteoglycans, which 
are proteins with bound glycosaminoglycan (GAG) chains. The major 
proteoglycan of cartilage, aggrecan, is comprised of hyaluronic acid (HA) that 
aggregates with a protein core with many bound chondroitin sulfate and keratan 
sulfate chains. Because these GAGs create a highly negative matrix, cartilage 
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exhibits increased water content. GAGs contribute extensively to the 
compressive strength of cartilage by their bulk presence in the matrix and due to 
the swelling of the retained water. Additionally, proteoglycans can sequester 
bioactive molecules such as growth factors. 5 Several small proteoglycans 
including lumican, decorin, and fibromodulin also interact with collagen. These 
interactions can regulate fibril diameter, fibril-fibril interactions, and susceptibility 
to degradation.6 For instance, knocking out perlecan, a heparan sulfate 
proteoglycan, reduced the size and density of collagen fibrils. 7•8 These various 
roles of proteoglycans illustrate their contributions to the functional properties of 
cartilage. 
Articular cartilage disease and repair 
Articular cartilage has a low repair capacity due to its lack of vasculature, 
lymphatics, and cells.9 Cartilage injury produces a mechanically inferior repair 
fibrocartilage,10·11 which prevents recovery of cartilage functionality. In particular, 
increased collagen I and decreased GAG content within fibrocartilage alters the 
tissue's mechanical properties. This repair tissue eventually degenerates and 
contributes to osteoarthritis. 
Osteoarthritis is a significant global health problem that impacts millions 
and creates a serious economic burden. In the United States alone, expenditures 
for arthritis and other rheumatic conditions exceeded $320 billion in 2003.12 
Osteoarthritis is particularly problematic within the elderly population; for 
example, it has been estimated that 10% of people over age 60 have 
osteoarthritis.13 The primary symptoms are inflammation of the joint and joint 
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pain; in severe cases, these symptoms can impair physical function and 
adversely impact the patient's lifestyle. The prevalence and severity of 
osteoarthritis provides a strong impetus for engineering articular cartilage. 
The lack of an effective clinical treatment for osteoarthritis and the limited 
regenerative capacity of cartilage make tissue engineering a particularly 
promising approach. Due to the limited regenerative capacity and physiological 
importance of articular cartilage, any damaged or diseased tissue needs to be 
replaced. Tissue engineering has the potential to substantially improve the 
treatment of cartilage defects. The hydrated matrix of cartilage, composed 
primarily of proteoglycans and collagen, creates the mechanical integrity of the 
tissue. The importance of the matrix in cartilage biomechanics, and its ability to 
withstand a demanding mechanical environment, necessitates producing a 
suitable matrix in tissue engineered constructs. Ultimately, creating neotissue 
with the same biomechanical properties as native tissue will help create a viable 
cartilage repair method. 
Unfortunately, an acceptable cartilage replacement treatment does not 
currently exist, so physicians are typically limited to treating patients 
symptomatically.14 To provide a more effective treatment, several techniques 
have been developed to promote cartilage repair including microfracture, 
osteochondral grafts, and autologous chondrocyte implantation. However, 
current cartilage repair methods have achieved limited clinical success, 
particularly due to their dependence on tissue harvested from a non-weight 
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bearing portion of the knee. 15 Additionally, using xenogenic or allogenic cells can 
pose immunogenicity problems. 
Several repair treatments are currently employed, but disadvantages have 
prevented any methods from becoming a widely accepted treatment. 
Microfracture repair has shown some success clinically, but it is only appropriate 
for a fraction of patients.15·16 Although osteochondral grafting avoids 
immunogenicity problems, it requires multiple surgical sites and subsequently 
makes it a more invasive treatment. 17"19 Many studies have also focused on 
suspended chondrocyte implantation. Allogenic suspended chondrocytes pose 
immune rejection problems, which has precluded widespread clinical use.20 A 
more common suspended chondrocyte technique is autologous chondrocyte 
implantation, which has an established clinical record. For instance, autologous 
grafts have maintained their durability even in a nine year study?1 Despite 
various studies showing promising results for autologous chondrocyte 
implantation, there have also been concerns such as the presence of 
fibrocartilage in the replacement tissue.22 In general, these current replacement 
methods have all achieved some clinical success, but the need for a more 
effective solution still exists. 
Exogenous stimuli for cartilage tissue engineering 
Many external agents have shown promise for cartilage engineering. For 
example, growth factors increase matrix synthesis and promote chondrogenic 
differentiation, making them useful for improving tissue engineered constructs. 
Additionally, administering HA has been shown to influence the matrix structure 
6 
and composition of chondrocyte cultures. Chondroitinase-ABC (C-ABC}, an 
enzyme that depletes GAG content, has also been used to improve the functional 
properties of constructs. These external stimuli will be discussed in more detail 
below. 
Growth factors 
The TGF-J3 superfamily, which includes forms of TGF-J3 and the bone 
morphogenic proteins (BMPs), has been extensively investigated for its beneficial 
effects on cartilage. This class of growth factors is known to contribute to both 
embryonic cartilage developmenf3 and chondrogenic differentiation of 
mesenchymal progenitor cells?4-27 Furthermore, TGF-J31 has been shown to 
improve in vivo cartilage repair.28 Administering TGF-J3 to tissue engineered 
constructs has also been extensively studied. For instance, administering TGF-J3 
increased GAG deposition in three-dimensional cultures of equine 
chondrocytes,29 rabbit auricular chondrocytes,30 and bovine articular 
chondrocytes.31 Other studies have shown that BMP-2 increases GAG deposition 
in explant cultures32 and engineered cartilage_33 Many BMPs have also been 
shown to promote collagen synthesis. For instance, BMP-234 and BMP-735 have 
been employed to increase collagen deposition. The prevalence of exciting TGF-
J3 superfamily results has made it one of the most widely applied classes of 
anabolic agents for in vitro cartilage regeneration. 
Another well-characterized growth factor for in vitro cartilage culture is 
insulin growth factor-1 (IGF-1). IGF-1 treatment has been shown to increase 
GAG production in both explants36 and tissue engineered constructs.37•38 In self-
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assembled constructs, treatment with BMP-2 and IGF-1 resulted in a 118% 
increase in compressive stiffness and a 54% increase in GAG production.39 
Additionally, combining IGF-1 treatment with direct compression increased 
protein and proteoglycan synthesis by 180% and 290%, respectively.4° For 
bovine articular chondrocytes cultured on alginate beads, IGF-1 increased 
collagen gene expression and deposition,41 but it did not impact the number of 
crosslinks.42 These studies showed the ability of IGF-1 to improve in vitro 
cartilage culture. 
Despite many studies that demonstrated the role of growth factors, the 
responses to a growth factor have not been consistent in many cases. For 
example, members of the TGF-13 superfamily have been shown to increase or 
decrease collagen deposition depending on the experimental system.29•37•42-44 In 
addition to the variation in culture systems, the developmental stage of the 
cell,30•45 zone of cell source,41 and the amount of extracellular matrix already 
deposited44 also influenced the response to the growth factor. Synergism 
between growth factors also altered their impact. 39 The complexity of the growth 
factor response complicated the generalization of an optimal treatment regimen. 
Chondroitinase-ABC 
Chondroitinase-ABC (C-ABC) is a GAG lyase that selectively degrades 
chondroitin and dermatan sulfates,46 which has been shown to influence the 
biochemical and biomechanical properties of both explants and tissue 
engineered constructs. For instance, when C-ABC was used to treat cartilage 
explants that were then cultured for 2 weeks, GAG levels recovered and the 
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tissue exhibited increased tensile properties.47 Additionally, treating agarose 
encapsulated chondrocytes with C-ABC resulted in increased collagen 
concentration.48 These results are highly relevant to tissue engineering because 
tissue engineered constructs tend to overproduce GAGs and subsequently 
create an imbalance in matrix components.49•5° C-ABC could improve the quality 
of neotissue matrix by countering this GAG overproduction. 
Compared to GAG content and compressive properties, collagen and 
tensile properties of engineered articular cartilage have remained inferior. A 
recent study has shown that C-ABC treatment of self-assembled constructs 
increases their tensile properties.51 Self-assembled constructs were treated with 
C-ABC at 2 weeks, followed by an additional 2 weeks of culture. At 4 weeks, the 
ultimate tensile strength and tensile modulus of C-ABC treated constructs 
increased by 121% and 80%, respectively. The GAG content increased from 2 to 
4 weeks; the compressive stiffness of C-ABC treated constructs also increased, 
but did not recover to control values. This study showed the potential of C-ABC 
for increasing the tensile properties of tissue engineered articular cartilage. 
Biomechanica/ stimuli 
In addition to the biochemical stimuli described above, mechanical stimulation 
has also been investigated to improve the functional properties of constructs. 
Mechanical loading of diarthrodial joints results in direct compression of 
chondrocytes, and chondrocytes also experience hydrostatic pressure due to 
compression of synovial fluid inside the joint capsule. Recapitulating the 
mechanical environment of native chondrocytes is important due to the extreme 
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forces that these cells endure, which have been shown to influence their 
phenotype. 52 Some of the stimulation methods that have been employed to 
promote in vitro chondrocyte culture include hydrostatic pressure and direct 
compression. 
Direct compression has been used to modulate matrix composition and 
concomitantly influence construct properties. Direct compression at various 
frequencies and strain levels has been shown to increase collagen 
deposition.53•54 By applying dynamic compression to medial meniscal explants, it 
was shown that aggrecan was up-regulated by 108%.55 The beneficial effects of 
dynamic compression have also been observed in self-assembled constructs: 
applying 17%, 0.1 Hz compression increased the aggregate modulus by 70%. 
These results have shown the potential of direct compression to further improve 
tissue engineered constructs. 
Although there has not been extensive examination of hydrostatic 
pressure for tissue engineering, several studies have shown promise for this type 
of stimulation. Hydrostatic pressure has also been shown to increase collagen 
gene transcription,56 collagen production,57•58 and construct tensile properties.59 
For instance, applying 10 MPa hydrostatic pressure to self-assembled constructs 
at 1 Hz for 4 hours per day and 5 days a week increased collagen content. 57 
Additionally, the combination of hydrostatic pressure and growth factor treatment 
was found to produce synergistic increases in collagen content and additive 
increases in both Young's modulus and the aggregate modulus. 59 These findings 
were exciting as coupling hydrostatic pressure stimulation with growth factor 
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application allowed for the formation of tissue engineered constructs with 
biomechanical and biochemical properties spanning native tissue values. Studies 
on PGA meshes have shown that hydrostatic pressure can increase matrix 
production.60•61 Despite these promising results, hydrostatic pressure has also 
been shown to be deleterious. In particular, applying hydrostatic pressure above 
physiological levels exhibited harmful effects and led to decreased matrix 
production and increased expression of inflammatory signaling cytokines such as 
interleukin-6 and tumor necrosis factor. 62 These studies showed the potential of 
hydrostatic pressure to improve construct biomechanical and biochemical 
properties by choosing an appropriate stimulation regimen. 
Cell sources for cartilage engineering 
A readily available cell source that does not dedifferentiate is crucial for any 
tissue engineering strategy. Although animal sources pose potential 
immunogenicity problems, their accessibility makes them preferable for initial 
tissue engineering studies. Fully differentiated chondrocytes can be harvested 
from various animals and then used to engineer neotissue. Alternatively, 
progenitor cells such as mesenchymal stem cells and human embryonic stem 
cells (hESCs) can be differentiated and then used to engineer tissue. Each cell 
source has distinct advantages and disadvantages. 
The most plentiful cell source is hESCs. The high proliferation capacity of 
these cells makes them an unlimited cell source if they are cultured such that 
undesired differentiation is prevented. Because hESCs are totipotent, they can 
be differentiated into any cell type including the chondrocyte. Ethical concerns 
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have limited the use of stem cells, but new technologies such as induced 
pluripotent stem cells may avoid these issues. Although hESCs have great 
potential for tissue engineering, their use is still limited because chondroinduction 
protocols are still being developed. 
Mesenchymal stem cells (MSCs) can differentiate into mesenchymal 
tissues such as bone, cartilage, and muscle. Unlike hESCs, MSCs are present in 
adults and are therefore easier to isolate and expand. Chondrogenic 
differentiation of MSCs has been examined in high-density pellet culture.24 
Additionally, MSCs have been studied for cartilage engineering in various types 
of scaffolds.63-65 Despite strides toward achieving chondroinduction in vitro, MSC 
culture in chondrogenic medium often resulted in chondrocyte hypertrophy.66•67 
This problem will need to be addressed prior to using MSCs for tissue 
engineering. 
Primary chondrocytes can be obtained by harvesting tissue from articular 
cartilage and then enzymatically digesting the matrix. Because immature 
chondrocytes exhibit higher metabolic activity, they are often preferred for tissue 
engineering studies.68 Passaging chondrocytes can be used to expand these 
cells. However, primary cells are preferred due to potential dedifferentiation 
during monolayer culture.69 To avoid these complications, only primary 
chondrocytes will be used for the experiments described in this proposal. 
Tissue engineering approaches 
The pressing clinical need for cartilage replacement therapy has resulted in 
various tissue engineering strategies. Although many methods have been 
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employed, most can be categorized as scaffold-based or scaffoldless 
approaches. 
Scaffold-based 
Scaffold-based tissue engineering uses a synthetic and/or natural polymer to 
create a temporary matrix for the cells to populate. This matrix degrades over 
time as the chondrocytes proliferate and deposit new matrix. To ensure effective 
neotissue formation, the scaffold needs to degrade without toxic byproducts and 
promote chondrocyte proliferation and biosynthesis. 
Collagen has been extensively employed as a scaffold for cartilage 
engineering due to its natural biocompatibility, porosity, and low immunogenicity. 
Collagen matrices have also been found to have the proper molecular cues to 
stimulate collagen production?0 The prevalence of collagen in the articular 
cartilage matrix makes collagen particularly attractive for cartilage tissue 
engineering applications; however, as with many natural biomaterials, collagen 
poses a risk for pathogen transmission. In particular, concerns have been raised 
about the increased frequency of prion diseases, which may be associated with 
collagen scaffolds. 71 
Hyaluronic acid (HA) has also been examined as a potential scaffold. One 
of the most thoroughly studied forms of HA for tissue engineering is the HA 
benzyl ester HYAFF©11. By modulating the degree of esterification, the degree 
of HA solubility and degradation can be controlled. The biocompatibility of these 
esterfied polymers has been established in various studies72•73 and they have 
been shown to produce hyaline-like cartilage in rabbit osteochondral defects.64 
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Furthermore, the clinical product Hyalograft C©, which is based on HYAFF© 11, 
has shown positive clinical outcomes in various studies. 74-76 HA has also been 
incorporated into many conventional biomaterials such as alginate gels, 77 
collagen gels, 78 and PLGA scaffolds. 79 
Fibrin has been investigated as a tissue engineering scaffold because of 
its crucial role as a provisional matrix during wound healing. During the clotting 
response, the protein fibrinogen is cleaved into fibrin. For example, using fibrin 
scaffolds to treat full thickness defects in horses significantly increased aggrecan 
levels and the proportion of collagen 11.8° Fibrin has also been employed clinically 
to treat osteochondral fractures. 81 •82 The rapid degradation of fibrin can be 
advantageous for wound healing, but reduce the mechanical integrity of the 
scaffold and thus pose problems for longer-term applications. Modulating 
parameters such as the fibrinogen concentration can be used to alter the 
mechanical properties of the scaffold.83 
Alginate is a highly biocompatible hydrogel derived from algae. A key 
advantage of alginate is its ability to be polymerized in situ, which minimizes the 
invasiveness of the implantation procedure. Alginate generally exhibits minimal 
inflammatory responses during in vivo studies, which provides a key advantage 
over agarose. 84•85 For instance, bovine chondrocytes in alginate disks that were 
implanted in nude mice for 12 weeks exhibited gross cartilage forrnation.86 
Alginate also appears to prevent dedifferentiation in long term culture: 
chondrocytes cultured for 8 months in alginate gels continued to produce 
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collagen II and aggrecan without synthesizing collagen I. 87 However, some have 
raised toxicity concerns regarding alginate.88 
Various synthetic materials have also been investigated for cartilage 
tissue engineering. poly(glycolic acid) (PGA), poly(lactic acid) (PLA) and 
copolymers of these two polymers.89•90 PLA, which is more hydrophobic, 
degrades more slowly than PGA. Hydrogels such as poly(ethylene oxide) (PEO) 
provide many of the benefits of natural hydrogels like alginate. Another study 
showed that implanting bovine chondrocytes in PEO in nude mice for 12 weeks 
resulted in neotissue with significantly higher matrix deposition and cell 
proliferation than controls. 91 These common biomaterials have been widely 
investigated for cartilage engineering applications. 
Scaffold less 
There are various scaffold less approaches including pellet culture, 92 aggregate 
culture,93 and self-assembly.94 The key advantage of these methods is increased 
cell-cell interaction, which has been shown to promote chondrocyte 
differentiation.24•95•96 Although many variations of scaffoldless culture exist, most 
of the techniques depend on high density culture to foster cell-cell interactions 
and reduce the need for a scaffold. 
One of the most common scaffoldless methods is pellet culture, which 
entails centrifuging chondrocytes to create a high density culture. Pellet culture 
has been applied to a wide range of chondrocytes including growth plate 
chondrocytes97 and hyaline chondrocytes.93 This culture method has been used 
to produce collagen networks that have the same composition and fibril sizes as 
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explant cultures.98 Additionally, pellet culture has been employed to induce 
cartilage differentiation of human adult stem cells.99 Pellet culture has also been 
studied in combination with other stimuli such as cyclic compression 100 and 
growth factors 101 However, a key limitation of this culture method is that it yields 
only one small pellet per centrifugation tube. This scaffoldless approach has 
been somewhat successful at reproducing the cartilage phenotype, but the 
restricted sizes and shapes of the constructs limits the versatility of pellet 
cultures. Self-assembly, which is scaffold less methodology focus of this proposal, 
is described in the following section. 
Self-assembly 
A novel chondrocyte self-assembly has recently been developed for cartilage 
tissue engineering.94·102 When chondrocytes are cultured at high density in non-
adherent wells, the cells aggregate to form constructs with functional properties 
approaching native values. For example, on a dry weight basis these tissue-
engineered constructs contained two thirds more GAG than native tissue. 
Collagen reached one third the level of native tissue, and the stiffness reached 
more than one third that of native tissue.94 Increases of N-cadherin expression 
during neotissue formation suggests that differential adhesion mediates self-
assembly.103 After extensive scaffold research in articular cartilage engineering, 
our group decided to develop a methodology that avoids the complications 
associated with scaffolds. Self-assembly provides numerous advantages over 
scaffolds including increased retention of phenotype, increased cell-cell contact, 
and lack of degradation products. 
---------------------
16 
A variety of mechanical and biochemical stimuli have been investigated to 
enhance self assembly. For instance, growth factors 104 
' 
hydrostatic 
pressure,57•105 and combinations of these stimuli59 have been shown to improve 
the biochemical and biomechanical properties of constructs. Although self-
assembly has improved tremendously in recent years, work still needs to be 
undertaken to achieve native tissue properties. This proposal aims to enhance 
self-assembly by applying exogenous agents that modulate the matrix 
composition and subsequently enhance functional properties. 
Thesis aims 
This thesis aims to improve self-assembly for articular cartilage tissue engineering. 
Self-assembly is a novel process that involves high-density seeding of chondrocytes in 
non-adherent molds that allows cells to form constructs. The global hypotheses that 
motivated this thesis are 1) exogenous catabolic and anabolic agents can be applied 
to modulate matrix composition and subsequently enhance the functional properties of 
self-assembled articular cartilage, and 2) administering these agents individually or in 
combination will produce differential gene expression indicative of pathways related to 
enhanced structure-function relationships in engineered constructs. 
These hypotheses were assessed by analyzing the biochemistry and 
biomechanics of constructs. In particular, creep indentation and tensile testing were 
employed to evaluate biomechanics. Immunohistochemistry, histology, and 
quantitative biochemistry of DNA, collagen, and glycosaminoglycans (GAGs) were 
used to determine the matrix composition of constructs. To evaluate gene expression, 
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microarray analysis was conducted. The following aims were employed to test the 
overall hypotheses of this proposal: 
1. To examine the effects of application frequency and TGF-~1 administration on 
chondroitinase ABC (C-ABC) treatment of self-assembled articular cartilage. 
2. To investigate the effects of exogenously adding hyaluronic acid (HA) to self-
assembled constructs. 
3. To examine the mechanisms underlying the response to HA, C-ABC, and TGF-
~1 in self-assembled articular cartilage. 
Chapters 1-2 include studies for Aim 1. Studies for Aim 2 are described in Chapters 3-
4. Mechanistic information for C-ABC and TGF-~1 is contained in Chapter 2; 
investigation of the HA mechanism of action is included in Chapter 3. Chapters 5-6 
contain additional original research studies and Chapters 7-8 are review articles. 
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Chapter 1: Effects of multiple chondroitinase ABC 
* applications on tissue engineered articular cartilage 
Abstract 
Increasing tensile properties and collagen content is a recognized need in 
articular cartilage tissue engineering. This study tested the hypothesis that 
multiple applications of chondroitinase ABC (C-ABC), a glycosaminoglycan 
(GAG) degrading enzyme, could increase construct tensile properties in a 
scaffold-less approach for articular cartilage tissue engineering. Developing 
constructs were treated with C-ABC at 2 wks, 4 wks, or both 2 and 4 wks. At 4 
and 6 wks, construct sulfated GAG composition, collagen composition, and 
compressive and tensile biomechanical properties were assessed, along with 
immunohistochemistry (IHC) for collagens type I, II, and VI, and the proteoglycan 
decorin. At 6 wks, the tensile modulus and ultimate tensile strength of the group 
treated at both 2 and 4 wks were significantly increased over controls by 78% 
and 64%, reaching values of 3.4 and 1.4 MPa, respectively. Collagen 
concentration also increased 43%. Further, groups treated at either 2 wks or 4 
wks alone also had increased tensile stiffness compared to controls. Surprisingly, 
though GAG was depleted in the treated groups, by 6 wks there were no 
significant differences in compressive stiffness. IHC showed abundant collagen 
type II and VI in all groups, with no collagen type I. Further, decorin staining was 
Chapter published in Journal of Orthopaedic Research: Natoli RM, Responte DJ, Lu BY, 
Athanasiou KA. Effects of multiple chondroitinase ABC applications on tissue engineered articular 
cartilage. J Orthop Res. 27(7): 949-56, 2009. 
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reduced following C-ABC treatment, but returned during subsequent culture. The 
results support the use of C-ABC in cartilage tissue engineering for increasing 
tensile properties. 
Introduction 
Degeneration of articular cartilage poses a significant clinical problem. The low 
regenerative capacity of cartilage limits healing, making the need for replacement 
tissue important. The primary goal of cartilage tissue engineering is to produce 
neotissue with sufficient mechanical properties to, when implanted, function in 
the native environment. 
Self-assembly of chondrocytes has shown promise for cartilage tissue 
engineering. 94• 102 In this process, chondrocytes are cultured in non-adherent 
agarose wells, and inter-cellular adhesion directs self-assembly through an N-
cadherin binding process.103 Other scaffold-less systems, such as pellet and 
aggregate culture, have also been used in cartilage tissue engineering. 92•93• 106 
Collectively, these approaches provide potential benefits over traditional scaffold-
based strategies, including increased biocompatibility and a lack of exogenous 
degradation products. Self-assembly has been studied with growth factors 107•108 
and mechanical stimulation,57•107 but efforts to-date have not produced constructs 
with tensile properties in the range of native tissue. Engineered constructs 
generally have significantly less collagen than native tissue,109-112 and an 
insufficient collagen network reduces construct functionality by impairing their 
tensile stiffness and resistance to proteases.113 One way to improve upon this 
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limitation is application of exogenous agents that modulate the matrix of the 
developing tissue. 
One potential exogenous agent is the glycosaminoglycan (GAG) 
degrading agent chondroitinase ABC (C-ABC). In a recent study, C-ABC 
treatment of cartilage explants followed by 2 wks of culture resulted in 
reconstitution of GAG content and increased tensile properties.47 Moreover, C-
ABC treatment of agarose encapsulated chondrocytes increased collagen 
concentration.48 Cartilage grown in vitro tends to lack maturational growth and 
overproduces GAGs, resulting in an imbalance between GAG and collagen 
content that reduces tissue tensile properties.49·50 Thus, using C-ABC, which 
selectively degrades chondroitin and dermatan sulfates,46 could benefit the 
matrix by restoring the balance between GAG and collagen content. 
The purpose of the present study was to elucidate the temporal effects of 
multiple C-ABC treatments on self-assembled articular cartilage constructs. To 
investigate this, constructs were treated with C-ABC at 2 wks, 4 wks, or both 2 
and 4 wks, with construct assessment at 4 and 6 wks. We hypothesized that a 
single C-ABC treatment would increase tensile mechanical properties, and that 
multiple treatments would further enhance tensile properties. Additionally, by 
allowing additional culture time post-treatment, it was expected that constructs 
treated at 2 wks would regain GAG content and compressive stiffness similar to 
untreated controls. 
Methods 
Chondrocyte isolation and culture 
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Bovine chondrocytes were isolated and self-assembled as previously 
described.94 Cartilage from the distal femur and patellofemoral groove of male 
calves (Research 87, Boston, MA) was digested in collagenase type II for 24 hrs. 
Cells were counted using a hemocytometer and then frozen at -80°C in DMEM 
containing 20% FBS and 10% DMSO. Within days, cells were thawed and 
counted. Chondrocyte viability was >90% upon thawing. Cells were then seeded 
at -5 million cells in 100 DL of media into 5 mm diameter cylindrical agarose 
wells. An additional 400 !JL of media was added 4 hrs later. Chondrogenic 
medium composed of DMEM with 4.5 mg/mL glucose and L-glutamine 
(Biowhittaker/Cambrex, Walkersville, MD), 100 nM dexamethasone (Sigma, St. 
Louis, MO), 1% fungizone, 1% penicillin/streptomycin, 1% ITS+ (BD Scientific, 
Franklin Lakes, NJ), 50 Dg/mL ascorbate-2-phosphate, 40 Dg/mL L-proline, and 
100 Dg/mL sodium pyruvate (Fisher Scientific, Pittsburgh, PA) was used for 
seeding and subsequent media changes. This chondrogenic medium formulation 
contains no FBS and no stimulatory factors other than those listed above. The 
500 D L of media were changed daily throughout the experiment. At 1 0 days, all 
constructs were transferred to tissue culture plates in which only the bottom of 
the wells was coated with a thin layer of agarose 114 and randomly assigned to 
one of the four treatment groups. Of note, separate harvests were used for the 4 
and 6 wk experiments. In the 4 wk experiment, cells from 3 distinct calves were 
used. Based on the promising results at 4 wks, a 6 wk study was then conducted. 
Cells from 4 distinct calves were used in the 6 wk study. Separate batches of 
agarose wells were also fabricated for each experiment. 
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C-ABC treatment and construct processing 
In the 4 wk experiment, constructs were treated with C-ABC at 2 wks 
(early), 4 wks (late), or 2 and 4 wks (combined). For treatment, constructs were 
exposed to C-ABC (Sigma or Associates of Cape Cod, Falmouth, MA) at an 
activity of 2 U/ml in chondrogenic media for 4 hrs at 37°C, followed by five 
washes in 400 J,JL chondrogenic media. At 4 wks, samples were prepared for 
histology, quantitative biochemistry, and mechanical testing. Hence, the late and 
combined groups did not have any recovery time post-treatment in the 4 wk 
experiment. In the 6 wk experiment, constructs were treated early, late, or 
combined, but culture duration was lengthened :to 6 wks, at which time samples 
were prepared for histology, quantitative biochemistry, and mechanical testing. 
Separate groups served as untreated controls for both experiments. Just prior to 
mechanical testing, constructs were removed from culture and processed. A 3 
mm diameter core was removed from the construct's center with a biopsy punch 
for creep indentation testing. The remaining outer ring was portioned -60% for 
biochemical analysis and -40% for tensile testing. This method of tissue 
processing tests tensile properties and assays the biochemical content of the 
outer annulus, which is presumably representative of the entire construct. 
However, any inhomogeneities that are specific to the annulus of tissue 
engineered constructs may bias the results. Indeed, inhomogeneities in tissue 
engineered articular cartilage have been observed at similar time points to those 
investigated in this study.115 However, as all specimens are prepared similarly, 
any bias is not likely to affect inter-group comparisons. 
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Gross morphology, histology, and immunohistochemistry (IHC) 
Construct diameter was measured from digital photographs using lmageJ 
(National Institutes of Health, Bethesda, MD). For histology, constructs were 
cryoembedded and sectioned at 14 J,Jm. Some sections were fixed in 10% 
phosphate buffered formalin and stained with Safranin 0/fast green for GAG 
content. For IHC, slides were first fixed with acetone at 4°C for 20 min. For 
collagens type I, II, and VI, slides were rinsed with IHC buffer, quenched of 
peroxidase activity, and blocked with horse serum for collagen type I and goat 
serum for collagens type II and VI (Vectastain ABC kit, Vector Labs, Burlingame, 
CA). Sections were then incubated for 1 hr with either mouse anti-collagen type I 
diluted 1:1000 (Accurate Chemicals, Westbury, NY), rabbit anti-collagen type II 
diluted 1 :300 (Cedarlane Labs, Burlington, NC), or rabbit anti-collagen type VI 
diluted 1:300 (US Biological, Swampscott, MA). The secondary antibody, made 
by adding one drop of stock solution is added to 10 mL of buffer in the mixing 
bottle (anti-mouse or anti-rabbit lgG, Vectastain ABC kit), was then applied for 30 
min, and color was developed using the Vectastain ABC reagent and 5 min 
exposure to DAB. For decorin, whole rabbit serum (LF-94) was a generous gift 
from the laboratory of Dr. Larry W. Fisher.116 Following fixation in cold acetone 
and peroxidase quenching, sections were treated with 0.2 U/mL protease free C-
ABC (Associates of Cape Cod) in a solution of 0.01 M Tris, 0.01 M NaCI, and 
0.012 M NaAc containing 0.1% bovine serum albumin (BSA) for 1 hr at 37°C to 
expose the core protein. Sections were then blocked with goat serum and 
incubated overnight at 4°C in the presence of LF-94 diluted 1:500 in tris-buffered 
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saline (TBS) containing 1% BSA. Finally, the secondary antibody, made as 
described above (anti-rabbit lgG, Vectastain ABC kit), was applied for 1 hr, and 
color was developed using the Vectastain ABC reagent and 5 min exposure to 
DAB. In addition to IHC staining of experimental groups, bovine articular cartilage 
was used as a positive control for collagen type II, collagen type VI, and decorin 
and as a negative control for type I collagen. Bovine tendon and bone were used 
as positive controls for collagen type I. As additional negative controls, tissues 
were stained for each protein as described above, but without application of the 
appropriate primary antibody. 
Biochemical analysis 
The portion of the sample assigned to biochemical analyses was weighed wet, 
lyophilized for 48 hrs, weighed dry, and subjected to a sequential pepsin-elastase 
digestion previously described.108 Briefly, samples were re-suspended in 0.8 ml 
of 0.05 M acetic acid containing 0.5 M sodium chloride. To this suspension, 0.1 
ml of a 10 mg/ml pepsin (Sigma) solution in 0.05 M acetic acid was added, and 
the suspension was mixed at 4°C for 96 hrs. Next, 0.1 ml of 1 Ox TBS buffer was 
added along with 0.1 ml pancreatic elastase (1 mg/ml dissolved in 1x TBS 
buffer). This suspension was mixed at 4°C overnight. Following this protocol, no 
residual neo-tissue remained. DNA content was assessed with the Quant-iT™ 
PicoGreen® dsDNA Assay Kit (Invitrogen, Carlsbad, CA). Following hydrolysis 
with 4N NaOH for 20 min at 11 0°C, collagen content of the samples was 
quantified with a modified chloramine-T hydroxyproline assay. 117 Finally, sulfated 
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GAG content was quantified using the Blyscan Glycosaminoglycan Assay kit 
(Accurate Chemical and Scientific Corp., Westbury, NY). 
Creep indentation testing 
Compressive mechanical properties were determined by creep indentation 
testing of the central 3 mm core biopsy assuming a linear biphasic model.118 
Thickness was measured using a micrometer, and specimens were attached to a 
flat stainless steel surface with a thin layer of cyanoacrylate glue. The attached 
specimen was then placed into the creep indentation apparatus, which was used 
to automatically load and unload the specimens while monitoring specimen creep 
and recovery. In the 4 wk experiment, the late and combined treatment groups 
were tested using a 0.05 g tare followed by a 0.27 g test load. These lighter loads 
allowed control over excessive deformation that resulted immediately following 
GAG removal. All other specimens were tested with a tare load of 0.2 g followed 
by a test load of 0.7 g. The loads were applied to the specimens through a 0.8 
mm diameter, flat-ended, porous tip. To determine construct mechanical 
properties, a semi-analytical, semi-numerical, linear biphasic model was 
employed,119 followed by a non-linear finite element optimization (FEO) to refine 
the solution and obtain values for the aggregate modulus, permeability, and 
Poisson's ratio. 120 To assess the appropriateness of the biphasic model for 
assessment of self-assembled tissue engineered constructs, a goodness-of-fit 
test was performed. The coefficient of determination from the FEO output and 
experimental displacement data was calculated using the following equation: 
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In this equation, yrP are the experimental displacement data, y[Eo are the 
theoretical values obtained from the FEO, and Yavgexp is the average of the 
experimental displacement data. This method has been used before to assess 
the appropriateness of several biomechanical models for articular cartilage.121 
Tensile testing 
The portion of each sample assigned to tensile testing was cut into a dog-bone 
shape and glued to paper tabs. 122 This procedure prepares specimens with 
slightly curved lateral edges from the outer annulus, which may introduce artifact 
into the testing. However, as all specimens were prepared in the same manner, 
this potential artifact would be evenly distributed. lmageJ was used to determine 
sample gauge length and width from photographs. Gauge length was defined as 
the distance between the paper tabs. Thickness was measured with a 
micrometer. Tensile tests were performed at a strain rate of 1% gauge length per 
second on a mechanical testing system (lnstron Model5565, Canton, MA). There 
was no pre-conditioning of the specimens. The lnstron monitors and records 
displacement, which when combined with gauge length, allows strain to be 
calculated. Young's modulus was determined by linear regression of the linear 
portion of the stress-strain curve based on initial cross-sectional area. The 
ultimate tensile strength (UTS) was taken to be the maximal stress prior to 
failure. 
Statistical analyses 
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Each group consisted of n = 8 samples. Two samples were randomly assigned 
for histology and IHC. The remaining six were used in the biochemical, 
compression, and tension tests. At each time point, a 2-way ANOVA based on 
main factors of treatment at 2 wks or treatment at 4 wks was performed to 
investigate additive or synergistic effects.123 Where warranted, the ANOVA was 
followed by a Student-Newman-Keuls post-hoc test on a cross of the main 
factors. Significance was set at p < 0.05. All data are presented as mean ± 
standard deviation (S.D.). 
Results 
4 wk experiment 
Figure 1-1 shows results from histology and IHC. At 4 wks, Safranin-0/fast green 
staining for GAGs showed GAG presence in the control and early treatment 
groups, and verified GAG removal in the late and combined treatment· groups. 
Staining for collagens type II and VI (data not shown for type VI) was evident in 
all constructs. With respect to collagen type VI, pericellular staining was present, 
but it was not exclusive. There was also diffuse staining throughout the construct. 
Constructs did not stain for collagen type I. Decorin stained intensely throughout 
constructs in the control and early treatment groups, but stained only on the 
perimeter of constructs in the late and combined treatment groups. 
One-time treatment at 2 wks or 4 wks was a significant factor for diameter, 
wet weight (WW), and thickness. Further, with respect to decreasing WW, the 
interaction term was significant (p = 0.03). For diameter, each group was 
significantly different from the others, except for early and combined treatments 
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being similar. Diameters measured 6.02 ± 0.17, 5.45 ± 0.07, 5.71 ± 0.18, and 
5.31 ± 0.07 mm for the control, early, late, and combined groups, respectively. 
For thickness, each group was significantly different from the others, except for 
late treatment being similar to early and combined. Thicknesses measured 0.45 
± 0.04, 0.36 ± 0.03, 0.34 ± 0.05, and 0.30 ± 0.03 mm for the control, early, late, 
and combined groups, respectively. For V'NV, each group was significantly 
different from the others, except for early and late treatments being similar. V'NVs 
measured 14 ± 1.7, 9.2 ± 0.8, 8.3 ± 1.2, and 5.5 ± 0.6 mg for the control, early, 
late, and combined groups, respectively. In terms of DNA content, treatment at 4 
wks was a significant factor. Post-hoc testing showed the combined treatment 
group had significantly less DNA than control (30 ± 5.6 J.Jg per construct 
compared to 21 ± 1.8 J.Jg). The early group had 28 ± 5.2 J.Jg and the late group 
had 26 ± 6.5 J.Jg. 
Turning to extracellular matrix (ECM) content, for both GAGIWW and 
collagen/WW treatment at 2 wks or treatment at 4 wks was a significant factor. 
Table 1-1 shows GAGIWW and collagen/WW. Post-hoc testing of GAGIWW 
showed each group was significantly different from the others, except for late 
treatment being similar to combined. Post-hoc testing of collagen/WW showed 
the combined treatment group was significantly different from all others. GAG or 
collagen per construct can be obtained by multiplying the V'NV% by the total wet 
weight. Post-hoc testing of GAG/construct was identical to GAGIWW. Post-hoc 
testing of collagen/construct showed the combined treatment group was 
significantly different from control and the late treatment groups. 
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Compressive and tensile mechanical properties were also measured. 
Treatment at 2 wks or treatment at 4 wks was a significant factor for compressive 
stiffness. The interaction term was also significant (p = 0.012). Further, treatment 
at 4 wks was as significant factor for permeability. All treatment groups were 
significantly less stiff in compression compared to control (Fig. 1-2A). Post-hoc 
testing of permeability showed an increasing trend with treatment. Permeabilities 
measured 3.11 ± 1. 73, 9.35 ± 5.92, 75.5 ± 64.6, and 86.8 ± 85.9 x 1 o-15 m4/N·s 
for the control, early, late, and combined groups, respectively. Post-hoc testing of 
Poisson's ratio showed combined treatment was significantly greater than early 
or late treatment. Poisson's ratio measured 0.093 ± 0.095, 0.035 ± 0.028, 0.054 
± 0.039, and 0.172 ± 0.097 for the control, early, late, and combined groups, 
respectively. Goodness-of-fit was assessed by calculating the coefficient of 
determination (~). There were no significant differences in ~ among the groups. 
The ~values were calculated to be 0.890 ± 0.046, 0.908 ± 0.041, 0.917 ± 0.033, 
and 0.910 ± 0.065 for the control, early, late, and combined groups, respectively. 
In terms of tensile properties, treatment at 2 wks or at 4 wks was a 
significant factor for UTS, and treatment at 2 wks was a significant factor for 
Young's modulus The interaction term was also significant for Young's modulus 
(p = 0.0008). All treatment groups had significantly greater UTS than control (Fig. 
28). Post-hoc testing of Young's modulus showed all groups were significantly 
different from each other except control and early treatment. Young's modulus 
measured 1299 ± 101, 1308 ± 257, 950 ± 284, and 1689 ± 159 kPa for the 
control, early, late, and combined groups, respectively. 
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6 wk experiment 
In the 6 wk experiment, histology and IHC results were similar to the 4 wk 
experiment, except GAG and decorin were present in the late and combined 
treatment groups (Fig. 1-1). Treatment at 4 wks was a significant factor for 
diameter, WW, and thickness. Further, with respect to decreasing diameter, the 
interaction term was significant (p = 0.046). For diameter, each group was 
significantly different from the others, except for late and combined treatment 
being similar. Diameters measured 5.27 ± 0.10, 5.14 ± 0.07, 4.99 ± 0.09, and 
5.00 ± 0.07 mm for the control, early, late, and combined groups, respectively. 
For thickness, late and combined treatments were significantly different than both 
control and early treatment, though the differences were small. Thicknesses 
measured 0.29 ± 0.03, 0.31 ± 0.03, 0.25 ± 0.04, and 0.24 ± 0.02 mm for the 
control, early, late, and combined groups, respectively. For WW, late and 
combined treatments were significantly different than both control and early 
treatment. WWs measured 5.9 ± 0.4, 5.7 ± 0.5, 4.9 ± 0.3, and 4.7 ± 0.3 mg for 
the control, early, late, and combined groups, respectively. DNA content at 6 wks 
showed a similar trend to 4 wks. Post-hoc testing showed the late and combined 
treatments had significantly less DNA than both control and early treatment. 
In terms of ECM content and mechanical properties, treatment at 4 wks 
was a significant factor for both GAG/WW and collagen/WW. Further, with 
respect to decreasing GAG/WW, the interaction term was significant (p = 0.02). 
Late or combined treatment resulted in significantly decreased GAG/WW 
compared to control or early treatment, while late or combined treatment resulted 
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in significantly increased collagenJWW compared to control (Table 1-1). Post-hoc 
testing of GAG/construct showed each group was significantly different from the 
others, except for late treatment being similar to combined. There were no 
significant differences in collagen/construct. 
In terms of compressive properties, treatment at 4 wks was a significant 
factor (p = 0.048) for compressive stiffness (Fig. 1-3A). There were no significant 
differences in aggregate modulus among the four groups. Post-hoc testing of 
permeability and Poisson's ratio also showed no significant differences among 
the groups. Permeabilities measured 19.7 ± 19.8, 17.6 ± 16.9, 15.7 ± 8.5, and 
20.7 ± 12.7 x 10-15 m4/N·s for the control, early, late, and combined groups, 
respectively. Poisson's ratio measured 0.138 ± 0.11 0, 0.085 ± 0.119, 0.072 ± 
0.033, and 0.133 ± 0.112 for the control, early, late, and combined groups, 
respectively. As seen at 4 wks, there were no significant differences among the 
groups for f2 values, which were 0.936 ± 0.031, 0.930 ± 0.028, 0.911 ± 0.054, 
and 0.907 ± 0.094 for the control, early, late, and combined groups, respectively. 
For tensile properties, treatment at 2 wks or at 4 wks was a significant 
factor for Young's modulus, and treatment at 4 wks was a significant factor for 
UTS. All treated groups had significantly greater Young's modulus than control 
(Fig. 1-38). Additionally, the combined treatment group was greater than early or 
late treatment. Post-hoc testing of UTS showed the control and early treatment 
group were not significantly different, and the late and combined treatment 
groups were not significantly different. All other comparisons were significantly 
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different. UTS measured 881 ± 181, 984 ± 143, 1343 ± 169, and 1441 ± 184 kPa 
for the control, early, late, and combined groups, respectively. 
Discussion 
In this study, we examined the effects of multiple C-ABC applications on self-
assembled tissue engineered articular cartilage constructs. Results showed that 
the group treated at both 2 and 4 wks (combined) had significantly greater tensile 
properties (ultimate tensile strength and Young's modulus) than control in both 
the 4 and 6 wk experiments, reaching a stiffness of 3.4 MPa at 6 wks. Further, 
treating at 2 wks (early) or at 4 wks (late) alone resulted in significantly greater 
ultimate tensile strength at 4 wks, and significantly greater Young's modulus at 6 
wks, compared to controls at these time points. Though compressive stiffness of 
all treatment groups was less than control in the 4 wk experiment, there were no 
significant differences at 6 wks. These results support our hypotheses that 
multiple C-ABC treatments would further enhance tensile properties compared to 
a single treatment, and, given longer culture time post-treatment, the early 
treatment group would not have a significantly different compressive stiffness 
compared to untreated controls. 
An interesting result of this study is that the compressive properties of all 
C-ABC treated groups were not significantly different from controls at 6 wks. 
Furthermore sulfated GAG returned following depletion in the early treatment 
group over 4 wks of culture. Additionally, though given only 2 wks of culture post-
treatment, compressive stiffness at 6 wks of the late and combined treatment 
groups was not significantly different from controls, despite significantly 
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decreased sulfated GAG content. This is potentially explained by the significantly 
increased collagen content in these groups compared to control, reaching 23% 
by 'JWt./. Indeed, collagen has been shown to have a role in the compressive 
behavior of articular cartilage. One study performed confined compression with 
the expectation that compressions greater than 5% would lead to the full load 
being borne by the proteoglycan osmotic pressure, evidenced by equal stresses 
in the axial and radial directions. However, it was found that the axial and radial 
stresses were not equal, highlighting a role for the collagen network in 
compression. 124 Williamson et a/. 125 examined bovine cartilage compressive 
properties as a function of age, showing that the compressive modulus increased 
180% from fetus to adult. This increase correlated with increased collagen during 
development, as GAG content changed negligibly. These findings underscore the 
concept that construct material properties reflect the balance of ECM 
components, and both collagen and GAG contribute to compressive stiffness. 
Analysis of compressive testing data also revealed that the liner biphasic 
theory well predicts the compressive behavior of self-assembled articular 
cartilage constructs. This claim is supported by the relatively high coefficients of 
determination that were calculated by comparing the experimental displacement 
data to the theoretical output of the FEO. The lowest fl calculated was 0.89. This 
is surprisingly good considering the relative simplicity of the linear biphasic 
theory. More complicated theories for the biomechanical behavior of articular 
cartilage, such as the biphasic-CLE-QL V model, 121 have achieved fl values of 
0.95 and 0.97 for confined and unconfined compression testing, respectively. It is 
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likely that these models would also better predict the behavior of self-assembled 
tissue engineered articular cartilage; however, it is not yet clear if self-assembled 
cartilage exhibits non-linear behavior for the same reasons or in the same 
proportions that native tissue articular cartilage does. As the permeability in linear 
biphasic theory captures these behaviors, the permeability values should be 
interpreted in this light, and not necessarily as the intrinsic permeability of the 
engineered constructs, which can only be properly measured through direct 
permeation experiments. As self-assembled constructs are further studied and 
become more robust, more detailed assessments of their biomechanical 
behavior can be made. 
Moreover, the results of this study show C-ABC treatment increases 
construct tensile properties. At 4 wks, the increase in tensile properties may be 
attributed to substantially decreased construct size (e.g., thickness) resulting 
from loss of GAG and its associated water or to increased ability of collagen to 
rearrange in the absence of a pre-stress generating swelling pressure.126•127 
However, as GAG returns, differences in construct size at 6 wks were markedly 
reduced. This suggests increased collagen concentration could be responsible 
for the increased tensile properties. Kempson et a/. 128 have shown that the 
tensile properties of articular cartilage are correlated to collagen content. 
However, another interesting possibility raised by results from this study is a role 
for the small proteoglycan decorin. Decorin is known to interact with type II 
collagen and has key roles in collagen fibrillogenesis, such as limiting fiber 
diameter.6•129 For example, fibroblasts seeded onto collagen scaffolds from 
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decorin knockout mice have been shown to increase scaffold tensile properties 
compared to wild-type cells.130 The decrease in decorin evident by IHC staining 
shown immediately post-treatment in the present study may allow larger diameter 
collagen fibers to be formed or previously blocked interactions between 
neighboring collagens to take place, both of which could lead to a more 
functional collagen network and increased tensile properties. This proposition is 
similar to a recently described mechanism whereby selective knockdown of the 
small proteoglycan lumican led to increased collagen deposition and fibril 
diameter in a polyglycolic acid scaffold based approach to cartilage engineering 
employing bovine nasal chondrocytes. 110 In addition to decorin and lumican, 
aggrecan and biglycan have a role in the observed changes. Selective 
modulation of small, regulatory matrix molecules could be an important 
consideration for future articular cartilage tissue engineering experiments. 
In addition to self-assembly, other scaffold-less culture systems for 
engineering cartilage replacement tissue have been studied.131-136 One study 
showed that human articular chondrocytes grown in serum free conditions exhibit 
an age-dependent ability to produce neo-tissue.131 However, mechanical 
properties were not assessed. Fedewa et al.132 plated rabbit articular 
chondrocytes at a concentration of 2 million cells per 25 cm2 and cultured them 
for up to 1 0 wks. Chondrocytes grew into cell sheets up to 130 J,Jm thick and 
produced collagens type II, IX, and XI, indicating that cell phenotype was not 
affected. At 10 wks, the engineered tissue's tensile stiffness was 1.3 MPa. 
Stiffness was further increased to 3.4 MPa by treatment with interleukin-1f3, but 
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the cell sheet thickness decreased to only 38 IJm. Using the same culture 
system, it was shown that increased construct tensile stiffness correlated with 
greater collagen volume fraction 136 and that bonds formed among collagen 
fibrils. 135 In the present study, greater construct collagen concentration was also 
related to increased tensile stiffness. Further, it is possible that interfibrillar 
collagen bonds formed upon GAG depletion with C-ABC. This possibility should 
be assessed in future studies. 
Another study used the plated chondrocyte culture system to assess the 
effects of proteoglycans on construct tear toughness. 134 C-ABC was used to 
remove GAG from the cell sheets at 8 wks, followed by tensile tear testing. C-
ABC treatment decreased the thickness of grown tissue, and material tear 
toughness was increased upon GAG removal, but not when adjusted for collagen 
content. The authors concluded that proteoglycans were not a determining factor 
of the grown tissue's fracture toughness. Finally, Gemmiti and Guldberg 133 
demonstrated that exposure of scaffold-less grown engineered cartilage to fluid 
flow-induced shear stress causes increased total and type II collagen. These 
increases in collagen were mirrored by increased tensile properties, reaching a 
stiffness of 2.28 MPa at 17 days. Despite these efforts, the tensile stiffness of 
engineered articular cartilage remains low compared to native tissue. Further 
research into methods for increasing tensile properties of scaffold-less grown 
tissue engineered cartilage remains necessary. 
In summary, C-ABC treatment is a promising approach for increasing 
tensile properties of self-assembled tissue engineered cartilage, perhaps by 
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inducing maturational instead of expansive growth,47 whereby construct size 
changes minimally while ECM continues to be deposited. A potential limitation to 
scaffold-free approaches is less control over construct thickness, which is further 
affected by C-ABC treatment. However, construct size could be increased before 
treatment by using more cells 137 or allowing additional culture time before C-ABC 
application. Using the self-assembly process, our laboratory has grown 
constructs greater than 1 mm thick, 107 though there is considerable biological 
variability. In conclusion, as hypothesized, treatment with C-ABC at both 2 and 4 
wks resulted in further enhancement of tensile properties compared to a single 
treatment at 2 or 4 wks. Future experiments should probe more deeply into the 
mechanism as to how temporary proteoglycan depletion affects the collagen 
network of tissue engineered constructs by examining aspects such as fiber size 
and degree of cross-linking. 
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Table 1-1: Construct GAG and collagen content normalized to wet weight. 
4wks 6wks 
GAGIV'NJ Collagen I V'NI GAGIV'NI Collagen I V'NI 
Group (%) (%) (%) (%) 
Control 6.9 ± 1.88 8.9±2.1 8 6.3 ± o.Ef' 16±2.1" 
C-ABC@2 
wks 4.4 ±0.8b 19 ± 3.1 8 5.5 ± 1.1A 20 ± 4.3A•8 
C-ABC@4 
wks 3.1 ± 1.7c 17 ± 3.48 2.7 ± 0.58 24 ± 3.98 
C-ABC @2 &4 
wks 1.6 ± 0.8c 38 ± 15b 3.3 ± 0.48 23 ± 2.08 
Values in table are mean ± S.D. (n = 6). V'NI = wet weight. Separate statistical 
analyses were run on each column. Within a column, groups not sharing a similar 
letter are significantly different from one another (p < 0.05 by Student-Newman-
Keuls post-hoc test). At 6 wks, the groups that had been treated at 4 wks 
contained significantly less sulfated GAGMNV, but significantly more 
collagenMNV, than control. 
Figure 1-1: Histology and IHC 
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Coli Colli 
Coli Colli 
A-H) Safranin-0/fast green stain for GAGs, 1-P) IHC for decorin, a-h) IHC for 
collagen type I, and i-p) IHC for collagen type II. At 4 wks, note the absence of 
GAG and substantially decreased decorin staining immediately following C-ABC 
treatment in the group treated at 4 wks and group treated at both 2 and 4 wks (C, 
D, K, and L, respectively) . GAG and decorin staining returned in these groups by 
6 wks (G, H, 0, and P, respectively). Scale bar in Pis 2001Jm. 
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Figure 1-2: Four week biomechanical properties 
Compressive Stiffness and Tensile Strength for the 4 week Experiment 
A) Compressive Stiffness B) Tensile Strength 
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A) Compressive stiffness and B) ultimate tensile strength. Bars represent mean± 
S.D. Groups not connected by the same letter are significantly different. The 
aggregate modulus of all treated groups was significantly less than control. The 
ultimate tensile strength of all treated groups was significantly greater than 
control, reaching 931 ± 155 kPa in the combined group. The group treated at 
both 2 and 4 wks was significantly greater than the groups treated at only 2 or 4 
wks. 
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Figure 1-3: Six week biomechanical properties 
Construct Stiffness for the 6 week Experiment 
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A) Compressive stiffness and B) tensile stiffness. Bars represent mean ± S.D. 
Groups not connected by the same letter are significantly different. There were 
no significant differences in aggregate modulus. Young's modulus of all treated 
groups was significantly greater than control, reaching 3.4 ± 0.5 MPa in the 
combined group. Further, the group treated at both 2 and 4 wks was significantly 
greater than the groups treated at only 2 or 4 wks, which measured 2.4 ± 0.4 and 
2.6 ± 0.5 MPa, respectively. 
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Chapter 2: Mechanisms underlying the synergistic 
enhancement of self-assembled neocartilage treated 
with chondroitinase-ABC and TGF-J31* 
Abstract 
Developing a platform for in vitro cartilage formation would enhance the study of 
cartilage development, pathogenesis, and regeneration. Promoting maturational 
growth of the matrix and achieving native biomechanical properties are major 
challenges of current in vitro cartilage growth efforts. To improve neocartilage 
formation, our group developed a novel self-assembly process for articular 
chondrocytes, which has been improved in this study using a novel combination 
of catabolic and anabolic agents. TGF-J31 was applied in conjunction with the 
enzyme chondroitinase-ABC (C-ABC) to additively increase tensile properties 
and synergistically enhance collagen content. Additionally, microarray analysis 
indicated that TGF-J31 up-regulated MAPK signaling in contrast to C-ABC, which 
did not enrich genetic pathways. The lack of genetic signaling spurred 
investigation of the biophysical role of C-ABC, which showed that C-ABC 
treatment increased collagen fibril diameter and density. After four weeks of 
culture in nude mice, neocartilage treated with C-ABC and TGF-J31 exhibited 
stability and maturation. This study illustrates an innovative strategy for improving 
in vitro and in vivo articular cartilage formation and elucidated mechanisms 
• Responte DJ, Natoli RM, Athanasiou KA. Synergistic effects of chondroitinase ABC and TGF-131 
on tissue engineered articular cartilage. Nature Biotechnology (in preparation) 
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underlying TGF-131 and C-ABC treatment based on genetic pathways and 
biophysical mechanisms, respectively. 
Introduction 
Articular cartilage is crucial to proper joint function, providing a wear-resistant, 
low-friction surface covering the articulating surfaces of bones. Cartilage is 
largely acellular and relies on its extracellular matrix, which is predominantly 
composed of collagen and glycosaminoglycans (GAGs), to provide mechanical 
integrity. The matrix of cartilage contains aggrecan complexes with GAGs and an 
organized collagen network, both of which contribute to the tissue's 
biomechanics. Recapitulating the biomechanical and biochemical properties of 
native tissue has remained elusive despite decades of research. An effective 
method for in vitro grown cartilage would greatly advance the study of cartilage 
disease, regeneration, and development. 
A novel self-assembly approach, which uses high density cell culture to 
promote chondrocyte aggregation, recapitulates cartilage development and 
produces robust neocartilage.94•102 Various strategies have been employed to 
overcome deficiencies of de novo cartilage such as overabundance of GAGs49·50 
and tensile properties below those of native tissue. 138 For instance, applying 
exogenous stimuli such as growth factors, 104 hydrostatic pressure,57·105 and 
combinations of these stimuli59 has improved the functional properties of self-
assembled neocartilage. These developments highlight the potential of 
employing exogenous stimuli to enhance the self-assembly process. 
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The enzyme chondroitinase-ABC (C-ABC), which depletes 
glycosaminoglycans (GAGs), provides an innovative method for inducing 
maturational growth. Because in vitro cartilage generally overproduces 
glycosaminoglycans (GAGs),49•5° C-ABC has been investigated as a method of 
promoting matrix maturation. For example, treating cartilage explants with C-ABC 
and culturing for an additional 2 weeks increased tensile properties.47 C-ABC 
treatment of chondrocytes seeded on agarose hydrogels increased the collagen 
concentration and tensile properties of constructs. 139 Furthermore, both 
single11 •12 and multiple14° C-ABC treatments have been employed to increase the 
tensile properties of self-assembled neotissue without compromising 
compressive properties. These results suggest that C-ABC is an exciting new 
method for improving in vitro cartilage growth. 
TGF-131 has also been investigated for its beneficial effects on cartilage 
growth. For instance, administering TGF-13 increased GAG deposition in three-
dimensional cultures of equine chondrocytes,29 rabbit chondrocytes,30 and bovine 
articular chondrocytes.31 Additionally, administering TGF-131 to self-assembled 
cartilage enhanced GAG and collagen production and concomitantly increased 
compressive and tensile properties.39 TGF-131 has also been employed in 
conjunction with hydrostatic pressure 59 and direct compression 141 to enhance the 
functional properties of neocartilage. These studies illustrate the ability of TGF-131 
to enhance both the matrix composition and biomechanical properties of in vitro 
cartilage. 
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This study used a combination of C-ABC and TGF-(31 treatments to 
integrate anabolic and catabolic strategies for enhancing cartilage formation. The 
objectives of this study were to 1) assess the effects of combining TGF-(31 and 
C-ABC treatment on self-assembled neocartilage, 2) investigate potential 
mechanisms underlying the response to these stimuli, and 3) evaluate the in vivo 
response of neotissue treated with TGF-(31 and C-ABC. This study tested the 
hypotheses that 1) TGF-(31 administration will act synergistically with C-ABC to 
increase tensile properties and collagen content of self-assembled neotissue, 2) 
C-ABC and TGF-(31 will up-regulate functionally-relevant molecular signaling 
pathways, and 3) self-assembled neocartilage will exhibit stability and maturation 
in vivo. To test these hypotheses, we employed a full factorial design of factor C-
ABC (no treatment, treatment at 2 weeks) and factor TGF-(31 (no treatment, 
treatment during weeks 1&2 (continuous), treatment during weeks 1&3 
(intermittent). The biomechanics, biochemical content, gene expression, collagen 
ultrastructure, and in vivo properties of neotissue were assessed. 
Results 
C-ABC and TGF-/31 treatments maintain native cartilage phenotype 
Neocartilage was assessed at 4 weeks via histology and morphology to assess 
the gross properties and composition of the neotissue (Fig. 1). All constructs, 
which originated from 5 mm wells, showed no contraction and exhibited the 
following diameters: 5.97±0.16, 5.10±0.08, 5.32±0.11, and 5.03±0.09 mm for 
control, C-ABC, TGF-(31, and combined treatments, respectively. Both treated 
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and control neotissue exhibited uniform staining for GAGs and total collagen. 
Additionally, IHC showed that all constructs stained positive for collagen II but 
negative for collagen I. The presence of collagen II, GAGs, and total collagen but 
not collagen I demonstrates that both control and treated groups maintained 
normal cartilage phenotype. 
Combining C-ABC and TGF-~1 treatment synergistically enhances collagen 
content 
To investigate maturational growth of the matrix, the amount of collagen and 
GAGs was quantified at 4 weeks. GAG content (Fig. 2d) was highest for growth 
factor only groups, which exhibited values of 7.0±0.8%, 8.5±0.5%, and 9.2±0.8% 
for control, continuous TGF-(31, and intermittent TGF-(31, respectively. Groups 
treated with C-ABC had lower GAG contents except for the intermittent TGF-(31 
group, which was not statistically different than the control value. Combined 
treatment synergistically increased collagen content (Fig. 2c), reaching 
18.6±1.9% and 16.2±1.1% for continuous and intermittent TGF-(31 treatment, 
respectively. These results showed that combining TGF-(31 and C-ABC 
synergistically promotes maturation of matrix composition. 
Combined treatment additively increases tensile properties and promotes 
recovery of compressive stiffness 
To quantify the influence of C-ABC and TGF-(31 on biomechanics, the aggregate 
modulus in compression and Young's modulus (Ev) in tension were determined. 
The compressive stiffness was highest for groups treated with intermittent TGF-
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f31 (Fig. 2b), which attained values of 170±22 kPa and 190±45 kPa when treated 
with and without C-ABC, respectively. The aggregate modulus was lower for 
continuous TGF-f31 treatment and lowest for groups receiving no TGF-f31 
treatment. The higher compressive stiffness for intermittent TGF-f31 treatment 
suggested that week 3 growth factor administration aided the recovery of 
compressive properties following C-ABC treatment, which initially results in 
negligible residual compressive stiffness following treatment due to GAG 
depletion. Enhanced mechanical properties reflected the observed changes in 
biochemical composition. 
Tensile testing showed that combining C-ABC and TGF-f31 treatments 
additively increased the tensile stiffness. Tensile stiffnesses were 0.89±0.22, 
1.33±0.23, 1.51±0.29, and 1.40±0.12 MPa for control, C-ABC, continuous TGF-
f31, and intermittent TGF-f31 treatments, respectively. Young's moduli were 
highest for combined treatments, which reached 1.95±0.21 MPa and 1.83±0.38 
MPa for continuous and intermittent treatment, respectively (Fig. 2a). The tensile 
stiffnesses for C-ABC in combination with TGF-f31 showed additive increases 
when compared to individually applied stimuli. 
Construct properties are on par with native tissue 
A functionality index (FI) was developed to quantify the similarity between 
neocartilage and native tissue, which was also tested as a positive control. As 
shown in Eq. 1, the Fl equally weights the compressive stiffness (Ec), tensile 
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stiffness (ET), GAG content (G), and collagen content (C). The subscripts 'nat' 
and 'sac' represent values for native and self-assembled cartilage, respectively. 
The Fl yields a score of 1 when neocartilage properties are equivalent to those of 
native tissue. Fl values were 0.41, 0.52, 0.78, and 0.84 for control, C-ABC, 
intermittent TGF-J31, and combined treatments, respectively. These Fl values 
suggest that combined treatment produces neotissue closest to native cartilage. 
TGF-J31 up-regulates MAPK signaling 
To elucidate the mechanisms underlying the effects of C-ABC and TGF-J31 on 
cartilage formation, microarray analysis was conducted at 2 weeks for control, C-
ABC, continuous TGF-J31, and combined treatment. The number of differentially 
expressed genes relative to control neotissue was 191, 548, and 537 for C-ABC, 
TGF-J31, and combined treatments, respectively. To understand gene expression 
changes on a more functional level, we used these differentially expressed gene 
lists to determine if any genetic pathways were enriched. 
For both TGF-J31 treatments, the only significantly enriched pathway was 
MAPK signaling, which was observed for TGF-J31 treatment (19 genes, p = 
0.0003) and combination treatment (19 genes, p = 0.00005). There was 
substantial overlap between the MAPK genes differentially regulated by TGF-J31 
and combination treatments, with each group only having one distinct gene 
(Table 1). Both groups showed up-regulation of MAPK intermediates relating to 
p38 signaling including MAPKK3, MAP3K5, MAP3K6, and MAPK13. In addition, 
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in both groups receiving TGF-~1 treatment TGF-~1 was up-regulated, while TGF-
~3 and TGF-~ receptor type II were down-regulated. The differential regulation of 
TGF-~1 and its receptor could suggest a feedback mechanism in response to 
TGF-~1 treatment. The enriched MAPK signaling observed for both groups 
receiving growth factor treatment could play a role in the observed increases in 
matrix production, which could subsequently enhance the mechanical properties 
of the neocartilage. 
In contrast to TGF-~1 administration, C-ABC treatment did not significantly 
enrich genetic pathways. The number of differentially regulated genes was also 
substantially lower for C-ABC treatment, which only altered the expression of 
approximately 35% as many genes as TGF-~1 application. Furthermore, the 
TGF-~1 and combined treatments had nearly identical gene expression patterns, 
both in terms of the number of genes and specific genes that were differentially 
expressed. The lower number of differentially expressed genes and lack of 
enriched pathways suggested that C-ABC did not influence gene expression 
significantly, in contrast to the response to the TGF-~1 treatments. 
To validate microarray data, real time PCR was employed to quantify the 
expression of intermediates involved in MAPK signaling including MAP3K5, 
MAPK13, protein tyrosine phosphatase (PTP), and MAP2K3 (Fig. 3). Both TGF-
~1 alone and combination treatments increased the expression of MAPK13, 
protein tyrosine phosphatase (PTP), and MAP2K3 while down-regulating 
MAP3K5. Additionally, the relative gene expression values were significantly 
lower for C-ABC, suggesting that TGF-~1 treatment altered the expression of 
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MAPK intermediates more so than C-ABC. These expression trends mirrored the 
microarray data. 
C-ABC plays a biophysical role 
The lack of genetic effects due to C-ABC treatment prompted further 
investigation of the role of C-ABC. It was hypothesized that C-ABC acted via a 
biophysical mechanism to influence tensile properties. Specifically, because 
collagen plays a major role in the tensile properties of cartilage, we considered 
that C-ABC was modulating the collagen network at the biophysical level, 
subsequently enhancing tensile properties. Several aspects of the collagen 
network contribute to its mechanics including fibril organization, fibril diameter, 
and post-translational modifications such as pyridinoline crosslinking. Polarized 
light microscopy showed that C-ABC did not produce any detectable collagen 
organization (data not shown). Because C-ABC did not appear to be promoting 
collagen orientation, we decided to also investigate collagen fibril diameters. 
Our previous work showed that C-ABC treatment depletes the small 
proteoglycan decorin, 138 which inhibits fibril growth, so it was hypothesized that 
C-ABC application would increase collagen fibril diameter. Control, intermittent 
TGF-131, C-ABC, and combined treatments were imaged using SEM at 4 weeks 
(Fig. 4a). SEM image analysis showed that mean fibril diameters were 43.3±8.6 
nm, 40.1±6.2 nm, 64.4±7.8 nm, and 59.2±4.3 nm for control, TGF-131, C-ABC, 
and combined treatments, respectively (Fig. 4b). These values corresponded to a 
50% increase in fibril diameter due to C-ABC treatment. TGF-131 treatment alone 
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did not significantly alter fibril diameter. Similar trends were observed for the 
density of fibrils, which was computed as the percent area occupied by collagen. 
Fibril density increased by 36% and 29% following C-ABC and combined 
treatments, respectively. These results indicated that C-ABC treatment was 
increasing fibril diameter and density, while TGF-~1 treatment did not have a 
significant influence. 
Constructs treated with C-ABC and TGF-{31 exhibit in vivo stability and 
maturation 
To assess any changes in morphological, biochemical, or biomechanical 
properties following in vivo culture, neotissue (grown for 4 weeks in vitro and 
treated with C-ABC and intermittent TGF-~1) and native cartilage controls were 
implanted subcutaneously in athymic mice. Mice were sacrificed at 4 weeks after 
implantation (8 weeks total neotissue growth) and all samples were removed 
without complications. Both neocartilage and explants exhibited a cartilage 
phenotype as evidenced by histological analysis (Fig. 5a). Although both 
constructs and explants had the same diameters upon implantation, explants 
showed lower diameters and increased thicknesses post-sacrifice. Post-sacrifice 
diameters were 4.9±0.16 mm and 5.8±0.09 mm for explants and neocartilage, 
respectively. Respective thicknesses for explants and neocartilage were 
1.82±0.14 mm and 1.25±0.07 mm. 
Neocartilage constructs exhibited both biochemical and biomechanical 
maturation in vivo. Post-sacrifice explant tensile stiffness decreased {p=0.02) and 
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the aggregate modulus remained unchanged (Fig. 5b, 5d). For constructs, tensile 
stiffness was significantly higher post-sacrifice (p=0.01 ), exhibiting 3.15±0.47 
MPa compared to 1.95±0.62 MPa (Fig. 5b). Increased collagen content (Fig. 5c) 
paralleled the increased tensile properties: collagenlww was 12.5±1.8% and 
19.0±2.3% for pre-implantation post-sacrifice groups, respectively. Although 
GAG content and compressive stiffness did not increase for explants, post-
sacrifice neocartilage exhibited enhanced GAG content (Fig. 5e) and increased 
compressive stiffness (Fig. 5d). These results showed that self-assembled 
neocartilage matures in vivo, further enhancing the effects noted in vitro. 
Discussion 
This is the first study to examine the mechanisms underlying dual anabolic and 
catabolic treatments for enhancing articular cartilage formation. Results 
confirmed our hypothesis that combining these agents (C-ABC and TGF-(31) 
would further enhance tensile properties compared to either treatment acting 
alone. Novel contributions of this study include demonstrating 1) C-ABC and 
TGF-(31 can be applied to synergistically enhance neotissue formation, 2) TGF-
(31 can be applied to aid the recovery of compressive stiffness following C-ABC 
treatment, 3) TGF-(31 increases MAPK signaling in self-assembled neocartilage, 
4) C-ABC treatment increases collagen fibril diameter and density, and 5) 
neocartilage exhibits stability and maturation in vivo. 
Neotissue treated with both TGF-(31 and C-ABC exhibited in vitro 
maturation, attaining biochemical and biomechanical properties approaching 
native values. This is particularly exciting for collagen content and tensile 
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properties, which are typically lower for in vitro cartilage. 142 For combined 
treatment groups, the collagen content spanned adult values for both human and 
bovine cartilage,21 •22 indicating that TGF-131 and C-ABC help recapitulate 
cartilage development. The additive increase of Young's modulus coupled with 
synergistic increases in collagen content showed the promise of applying TGF-131 
and C-ABC in combination. Collectively, these results indicated that dual 
treatment promoted in vitro cartilage development, producing neocartilage on par 
with native tissue, as evidenced by the higher functionality index. 
Growth factor treatment during week 3 also promoted the recovery of 
compressive stiffness following C-ABC treatment, which was a concern from 
prior work.51 •138 In addition, intermittent TGF-131 treatment combined with C-ABC 
treatment expedited the recovery of compressive properties and supplemented 
improvements to construct collagen content and tensile properties seen with C-
ABC treatment alone. The contribution of TGF-131 to compressive recovery 
following C-ABC treatment showed how an anabolic agent can be employed to 
overcome one of the challenges associated with C-ABC. This reinforced the 
benefits of combining anabolic and catabolic agents during neotissue formation. 
Microarray analysis showed that TGF-131 up-regulated MAPK signaling via 
p38, suggesting that this is the primary mechanism of TGF-131 signaling in self-
assembled neocartilage. Other work has shown that inhibiting p38 MAPK 
signaling in chondrocytes represses TGF-131 gene expression in a dose-
dependent manner.27 Similarly, inhibiting p38 MAPK activity reduced TGF-13-
induced proteoglycan synthesis in articular chondrocytes, 143 showing that p38 
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signaling influences biosynthesis. Various studies also showed the role of p38 
signaling in chondrogenesis, which was suppressed by p38 inhibition.144 
Furthermore, inhibition of chondrogenesis using epidermal growth factor145 or 
retinoic acid146 both corresponded with reduced p38 activity, reinforcing the role 
of p38 in cartilage development. These studies highlight the developmental and 
biosynthetic role of p38 signaling in chondrocytes, which could explain the 
increased GAG and collagen contents observed in self-assembled neotissue 
treated with TGF-~1. 
C-ABC has been employed to induce maturational growth during cartilage 
formation,51 •138•139 but its mechanism has not been previously interrogated. Unlike 
TGF-~1, C-ABC treatment does not appear to enrich functionally relevant 
pathways, suggesting that it did not significantly alter gene expression. The 
similarity between the gene expression profiles of TGF-~1 and combined 
treatments reinforced the minimal influence of C-ABC on genetic signaling. 
Although it is conceivable that C-ABC could indirectly alter gene expression by 
modulating the bioavailability of signaling molecules or reducing the abundance 
of matrix molecules that interact with chondrocytes, these effects did not appear 
to be predominant in self-assembled constructs. Increased tensile properties due 
to C-ABC treatment without gene expression changes suggested that C-ABC 
could have a biophysical mechanism. 
Indeed, SEM analysis identified a potential biophysical mechanism 
underlying C-ABC treatment by illustrating increased collagen fibril diameters. 
The increased fibril diameters noted with C-ABC treatment, which parallel the 
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fibril growth that occurs as cartilage matures, 142 show that C-ABC promotes 
maturation of the collagen network. Fibril diameters of C-ABC treated constructs, 
which were 59±4.3 nm, are on par with the native tissue values of 30-80nm.147•148 
In addition, fibril diameter has been shown to influence the stiffness of collagen 
fibers, 149 which supports the hypothesis that the increased Young's modulus 
following C-ABC administration relates to fibril diameter, in addition to increased 
collagen content. This finding also suggests that exciting new strategies such as 
altering decorin expression could be employed to alter the collagen network. It is 
well known that small leucine-rich proteoglycans impact collagen fibrillogenesis, 
so they offer a rich new area of research for improving neocartilage. 
This study also was the first to show that self-assembled cartilage can 
mature in vivo. Interestingly, explant tensile properties decreased while 
neocartilage properties increased. Other work has shown that cartilage explants 
can swell and subsequently demonstrate reduced tensile properties,150 which 
could explain why the explants were less stiff and had increased thicknesses. 
The improved neocartilage properties could result from the nutrient rich 
environment that in vivo environments provide, which has been shown to 
improve the properties of implanted engineered tissue. 151 Because the 
neocartilage was significantly more cellular than native tissue, it could have had a 
more pronounced response to in vivo nutrients and growth factors. The increased 
biochemical and biomechanical properties, without concomitant swelling or 
contraction, suggest that self-assembled cartilage can develop in vivo. 
56 
This study showed how anabolic and catabolic agents can be combined to 
promote in vitro and in vivo neocartilage maturation. TGF-131 application 
increased MAPK signaling, which could be responsible for increased 
biosynthesis and the observed increases in matrix composition. Additionally, this 
is the first study to identify a potential mechanism for the effects of C-ABC on 
enhanced cartilage formation. The two distinct mechanisms underlying C-ABC 
and TGF-131 treatments could help explain the synergistic effects of combining 
these agents. Based on the maturation that constructs displayed when implanted 
in mice, in vivo culture presents an exciting opportunity for improving de novo 
cartilage formation. Future experiments could further investigate the mechanisms 
underlying the effects of these stimuli and examine the response of self-
assembled neocartilage in larger animal models. 
Methods 
Neocartilage culture 
Immature bovine chondrocytes were harvested and cultured as described 
previously.94 For C-ABC treatment, constructs were treated with C-ABC (Sigma) 
at an activity of 2 U/ml in chondrogenic medium for 4 hours.47 TGF-131 
(Peprotech) was administered daily media at 30 ng/ml. At 4 weeks, constructs 
were prepared for biochemistry, histology, and biomechanics. 138 
Quantitative biochemistry 
Samples were frozen at -20°C for 24h and then lyophilized for dry weight 
determination. Subsequently, a pepsin and elastase protocol138 was used to 
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digest each sample. A Blyscan Glycosaminoglycan Assay kit (Accurate Chemical 
and Scientific Corp.) was used to quantify sulfated GAG content. Collagen 
abundance was determined using chloramine-T based assay.117 
Histology 
Samples were cryoembedded and sectioned at 12 1Jm. Histology samples were 
fixed in formalin and then stained with Safranin-0/fast green and Picrosirius Red 
as described previously.138 For IHC, samples were fixed in 4°C acetone and 
stained for collagen II or collagen 1. 138 
Mechanical testing 
A creep indentation apparatus 152 was used to quantify compressive properties. 
Samples were tested as described previously138 using a semi-analytical, semi-
numeric, biphasic model118 and finite element optimization153 to yield each 
sample's aggregate modulus. For tensile testing, dermal punches were used to 
create dog-bone shaped samples.122 A material testing system (lnstron Model 
5565) was used to apply uniaxial tension.138 The slope of the linear portion of 
each stress-strain curve was reported as the Young's modulus (Ev). 
Scanning electron microscopy (SEM) 
SEM was performed for control, intermittent TGF-131, C-ABC, and combined 
intermittent TGF-131 and C-ABC groups. Samples were fixed in 3% 
glutaraldehyde for 12h at 4 oc and then dehydrated in an ascending series of 
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ethanol. Samples were subsequently critical point dried and sputter coated with 
gold prior to imaging. Three locations were used for each sample and n=3. For 
each image, a 4x4 grid was drawn and three squares were randomly chosen 
from each image for diameter quantification using lmageJ. To quantify density, 
the lmageJ threshold function was used to set threshold limits. The measure 
function was then used to compute the area percentage corresponding to fibrils, 
which was reported as density. 
RNA isolation and microarray hybridization 
RNA was isolated at 2 wks for control, C-ABC, continuous TGF-~1, and C-ABC 
combined with continuous TGF-~1 (n=3). Isolation was performed 4h following 
the administration of C-ABC and/or TGF-~1 using a Qiagen RNeasy Lipid Tissue 
Mini Kit. RNA was analyzed using a nanodrop to determine RNA purity and 
concentration; an Agilent bioanalyzer was employed to ensure RNA was not 
degraded. 400ng of RNA was hybridized to bovine microarrays (Agilent) based 
on the manufacturer's one color gene expression protocol. Arrays were imaged 
using an Agilent high-resolution C scanner; images were processed using 
Agilent's Feature Extraction Software 1 0.5. 
Microarray analysis 
Entrez Gene IDs were cross-referenced with HomoloGene build 65 
(ftp://ftp.ncbi.nih.gov/pub/HomoloGene/build651) to determine human orthologs. 
Normalized intensities of each gene were used to determine differentially 
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expressed genes relative to control samples (n=3 for each group). The 
Benjamini-Hochberg multiple testing correction was applied to generate adjusted 
p-values; data were filtered based on adjusted p-values < 0.005 and a minimal 2 
fold change. Enriched pathways were determined based on p < 0.001. 
PCR 
The primer for GAPDH was synthesized as described previously. 59 Other primers 
including MAP3K5, MAPK13, protein tyrosine phosphatase (PTP), and MAP2K3 
were purchased from Invitrogen. RT was performed by incubating 500 ng of RNA 
with SuperScript Ill (Invitrogen) as recommended by the manufacturer. Real-time 
PCR was done using SYBR Green mastermix and 1 ~M primers on a Rotor-gene 
3000 real-time PCR machine (Corbett Research). A 10 min denaturing step was 
employed, followed by 45 cycles of 95°C (15s) and sooc (60s). The take-off cycle 
(CT) for each gene of interest (GOI) was compared to the housekeeping gene 
GAPDH. Relative gene expressions were calculated using the 2-McT method. 
In vivo study 
Four male athymic mice, age 6-8 weeks were utilized under the approval of the 
Animal Use and Care Administrative Advisory Committee, University of 
California, Davis. Under general anesthesia, one construct (treated with C-ABC 
and intermittent TGF-131) and one cartilaginous bovine explant were implanted in 
a subcutaneous pouch, one in each side of the thorax, in a random fashion. The 
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mice were humanely sacrificed at 4 weeks and the implanted tissues were 
harvested. 
Statistical analysis 
Biochemistry and mechanical testing data (n=6) were analyzed using a two-factor 
ANOVA of the factors C-ABC treatment or TGF-~1 treatment with p<0.05. Post-
sacrifice and pre-implantation data were compared using an unpaired, one-tail t-
test. PCR data (n=3) were analyzed using a one-factor ANOVA with p<0.05. 
SEM diameters were analyzed using repeated measures ANOVA, with 9 data 
points per sample (n=3). Student Newman-Keuls post-hoc test was applied 
when warranted. The interaction term of a two-factor AN OVA was used to test for 
additive or synergistic effects as described previously.123 All data are shown as 
mean± standard deviation. 
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Table 2-1: Differentially expressed genes in the MAPK pathway. 
TGF-(31 C-ABC + TGF-(31 
Gene FC Regulation FC Regulation 
RAS p21 activator 2 2.1 up 2.2 Up 
Dual specificity phosphatase 2.8 up 2.5 Up 
4 
FGF2 4.0 up 4.1 up 
MAPK 8 interacting protein 1 4.6 up 3.9 up 
MAP2K3 4.1 up 3.9 up 
protein tyrosine phosphatase, 5.5 up 3.3 up 
type 7 (PTP) 
TGF-J31 6.6 up 6.9 up 
calcium channel, J33 subunit 2.2 down 2.5 down 
FGF13 3.2 up 3.4 up 
FGF18 2.3 up 3.2 up 
MAPK13 3.2 up 2.1 up 
MAP3K5 3.2 down 2.6 down 
MAP3K6 5.1 up 5.4 up 
p21 protein-activated kinase 2.6 up 2.8 up 
1 
PDGF receptor 3.2 down 3.6 down 
tyrosine phosphatase - 14.4 up 13.7 up 
receptor type 5 
TGF-J3 receptor II 2.6 down 2.7 down 
TGF-J33 2.4 down 2.1 down 
RAS guanyl releasing protein 4.5 up 
4 
MAPK serine/threonine 2.3 up 
kinase 1 
Microarray analysis was used to determine genes that were differentially 
expressed in 2 week self-assembled neocartilage treated with TGF-J31 (during 
weeks 1&2) or with chondroitinase-ABC (C-ABC) and TGF-J31. These 
differentially expressed genes significantly enriched the MAPK pathway. Fold 
changes are relative to control values. Dashes represent no differential 
expression for that gene. 
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Figure 2-1: Histology and gross morphology at 4 weeks. 
Morphology GAG Collagen Collagen II Collagen I 
Control 
C-ABC 
C-ABC 
+ 
TGF-(31 
Neocartilage treated with chondroitinase-ABC (C-ABC), intermittent TGF-J31 , or 
C-ABC combined with TGF-~ 1. Histology showed that control and treated 
constructs had uniform distributions of glycosaminoglycans (GAGs) , total 
collagen , and collagen II without exhibiting collagen I staining. Picrosirius Red 
was used to stain total collagen and Saf-0/fast green was used for GAG staining. 
IHC was employed to assess collagen I and collagen II distributions. Scale bar is 
200 J.Jm for histology images and gross morphology markings are 1 mm. 
Figure 2-2: Biomechanical and biochemical properties at 4 weeks. 
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Neocartilage was treated with chondroitinase-ABC (C-ABC), TGF-~1 , or C-ABC 
and TGF-~1 . (a) Tensile stiffness was enhanced by C-ABC and TGF-~ 1 
treatments and additively increased for combined treatment groups. (b) 
Compressive stiffness was highest for groups treated with intermittent TGF-~1 . 
(c) Combined C-ABC and TGF-~1 treatment synergistically increased collagen 
content. (d) GAG content was highest for groups treated with TGF-~1 . Bars 
labeled with different letters exhibit significant differences (p < 0.05). 
Figure 2-3: PCR of MAPK signaling gene expression in neocartilage 
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Gene expression levels for MAP3K5, MAPK13, protein tyrosine phosphatase 
(PTP), and MAP2K3 were normalized to control values. Combined treatments 
and TGF-~1 treatments generally had gene expression levels that were not 
statistically distinct. Negative values reflect down-regulation in relation to control. 
Bars labeled with different letters exhibit significant differences (p < 0.05). 
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Figure 2-4: SEM analysis of neotissue at 4 weeks. 
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(a) Representative SEM images of control neotissue and neocartilage treated 
with chondroitinase-ABC (C-ABC). (b) Quantification of fibril diameters based on 
image analysis of 3 locations on each neotissue sample with n=3. Bars labeled 
with different letters exhibit significant differences (p < 0.05). 
Figure 2-5: Properties of constructs post-sacrifice 
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Self-assembled articular cartilage was cultured for 4 weeks with TGF-J31 
treatment during weeks 1 &3 and chondroitinase-ABC (C-ABC) administration at 
day 14. Neocartilage was then implanted in nude mice for 4 weeks with condylar 
cartilage explants as controls (n=4). (a) Gross morphology and histology using 
Picrosirius Red for collagen , Safranin-0/fast green for glycosaminoglycans, and 
immunohistochemistry for collagen I and collagen II. Scale bar is 200 IJm. (b) 
Post-sacrifice tensile stiffness increased for neocartilage while explant stiffness 
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decreased. (c) Collagen content increased for constructs post-sacrifice while it 
decreased for native cartilage. (d) Compressive stiffness increased for constructs 
but did not significantly change for explants. (e) Glycosaminoglycan (GAG) 
content increased for both native tissue and neocartilage post-sacrifice. Bars 
labeled with different letters exhibit significant differences (p < 0.05). 
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Chapter 3: Identification of potential biophysical and 
molecular signaling mechanisms underlying hyaluronic 
* shows that acid enhancement of cartilage formation 
Abstract 
This study exogenous hyaluronic acid (HA) acts via both biophysical and genetic 
mechanisms to enhance biomechanical and biochemical properties of self-
assembled neocartilage. The influence of HA commencement time, 
concentration, application duration, and molecular weight was assessed. HA 
treatment of developing neocartilage increased compressive stiffness 1-fold and 
increased glycosaminoglycan (GAG) content by 35%. Additionally, applying HA 
increased GAG retention within self-assembled neotissue, indicating that HA 
could enhance compressive stiffness by increasing the osmotic pressure that 
negatively charged GAGs create. To investigate the influence of HA 
administration on gene expression, microarray analysis was conducted and 
validated with PCR. HA administration up-regulated 503 genes, including multiple 
genes associated with TGF-13 signaling, revealing a potential mechanism for 
altering matrix composition. This study is the first to show that exogenous HA 
application can enhance biochemical and biomechanical properties during 
cartilage formation, illustrating the potential use of HA to improve future cartilage 
regeneration efforts and better understand cartilage development. 
• Responte DJ, Natoli RM, Athanasiou KA. Identification of potential biophysical and molecular 
signaling mechanisms underlying hyaluronic shows that acid enhancement of cartilage formation. 
Nat. Commun. (submitted) 
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Articular cartilage lines the articulating surface of bones and provides a 
low-friction, load-bearing surface. Developing an effective in vitro method for 
cartilage formation could provide a platform technology for investigating novel 
regeneration strategies, studying cartilage pathogenesis, and examining cartilage 
development. However, numerous problems including chondrocyte de-
differentiation70 and difficulty reproducing the cartilage matrix109-112 have hindered 
the development of effective in vitro cartilage growth models. 
Recent efforts have focused on developing in vitro neocartilage that 
recapitulates the biochemical composition and biomechanical properties of native 
tissue. The primary matrix constituents of cartilage are glycosaminoglycans 
(GAGs) and collagen, which confer tensile and compressive integrity to the 
tissue. Aggrecan, the major proteoglycan of cartilage, binds negatively charged 
GAGs and subsequently increases the fixed charge density of the tissue, 
increasing resistance to compressive loading.154 Collagen contributes primarily to 
tensile mechanics; both the amount and organization of collagen in articular 
cartilage correlate with tensile properties.128·155 Because the extracellular matrix 
(ECM) contributes extensively to cartilage biomechanics, modulating the 
composition, organization, and interactions between matrix molecules is a central 
goal of in vitro cartilage development. 
Our laboratory has pioneered a novel self-assembly approach for 
scaffoldless cartilage formation94·102 based on high density chondrocyte culture. 
Self-assembly avoids many of the problems associated with biomaterial scaffolds 
such as decreased retention of phenotype,70 limit cell-cell communication,58·156 
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and potential toxicity of degradation byproducts.157 This process also mimics 
cartilage development, 103 providing a platform for investigating in vitro cartilage 
formation. Surprisingly, a recent study showed that self-assembled constructs 
lacked hyaluronic acid (HA), 103 a high molecular weight polysaccharide present in 
the ECM that acts a scaffold for proteoglycans, 158 suggesting that it may be 
necessary to exogenously add HA to reproduce native cartilage formation. 
Applying HA to chondrocyte cultures has been shown to increase 
biosynthesis in various experimental models. For instance, HA application to 
monolayer cultures has been observed to increase proteoglycan synthesis in 
equine articular cartilage, 159 rabbit chondrocytes, 160•161 and bovine articular 
cartilage. 162 Furthermore, exogenous HA administration has been shown to 
promote the expression of adhesion-related molecules such as integrin 
receptors, paxillin, focal adhesion kinase, and mitogen-activated protein kinase, 
suggesting that HA application could modulate chondrocyte-matrix 
interactions.163 These studies show that HA has a significant signaling role that 
could influence the functional properties of neotissue, but there have not yet 
been studies on how exogenous HA treatment influences biomechanical 
properties. 
In this paper, we present a series of studies evaluating the effects of 
exogenous HA application on the de novo formation of self-assembled articular 
cartilage and potential mechanisms underlying these effects, which have 
implications for both developmental biology and regenerative medicine. The 
influence of HA application time, concentration, and molecular weight on the 
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biochemical and biomechanical properties of neocartilage were investigated. Our 
hypotheses were that exogenous HA treatment would 1) increase GAG content, 
2) enhance compressive stiffness, 3) differentially regulate functionally-relevant 
genetic pathways, and 4) increase GAG retention. To interrogate these 
hypotheses, HA was administered to neotissue in three sequential phases to 
examine the effects of HA commencement time (phase I), HA concentration and 
duration (phase II), and HA molecular weight (phase Ill). 
Results 
HA-treated neotissue resembles native cartilage phenotype 
In all experiments in this paper (except gene expression analysis), self-
assembled neocartilage was cultured for 4 weeks. The diameter of HA-treated 
constructs was not statistically different from the control value of 5.8±0.2 mm. 
Wet weight was significantly greater for HA treatment, with values of 14±2 and 
20±1 mg for control and HA-treated groups, respectively. Histological analysis 
(Fig. 3-1) showed that neocartilage produced collagen and GAG uniformly. 
Immunohistochemistry indicated that both control and treated samples stained 
positive for collagen II, while only HA-treated constructs stained positive for HA. 
Additionally, HA-treated neotissue produced matrix that reflected native articular 
cartilage phenotype: uniform distribution of GAGs, total collagen, collagen II, and 
HA. 
HA increases GAG content and compressive stiffness when applied at seeding 
72 
In phase I, the effects of application commencement time were studied. 
Neotissue was treated with 1 mg/ml HA at seeding (day 0) or at day 4, with 
subsequent continual HA exposure through media changes. To assess the 
effects of HA application on biochemical composition, GAG and collagen 
contents were quantified. Treated neotissue did not exhibit statistically different 
collagen contents normalized to wet weight (collww) from the control value of 
9.5±2.3%. However, GAG/ww was statistically higher for the day 0 group, which 
had a GAG/ww of 8.5±1.4% compared to the control value of 6.5±0.9% at 4 
weeks (Fig. 2b). The effects of HA on construct biomechanical properties were 
quantified by measuring Young's modulus (Ev), ultimate tensile strength (UTS), 
and aggregate modulus (a measure of compressive stiffness). For tensile 
properties, no group was statistically different from the control group, which had a 
UTS of 370±155 kPa and Ev of 641 ±370 kPa. The aggregate modulus was 
significantly higher for constructs treated with HA: the group treated at seeding 
reached 181±50 kPa while the control group was 65±33 kPa (Fig. 2a). 
Intermediate HA concentration enhances compressive stiffness 
In phase II, we carried forward the application of HA at seeding and then 
performed a full-factorial examination of the treatment duration (weeks 1-2, 
weeks 1-4) and HA concentration (0.1 mg/ml, 1 mg/ml, and 5 mg/ml). 
Neocartilage was again cultured for a total of 4 weeks. Constructs treated with 5 
mg/ml HA did not self-assemble, probably due to the high viscosity of the 
solution. GAG results (Fig. 2d) showed differences only for the 1 mg/ml group; no 
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significant differences were observed for the 0.1 mg/ml groups or between the 
two application durations. For the 1 mg/ml HA treatment, GAG content reached 
8.3±0.9%, which was 38% greater than the control value. Collagen contents for 
treated groups were not significantly different than the control value of 8.9±0.5%. 
Biomechanical properties of neotissue treated with 1 mg/ml paralleled phase I 
results. Treating with HA at 1 mg/ml increased the aggregate modulus by 
approximately 40% (Fig. 3-2c); however, the 0.1 mg/ml group did not exhibit 
significantly higher compressive stiffness. Neither the 0.1 mg/ml group nor the 1 
mg/ml group had tensile properties that statistically differed from control values of 
748±97 and 362±117 kPa for the Ev and UTS, respectively. Thus, the effects of 
HA treatment depended on concentration, but did not depend on whether 
application duration was 2 weeks or 4 weeks. 
HA molecular weight influences biomechanical and biochemical properties 
A range of HA molecular weights exist in native cartilage, varying between 3x1 05 
Da and 2x1 06 Da, 164 and HA size has profound influences on its biological 
function. To examine the influence of HA size, we assessed the effects of five 
different molecular weights: 5.1x103 Da, 1.2x104 Da, 3.1x104 Da, 1.7x106 Da, 
and 2.7x106 Da, all at concentrations of 1 mg/ml. Treatment commenced at 
seeding and was continuous for the first 2 weeks of culture based on phase II 
results. Constructs were assessed after 4 weeks of culture. Neocartilage had 
significantly higher GAG content (Fig. 2f) when treated with 1.7x106 Da or 
2.7x106 Da HA (p = 0.023). GAG/ww values were 6.0±0.9%, 6.5±0.7%, 
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5.9±1.0%, 5.5±1.3%, 7.4±0.9%, and 7.2±0.5% for the control, 5.1x103 Da, 
1.2x104 Da, 3.1x104 Da, 1.7x106 Da, and 2.7x106 Da groups respectively. The 
1. 7x1 06 Da and 2. 7x1 06 groups both showed increased compressive stiffness 
with values of 163±33 kPa and 136±37 kPa, respectively (Fig. 3-2e). Hence, only 
higher molecular weight HA had the ability to enhance the biochemical and 
biomechanical properties of neocartilage. 
HA promotes GAG retention 
Increasing GAG retention, which would increase the fixed charged density of the 
neotissue, could provide a biophysical mechanism for enhanced compressive 
properties. Thus, after 4 weeks of culture, GAG retention was assessed by 
incubating control and HA-treated constructs in PBS for 1 h, 2h, 4h, 6h, or 8h and 
quantifying the GAG content of each construct (Fig. 3-3). HA-treated neotissue 
had 1.6x1 06 Da HA applied at 1 mg/ml from seeding for the first 2 weeks of 
culture. GAG content was not statistically different for the first hour, but then 
began to decrease by 2h. By 8h, GAG content for control constructs had 
decreased to 3. 7% of the initial amount. HA treatment promoted significant GAG 
retention compared to control based on a 2-way ANOVA (p = 0.034) of the 
factors duration and HA treatment. For instance, after 8h of incubation in PBS 
total GAG content of the HA-treated was three times higher than that of the 
control (0.15±0.12 J..lg and 0.05±0.04 J..lg, respectively). 
Neocarti/age properties are on par with native tissue 
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To quantitatively compare the properties of neocartilage to native tissue, we 
employed a functionality index (FI) by giving equal weight to the GAG content 
(G), collagen content (C), compressive stiffness (Ec), and tensile stiffness (ET) 
(see Eq. 1). The subscripts 'nat' and 'sac' denote native and self-assembled 
construct values, respectively. 
The Fl is structured such that a score of 1 represents a construct with properties 
equivalent to those of native cartilage. Treating with 1 mg/ml, 1.6x1 06 Da HA 
beginning at seeding for a total of 2 weeks resulted in a Fl of 0.85, producing a 
considerable improvement over the control Fl of 0.56. 
Microarray and PCR analyses show that HA enriches functional gene pathways 
To investigate possible genetic mechanisms underlying the changes in functional 
properties, microarray analysis comparing the gene expression profiles of control 
constructs and HA-treated constructs was performed. For these experiments, 
neocartilage was treated with 1 mg/ml, 1.6x1 06 Da HA beginning at seeding. 
Gene expression was analyzed at 4 days based on prior data showing elevated 
levels of surface receptors on day 4.103 Results showed that HA application 
differentially regulated 794 genes: 503 genes were up-regulated and 291 genes 
were down-regulated. HA treatment up-regulated several genes relating to 
chondrocyte phenotype165 including collagen II, collagen XI, and chondroadherin. 
HA treatment down-regulated collagen I, which is associated with chondrocyte 
de-differentiation. The up-regulation of cartilage-specific genes and concomitant 
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decrease in collagen I expression suggested that HA administration promoted 
cartilage phenotype. 
As summarized in Table 3-1, genes only enriched pathways relating to 
TGF-13 signaling (9 genes, p = 0.003) and ECM-receptor interactions (11 genes, 
p = 0.0001). The ECM-receptor pathway included the upregulation of several 
collagen molecules (collagen II, Ill, and XI) and surface receptors (syndecan-4 
and integrin a7), suggesting that HA could modulate chondrocyte interactions 
with the surrounding ECM. The TGF-13 pathway list included several well 
established downstream intermediates of TGF-13 signaling including protein 
phosphatase and the transcription factors Myc and E2F4. These enriched 
pathways showed that exogenous HA administration modulated functionally-
relevant gene expression, which could contribute to the observed biochemical 
and biomechanical results. 
Quantitative real time PCR was used to validate microarray results. Gene 
expression values for collagen II, collagen I, Myc, E2F4, and protein 
phosphatase were quantified (Fig. 4). HA treatment increased the expression of 
collagen II, Myc, E2F4, and protein phosphatase by 13.2±2.1, 12.1±1.9, 7.1±1.4, 
and 9.0±4.3 fold, respectively. Additionally, HA treatment down-regulated 
collagen I expression 7.0±3.0 fold. These results paralleled the fold changes 
observed with microarray results. 
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Discussion 
This study has shown that exogenous HA application improves the biochemical 
and biomechanical properties of neocartilage and also enriches pathways 
relating to TGF-~ signaling and ECM-receptor signaling. Through several 
phases, an HA administration regimen was identified that enhances the 
biochemical and biomechanical properties of developing neocartilage. 
Subsequent study revealed potential mechanisms to explain the observed 
results. The experiments of this study confirmed the hypotheses that exogenous 
HA treatment 1) increases GAG content, 2) enhances compressive stiffness, 3) 
differentially regulates functionally-relevant genetic pathways, and 4) increases 
GAG retention. This is the first study to show that HA can be applied 
exogenously to improve the biochemical and biomechanical properties of tissue 
engineered cartilage. This work also demonstrates potential biophysical and 
genetic mechanisms that could produce these enhancements. 
Diffusion limitations could be underlying the observed dependence on 
commencement time but not application duration. Other studies have 
documented increased diffusion limitations during cartilage construct culture. For 
instance, 3 kDa dextran showed decreased diffusion as constructs were cultured; 
the authors attributed this reduced diffusion to increased matrix deposition.166 
Time-dependent diffusion limitations could decrease HA penetration at later time 
points and explain why HA application at seeding had a larger effect than when it 
was applied at day 4. The lack of dependence on application duration implies 
that the HA effects are maximized at the earlier stages of self-assembly, which 
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also makes sense in light of likely diffusion limitations. Previous diffusion studies 
and the effects observed in this study suggest that HA must be applied in the 
early stages of neocartilage formation to enhance construct properties. 
This study also showed that higher molecular weight HA can increase 
compressive stiffness by 75% and increase GAG content by 30%, which builds 
upon other studies that have shown the importance of HA molecular weight. In 
general, larger molecular weight HA is considered to be chondroinductive 167 
whereas smaller fragments, such as HA hexamers, are generally associated with 
inflammatory events and disruption of pericellular matrix formation. 168 HA 
molecular weight could influence signaling because HA size alters how many 
CD44 receptors it can bind, which in turn changes the signaling events related to 
CD44 receptor clustering. 169 These results suggest that HA molecular weight has 
a profound impact on its biological function, and imply that modulating chain 
length may be a powerful tool for altering the effects of HA applied in vitro. In 
particular, this study suggests that only higher molecular weight HA increases the 
GAG content and compressive stiffness of self-assembled neocartilage. 
The GAG retention results suggest that the effects of HA are also 
mediated by a biophysical mechanism. Because negatively charged GAGs 
create a large fixed charge density in the matrix, enhanced GAG retention could 
increase osmotic pressure and subsequently increase resistance to compressive 
loading. 158 Thus, increasing GAG retention could increase the osmotic pressure 
of neocartilage and subsequently enhance its compressive properties. 
Exogenous HA has been shown to suppress proteoglycan release from 
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chondrocyte cultures170•171 and reduce in vivo GAG release from canine joints.172 
Interactions between HA and other matrix molecules increase the viscosity of the 
matrix,173 which could decrease GAG release. Because increased GAG retention 
could increase compressive stiffness, this presents an exciting potential 
biophysical mechanism underlying the enhanced mechanical properties. 
In addition to biophysical effects, microarray and PCR results suggest that 
HA application has a molecular signaling role. Because HA up-regulated 
chondrogenic genes such as collagen II and down-regulated collagen I, it could 
be a potent chondrogenic agent for cartilage formation. Furthermore, the 
observed up-regulation of chondroadherin, which increases ERK signaling, 174 
could create secondary signaling effects. Increased expression of syndecan-4, 
which binds to TGF-(31 via its heparan sulfate chains, 175 also suggests that TGF-
(31 and HA could potentially be applied simultaneously to produce synergistic 
effects. These findings illustrate that HA administration increased the expression 
of key surface molecules such as syndecan-4 and integrin-a7 and matrix 
constituents including collagen II and collagen XI, which collectively could 
influence chondrocyte-matrix interactions. 
In addition to the differential expression of matrix molecules, up-regulation 
of intracellular signaling intermediates, such as the transcription factors Myc and 
E2F4 as well as protein phosphatase, suggests that HA may induce a Smad 
cascade. Although there is not a well-established mechanism regarding CD44 
signaling in chondrocytes, 176 data from this study indicate that HA may primarily 
signal using the TGF-(3 pathway in self-assembled neocartilage (Fig. 3-5). This 
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supports previous work showing that HA activates the TGF-13 receptor and 
subsequently induces Smad protein phosphorylation.177 Based on our previous 
investigations of direct TGF-13 treatment,59•178 signaling via the TGF-13 pathway 
could up-regulate matrix synthesis and thus improve biochemical and 
biomechanical properties. 
The observed changes in gene expression are probably mediated by the 
surface receptor CD44, which has been shown to bind the cytoplasmic domain of 
the TGF-13 receptor and influence signaling.177 However, conflicting results exist 
that show CD44 as a positive 177 and negative 179 regulator of the TGF-13 signaling 
pathway. Interestingly, while anti-CD44 antibodies completely inhibit HA binding 
to chondrocytes, HA-mediated gene expression is not completely blocked.180 
This result shows that factors in addition to CD44 signaling play a role in HA-
induced gene expression changes. Signaling via TGF-13 intermediates could 
supplement the biophysical effects to enhance the functional properties of 
cartilage neotissue. 
In summary, this study has shown that exogenous HA could act via both 
biophysical and genetic mechanisms to enhance the biomechanical and 
biochemical properties of self-assembled neocartilage. Although exogenous HA 
application has been studied in monolayer chondrocyte culture, this study has 
been the first to illustrate how HA can be applied exogenously to influence 
functional-relevant genetic pathways, and also improve biochemical and 
biomechanical properties during in vitro cartilage formation. Future studies could 
block CD44 to further investigate how HA influences intracellular signaling, apply 
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HA in conjunction with other agents such as TGF-~1 to synergistically improve 
construct functionality, and probe the biophysical mechanism of HA-induced 
GAG retention. 
Materials and methods 
Chondrocyte isolation and culture 
Bovine chondrocytes were isolated and cultured described previously. 94 For HA 
treatment, 1.7x106 Da HA (Sigma) was dissolved in chondrogenic media94 by 
stirring at 4°C for 48h and applied daily during construct feeding. For phase Ill, 
HA polymers with molecular weights of 5.1x103, 1.2x104, 3.1x104, 1.7x106, and 
2.7x106 Da (Lifecore Biosciences) were employed. 
Construct processing 
All experiments except for gene expression analyses were 4 weeks in duration. 
At 4 weeks, samples were prepared for histology, quantitative biochemistry, and 
mechanical testing. A 3 mm diameter punch was removed from the construct's 
center for creep indentation testing. The outer region was divided to create 
samples for biochemical assays and tensile testing. 
Histology and immunohistochemistry 
At 4 weeks, samples were cryoembedded and frozen at -20°C for at least 24 
hours prior to cryosectioning at 14 IJm. Some of these sections were fixed in 
formalin and stained with Safranin-0/fast green and Picrosirius Red to show 
GAG and collagen distributions, respectively. Other sections were fixed in 4°C 
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acetone and processed for collagen II IHC as described previously.138 For HA 
IHC, sheep anti-HA (Abeam) was diluted 1:100 followed by an anti-sheep lgG 
Vectastain ABC kit applied for 30 min. 
Quantitative biochemistry 
Samples were frozen at -20°C for at least 24 hours and then lyophilized for 48 
hours to obtain dry weights. Subsequently, each sample was digested using 
pepsin and elastase as described previously.138 Sulfated GAG content was 
assayed using the Blyscan Glycosaminoglycan Assay kit (Accurate Chemical 
and Scientific Corporation). Total collagen content was determined using a 
chloramine-T hydroxyproline assay.117 To assess GAG retention, constructs were 
incubated in PBS at 37°C and removed at 1h, 2h, 4h, 6h, or 8h. 
Creep indentation testing 
The aggregate modulus of each sample was determined using a creep 
indentation apparatus.152 A tare load of 0.2 g followed by a test load of 0.7 g was 
applied via a 0.8 mm porous indentation tip. Material properties were determined 
using a semi-analytical, semi-numeric biphasic model.119•153 
Tensile testing 
Samples were cut into dog-bone shapes and glued to paper tabs for gripping.122 
Prior to positioning the samples on the paper, pictures were taken and then 
analyzed using lmageJ to determine the width and gauge length. A micrometer 
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was used to determine sample thicknesses. Tensile tests were conducted at a 
strain rate of 1% of the gauge length per second on a materials testing system 
(lnstron Model 5565). Young's modulus was calculated as the slope of the linear 
region of the stress-strain curve; the maximum stress was reported as ultimate 
tensile strength. 
RNA isolation and microanay hybridization 
RNA was isolated at 4 days (n=3) for control constructs and HA-treated 
constructs (4h following the application of HA) using a Qiagen RNeasy Lipid 
Tissue Mini Kit. To assess RNA purity and concentration, RNA was analyzed 
using a nanodrop. An Agilent bioanalyzer was employed to assess the quality of 
the RNA. Bovine microarrays were acquired from Agilent. 400ng of total RNA 
were processed according to Agilent's one color gene expression protocol. The 
arrays were scanned on Agilent's high-resolution C scanner and analyzed using 
Agilent's Feature Extraction Software 1 0.5. 
Microanay data analysis 
Current annotations for the microarray probes were obtained from Agilent 
technologies (https://earray.chem.agilent.com/earray). The Entrez Gene IDs from 
the Agilent annotation were cross-referenced with HomoloGene build 65 
(ftp://ftp.ncbi.nih.gov/pub/HomoloGene/build651) to find the gene names for the 
corresponding human orthologs. Changes in gene expression were assessed 
between control and HA treatment based on the normalized intensities of each 
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gene. Genes with adjusted p-values < 0.01 were considered to be differentially 
expressed. Differentially expressed genes were entered into the Database 
for Annotation, Visualization and Integrated Discovery to determine enriched 
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways.181 Enriched 
pathways were defined as p < 0.005 and a minimal 5 genes appearing among 
the differentially expressed genes. 
Real time PCR 
Primers for GAPDH, COL2, and COL 1 were synthesized as described 
previously;69 other primers (Myc, E2F4, protein phosphatase) were purchased 
from Invitrogen. RT was performed by incubating 500 ng of RNA with 
SuperScript Ill (Invitrogen) as recommended by the manufacturer. Real-time 
PCR was done with a Rotor-gene 3000 real-time PCR machine (Corbett 
Research). SYBR Green mastermix was used with primers at a concentration of 
1 1JM. A 10 min denaturing step was employed, followed by 45 cycles of 95°C 
(15s) and 60°C (60s). The take-off cycle (CT) for each gene of interest (GOI) was 
compared to the housekeeping gene GAPDH. Relative gene expressions were 
computed as 2-McT, where llllCT = (CT,GOI - CT,GAPDH)HA - (CT,GOI -
CT ,GAPDH)control· 
Statistical analysis 
Biochemistry and biomechanics samples (n=6) were analyzed using a one-factor 
ANOVA in phases I and Ill. For phase II and GAG retention, a two-factor ANOVA 
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was employed. When warranted, Tukey's post hoc testing was performed to 
determine significant differences. Significance was defined as p < 0.05. 
Table 3-1: Differentially expressed genes of pathways enriched by HA. 
TGF-@ pathway targets 
Gene 
Activin 
inhibitor of DNA binding 1 
inhibitor of DNA binding 2 
Myc transcription factor 
E2F4 transcription factor 
protein phosphatase 
thrombospondin 1 * 
thrombospondin 2* 
thrombospondin 3* 
thrombospondin 4* 
Fold change 
6.82 
8.57 
4.67 
5.34 
4.78 
3.47 
4.92 
8.22 
4.26 
6.82 
Regulation 
up 
down 
up 
up 
up 
up 
up 
up 
up 
up 
ECM receptor pathway targets 
Gene 
chondroadherin 
Collagen, type I, alpha 1 
Collagen, type II, alpha 1 
Collagen, type Ill, alpha 1 
Collagen, type XI, alpha 2 
integrin, alpha 7 
syndecan 4 
Fold change Regulation 
13.42 up 
4.92 down 
4.47 up 
3.42 up 
5.01 up 
4.07 up 
5.52 up 
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HA treatment enriched only pathways relating to TGF-J3 signaling and ECM-
receptor interactions. Fold changes represent the gene expression of neotissue 
at 4 days treated HA (1 mg/ml, 1.6x106 Da HA) relative to control values. Targets 
marked with an asterisk were differentially expressed in both the TGF-J3 signaling 
and ECM-receptor interactions pathways. 
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Figure 3-1: Histology and IHC for HA treatment. 
GAG Collagen II HA 
Control 
HA 
Photomicrographs of Safranin-0/fast green staining for glycosaminoglycans 
(GAGs), Picrosirius Red for collagen, and immunohistochemistry for collagen II 
and hyaluronic acid (HA). Sections were prepared after 4 weeks of culture. All 
images are shown at 1 OX magnification. Scale bar represents 200 IJm. 
Figure 3-2: Biomechanical and biochemical properties. 
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Phase 1: (a) Day 0 hyaluronic acid (HA) application significantly increased the 
aggregate modulus. (b) Application of HA at day 0 resulted in a significantly 
higher glycosaminoglycan (GAG) content. Phase II: (c) 1 mg/ml HA 
administration enhanced compressive stiffness. (d) Application duration did not 
have a significant effect on GAG content, though HA application at 1 mg/ml 
significantly increased GAG content. Phase Ill: (e) High molecular weight HA 
also enhanced the aggregate moduli of constructs. (f) HA with higher molecule 
weights resulted in higher GAG content. 
Figure 3-3: GAG retention effects of HA treatment 
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The GAG retention was compared between control constructs and constructs 
treated with 1 mg/ml hyaluronic acid (HA) for 2 weeks. To assess GAG retention , 
total GAG content was quantified after various incubation periods in PBS 
following 4 weeks of culture. HA administration increased GAG retention for HA-
treated constructs based on a 2-way ANOVA of the factors duration and HA 
treatment. Data are presented as means with standard deviation error bars, n=6 
per bar. Groups marked with distinct letters significant different (p < 0.05). 
Figure 3-4: PCR results for neocartilage treated with hyaluronic acid. 
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All reported values are gene expression values of HA neocartilage normalized to 
control expression levels computed using the 2-MCT method. Data are presented 
as means with standard deviation error bars, n=3 per bar. 
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Figure 3-5: Potential hyaluronic acid signaling pathway 
Smad cascade 
Biosynthesis 
Microarray and PCR analysis showed that several TGF-~ intermediates, 
including the transcription factors Myc and E2F4, are up-regulated following HA 
treatment. HA-induced signaling may be mediated by HA binding to CD44, which 
is known to bind to and activate the TGF-~ receptor. 
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Chapter 4: Additive effects of exogenous hyaluronic acid 
and TGF-131 on tissue engineered articular cartilage* 
Abstract 
This study examines the application of hyaluronic acid (HA) and TGF-(31, applied 
individually and in combination, to improve the functional properties of self-
assembled cartilage constructs. Constructs were assessed after 4 weeks using 
biochemistry, histology, and biomechanics. Histology and IHC showed that both 
treatments promoted articular cartilage phenotype, demonstrating the expression 
of glycosaminoglycans (GAGs) and collagen II but not collagen I. HA and TGF-
(31 significantly increased the GAG content and compressive stiffness of 
constructs, and applying HA in conjunction with TGF-(31 additively increased the 
GAG content and compressive properties. Combined HA and TGF-(31 treatment 
produced neocartilage with a compressive stiffness of 230±34 kPa and a GAG 
content of 10.7±0.5%, which were respective increases of 150% and 65% above 
control values. This study demonstrated that HA and TGF-(31 can be applied in 
combination to further enhance the increased biochemical and biomechanical 
properties resulting from treatment with either agent applied individually. 
• Responte OJ, Athanasiou KA. Additive effects of exogenous hyaluronic acid and TGF-131 on 
tissue engineered articular cartilage. JOR (in preparation) 
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Introduction 
Articular cartilage damage and degeneration create a tremendous clinical 
burden, with 67 million individuals projected to be diagnosed by 2030.182 
Osteoarthritis (OA) is particularly problematic within the elderly population, with 
1 0% of people over age 60 exhibiting OA.13 OA is associated with poor quality of 
life issues including joint inflammation and pain; in severe cases, these 
symptoms can impair physical function and adversely impact the patient's 
lifestyle. The prevalence and severity of OA provide a strong impetus for 
developing new strategies to promote articular cartilage regeneration. 
Unfortunately, cartilage has an intrinsically limited healing capacity, so novel 
technologies are needed to produce repair tissue. 
Cartilage regeneration efforts have focused on recapitulating the 
biochemical composition and biomechanical properties of native cartilage. The 
primary matrix constituents of cartilage are collagen and glycosaminoglycans 
(GAGs), which confer tensile and compressive integrity to the tissue. Mechanical 
properties are crucial because constructs should be able to function in the 
demanding joint environment, which can impose forces of 20 MPa on 
cartilage. 183 Various tissue engineering strategies have been investigated to 
produce neocartilage that can withstand this strenuous environment. 
One particularly promising regeneration approach is a self-assembly 
process that recapitulates cartilage development103 and produces constructs 
with biochemical and biomechanical properties on par with those of native 
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tissue. 94 Self-assembly has been improved by applying various biochemical and 
biomechanical stimuli including hydrostatic pressure,57•105 growth factors,39 and 
the enzyme chondroitinase-ABC.51 •140 In addition to examining the effects of 
individual stimuli, self-assembly has been improved by combining stimuli to 
synergistically enhance construct properties. For instance, combining hydrostatic 
pressure and TGF-~1 treatment has been shown to additively increase the 
aggregate modulus by 164% and the Young's modulus by 231%. Additionally, 
the combined treatment had a synergistic effect on collagen content, increasing it 
by 173%.59 Despite these exciting developments, recent work has shown that 
self-assembled constructs do not contain hyaluronic acid (HA), 103 suggesting that 
his matrix component may need to be added exogenously. 
HA is a large, unsulfated glycosaminoglycan comprised of repeating units 
of glucuronic acid and N-acetylglucosamine. High molecular weight (105-107 Da) 
HA forms the core of aggrecan, a major constituent of cartilage matrix. HA has 
also been implicated in native cartilage development due to its presence in 
embryonic mesenchymal tissue and promotion of chondrogenesis. 168·184 HA 
contributes to in vitro matrix organization by promoting the development of 
pericellular matrices that resemble those of native chondrocytes.185 Additionally, 
HA application increases proteoglycan biosynthesis 160·186 and protein production 
in equine articular cartilage, 159 rabbit chondrocytes, 161 and bovine articular 
cartilage.162 The key role of HA in development and biosynthesis suggests that 
HA has important implications for in vitro cartilage formation. 
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TGF-131 is an anabolic agent that is known to improve cartilage 
biosynthesis and improve the properties of cartilage constructs. This class of 
growth factors is known to contribute to both embryonic cartilage developmenf3 
and chondrogenic differentiation of mesenchymal progenitor cells.24-27 
Furthermore, TGF-131 has been shown to improve in vivo cartilage repair.28 
Administering TGF-13 to tissue engineered constructs has also been extensively 
studied. For instance, administering TGF-13 increased GAG deposition in three-
dimensional cultures of equine chondrocytes,29 rabbit auricular chondrocytes,30 
and bovine articular chondrocytes. 31 
HA application to self-assembled constructs has not yet been investigated 
in combination with TGF-131. Thus, the objective of this study was to investigate 
the effects of combining HA with TGF-131. This study examined the hypotheses 
that HA and TGF-131 administration would 1) increase biochemical and 
biomechanical properties and 2) further enhance construct properties when 
applied in combination. To test these hypotheses, a full factorial design was 
employed with the factors HA (no treatment, treatment of 1 mg/ml) and TGF-131 
(no treatment, treatment during weeks 1 &2 (continuous), treatment during weeks 
1 &3 (intermittent)). 
Materials and methods 
Chondrocyte isolation and culture 
Bovine chondrocytes were isolated as previously described.94 Cartilage tissue 
was isolated from the distal femur and patellofemoral groove of three 1 week old 
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male calves (Research 87, Boston, MA) and digested in collagenase type 11 
(Worthington Biochemical Corp., Lakewood, NJ) for 24 hours in a 0.20% solution. 
Cells were counted with a hemacytometer and subsequently frozen at -80°C at a 
concentration of 30 million cells per mi. Cells were thawed and seeded in 5 mm 
diameter non-adherent, cylindrical wells made of 2% agarose. 5.5 million cells in 
100 1-11 medium were placed into each well; an additional 400 IJL of medium was 
added to each well after 4 hours. The constructs were removed from the 
cylindrical molds at 1 0 days and cultured in well plates coated with 2% 
agarose.114 
For the entire culture duration, constructs were fed with chemically-defined 
medium consisting of DMEM with 4.5 mg/ml glucose and L-glutamine 
(Biowhittaker/Cambrex, Walkersville, MD), 1% fungizone, 1% 
penicillin/streptomycin, 50 IJg/ml ascorbate-2-phosphate, 100 nM 
dexamethasone (Sigma, St. Louis, MO), 1% ITS+ (BD Scientific, Franklin Lakes, 
NJ), 40 IJg/ml L-proline, and 100 IJg/ml sodium pyruvate (Fisher Scientific, 
Pittsburgh, PA). Media was changed daily. For HA treatment, HA with a 
molecular weight of 1.6x1 06 Da (Sigma) was applied at 1 mg/ml in chondrogenic 
media. Growth factor groups were treated daily with TGF-131 at 30 ng/ml 
suspended in chondrogenic media used for daily feeding. 
Construct processing 
Constructs were processed at 4 wks for evaluation of histology, quantitative 
biochemistry, and mechanics. A 3 mm biopsy punch was used to remove the 
--------------------
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centers of the constructs, which were used for compressive testing. The outer 
rings of constructs were divided and used for tensile assessment, quantitative 
biochemistry, and histology. 
Histology and immunohistochemistry (IHC) 
Samples were assessed for distribution of GAG, collagen, collagen I, and 
collagen II. At 4 weeks, samples were cryoembedded and frozen at -20°C for at 
least 24 hours and then were cryosectioned at 14 ~m. Some of these sections 
were fixed in formalin and stained with Safranin-0/fast green and Picrosirius Red 
to show GAG and DNA distributions, respectively. Other sections were analyzed 
using IHC for collagen I or collagen II. Samples were prepared using a 
Vectastain ABC kit (Vector Labs) according to the manufacture's instructions. 
Primary detection was achieved with mouse anti-collagen type I diluted 1: 1 000 
(Accurate Chemicals) or rabbit anti-collagen type II diluted 1:300 (Cedarlane 
Labs). The secondary antibody (anti-mouse or anti-rabbit lgG, Vectastain ABC 
kit) was then added for 30 min and developed using the Vectastain ABC reagent 
and DAB. Immature bovine tendon was employed as a positive control for 
collagen I. Articular cartilage was used as a positive control f for collagen type II 
and a negative control for collagen I. 
Quantitative biochemistry 
Samples were frozen at -20°C for at least 24 hours and then lyophilized, weighed 
dry, and digested using a papain solution.187 DNA content was determined with 
98 
the PicoGreen® dsDNA Assay Kit (Invitrogen), and cell numbers were inferred 
assuming 7.8 pg of DNA per cell. Sulfated GAG content was assayed using the 
Blyscan Glycosaminoglycan Assay kit (Biocolor), which is based on 1 ,9-
dimethylmethylene blue binding (Accurate Chemical and Scientific Corp., 
Westbury, NY). Total collagen content was assayed using a modified chloramine-
T hydroxyproline assay.117 
Creep indentation testing 
Compressive mechanical properties were determined using a creep indentation 
apparatus.152 The properties were obtained based on a linear biphasic model118 
that was used to compute each sample's aggregate modulus, Poisson's ratio, 
and permeability. A tare load of 0.2 g followed by a test load of 0.7 g was 
employed for all other samples. The loads were applied via a 0.8 mm porous 
indentation tip. Material properties were determined using a semi-analytical, 
semi-numeric biphasic model was used.119 These results were subsequently 
refined using finite element optimization.153 
Tensile testing 
Samples were cut into dog-bone shapes and glued to paper tabs for gripping.122 
Prior to positioning the samples on the paper, pictures were taken and then 
analyzed using lmageJ to determine the width and gauge length. A micrometer 
was used to determine sample thicknesses. Tensile tests were conducted at a 
strain rate of 1% of the gauge length per second on a materials testing system 
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(lnstron Model 5565). The Young's modulus was calculated from the slope of the 
linear region of the stress-strain curve; the ultimate tensile strength was recorded 
as the maximum stress from the curve. 
Results 
Histology and gross morphology 
Histology results are summarized in Fig. 4-1. Histology demonstrated that all 
samples stained uniformly positive for total collagen and GAGs. In addition, IHC 
showed the presence of collagen II but not collagen I throughout the constructs. 
The absence of collagen I and presence of collagen II and GAGs suggested that 
all treatments promoted a cartilage phenotype. 
For all groups, chondrocytes self-assembled to form uniform discs. 
Analysis of gross morphology showed that TGF-131 treatments altered construct 
diameter. Control construct diameters increased to 6.07±0.19 mm compared to 
the original 5 mm diameter, whereas diameters for growth factor groups did not 
change. Diameter values were 5.10±0.15, 5.31±0.11, 5.05±0.08, and 4.97±0.12 
mm for intermittent TGF-131, continuous TGF-131, HA with intermittent TGF-131, 
and HA with continuous TGF-131, respectively. Treatment groups did not have 
significantly different amounts of DNA than the control group, which had 38.1 ± 
4.7 IJg per construct, which corresponded to 4.9 million cells. Groups treated with 
TGF-131 demonstrated significantly reduced thicknesses with values of 0.48 ± 
0.04, 0.31± 0.06, 0.37 ± 0.03, 0.34 ± 0.05, and 0.30 ± 0.03 mm for control, 
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intermittent TGF-~1, continuous TGF-~1, HA with intermittent TGF-~1, and HA 
with continuous TGF-~1, respectively. 
Biochemistry 
As shown in Fig. 4-2b, all treatment groups had higher GAG contents than the 
control group, with the combined treatment groups exhibiting the highest GAG 
abundances. GAG/ww reached 10.7±0.5% and 10.3±0.8% for HA in conjunction 
with continuous TGF-~1 and intermittent TGF-~1, respectively. These reflected 
additive increases over the other groups, which exhibited GAG contents of 
6.5±0.5%, 8.1 ±0.8%, 8.4±0. 7%, and 8.6±1.0% for control, HA, continuous TGF-
~1, and intermittent TGF-~1, respectively. 
Collagen contents of HA-treated groups were not significantly different 
than the control value of 7.7±0.7% (Fig. 4-3b). For groups treated with TGF-~1, 
collagenlww was significantly greater than control and HA groups, exhibiting 
collagen abundances of 9.9±0.7%, 10.2±0.7%, 10.7±0.5%, and 10.0±0.7% for 
continuous TGF-~1, intermittent TGF-~1, HA with continuous TGF-~1, and HA 
with intermittent TGF-~1, respectively. 
Mechanical testing 
Compressive properties were quantified by determining the aggregate modulus, 
Poisson's ratio, and permeability. The aggregate modulus was significantly 
higher for individual HA and TGF-~1 treatments and additively increased 
following combination treatment. The compressive stiffness was highest for 
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combined treatment groups (Fig. 4-2a), which exhibited aggregate moduli of 
230±34 kPa and 221 ±37 kPa when treated with continuous and intermittent TGF-
J31, respectively. These increases in compressive stiffness paralleled the 
enhanced GAG contents for treatment groups. Permeabilities were 20.4 ± 10.1, 
9.1 ± 0.3, 10.4 ± 6.2, and 8.1 ± 8.6 x 1 o-15 m4JN·s for control, HA alone, HA with 
continuous TGF-J31, and HA with intermittent TGF-J31. Post-hoc testing 
demonstrated that HA-treated groups had lower permeability values and that 
growth factor treatment alone did not significantly alter the permeability. 
Poisson's ratios for treatment groups were not significantly different than the 
control value of 0.047 ± 0.038. 
Tensile testing showed that TGF-J31 treatment significantly increased 
tensile stiffness (Fig. 4-3a). Tensile stiffnesses were 614±158, 1206±172 and 
1163±137, 1033±72, and 1271±167 kPa for control, continuous TGF-J31, and 
intermittent TGF-J31, HA with continuous TGF-J31, and HA with intermittent TGF-
J31, respectively. The Young's moduli for the HA groups were not statistically 
different than control. UTS values was significantly higher for constructs treated 
with growth factors, with values of 437±47, 750±65, 747±83, 728±65, 773±92 
kPa for control, continuous TGF-J31, and intermittent TGF-J31, HA with 
continuous TGF-J31, and HA with intermittent TGF-J31, respectively. In general, 
collagen and GAG contents mirrored the trends in tensile and compressive 
stiffness, respectively. 
Construct properties are on par with native tissue 
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To quantitatively compare the treatment groups and native cartilage, a 
functionality index (FI) was employed. The Fl compares native cartilage with 
engineered tissue based on the compressive stiffness (Ec), tensile stiffness (ET), 
GAG content (G), and collagen content (C) as shown in Eq. 1. Native tissue and 
engineered cartilage are denoted by the subscripts 'nat' and 'sac,' respectively. 
F/=!((1- (G .. ,-G,.J)+(1 (c .. ,-c,.J)+(1 (E!'.,~E~J)+(1 _(E;;,,-E~J)) (1) 
4 ~ ~ ~ ~ 
An Fl value of 1 corresponds to engineered cartilage properties that equal those 
of native tissue. Fl values were 0.41, 0.54, 0.73, and 0.88 for control, HA, 
intermittent TGF-131, and combined treatments, respectively. The higher Fl value 
for the combined treatment group indicates that combining HA and TGF-131 most 
effectively reproduces the properties of native cartilage. 
Discussion 
This study employed HA and TGF-131 treatments to assess the effects of 
combining these exogenous agents. Novel contributions of this study include 
showing that 1) HA does not interfere with TGF-131 signaling in self-assembled 
cartilage and 2) HA and TGF-131 can be applied to additively improve the 
biochemical and biomechanical properties of cartilage constructs. 
The application of 30 ng/ml and 1 mg/ml HA resulted in additive increases 
in the biochemical and biomechanical properties of constructs. Results supported 
the hypothesis that combining HA and TGF-131 would further improve 
biochemical and biomechanical properties compared to treating with either agent 
individually. The combination treatment increased the GAG content and 
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compressive stiffness by 64% and 151%, respectively. Results supported the 
hypothesis that combining HA and TGF-~1 would further improve biochemical 
and biomechanical properties compared to treating with either agent individually. 
The results highlight an important structure-function relationship in 
cartilage neotissue, particularly the relationship between GAG content and 
compressive properties. Significant increases in compressive stiffness due to 
both individual and combined treatments mirrored GAG content. GAG have been 
shown to be the influence compressive properties by creating a large fixed 
charge density and subsequently increasing the osmotic pressure of the 
tissue, 188 which increases resistance to compressive loading. Although the role of 
GAGs in compressive mechanics has been well-established, the collagen 
network also plays a crucial role. For example, collagen fiber organization 189 and 
collagen content125 have been shown to contribute to the compressive properties 
of cartilage. Thus, modulating the collagen network could provide a strategy for 
further improving the compressive properties of cartilage constructs. 
The increased compressive stiffness observed following HA treatment 
could be mediated by enhanced GAG retention. Applying HA exogenously has 
been shown to decrease GAG release from both in vitro chondrocyte 
cultures 170•171 and the in vivo joint space.172 This suppressed GAG release could 
be caused by the extensive interactions between HA and other ECM 
components, 173 which could increase the viscosity of the matrix. Increasing GAG 
retention could increase compressive properties by increasing the fixed charge 
density and osmotic pressure of the ECM, which consequently increased 
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compressive properties.158 The increased osmotic pressure related to GAG 
content could explain the increase compressive stiffness that was observed 
following HA and TGF-J31 treatments. 
In addition to the effects of HA and TGF-J31, it is likely that HA sequesters 
TGF-J31 in matrix. The large negative charge of HA and positive charge of growth 
factors like TGF-J31 results in the formation of ionic complexes, 190 which could 
sequester TGF-J31 in the matrix. This increased growth factor retention could 
increase the effective growth factor dosage compared to soluble TGF-J31 
administration. Similar effects were observed by tethering TGF-J31 to PEG 
hydrogels, which increased matrix production more so than soluble TGF-J31 
treatment.191 The ability of both biomaterials and anionic natural polymers to 
localize growth factors provides a strategy for controlling the spatial localization 
of TGF-J31 in the matrix. 
HA has also been shown to influence the response to other growth factors 
applied to engineered cartilage. For instance, adding HA to alginate and 
embedding chondrocytes showed that IGF-1 can become entrapped within the 
matrix and therefore interfere with the delivery of IGF-1 to chondrocytes.192 HA 
sequestered IGF-1 in the matrix, which was assessed by observing gene 
expression relating to IGF-1 signaling. Exogenous HA also increased IGF-1 
retention in cartilage explants and concomitantly increased proteoglycan 
synthesis, suggesting that HA promotes IGF-1 signaling in native cartilage.193 
Considering the formation of ionic complexes between growth factors and HA 
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discussed earlier, it is likely that HA will promote the retention of various signaling 
molecules and subsequently alter signaling. 
This study has shown that exogenously applying HA and TGF-J31 
additively increases the GAG content and compressive stiffness of self-
assembled cartilage. HA administration did not appear to interfere with TGF-131 
signaling, and could have enhanced TGF-131 retention in the matrix via 
electrostatic interactions. Because other work has shown beneficial effects of 
combining mechanical stimuli with growth factor treatment,59·141 future studies 
should examine how TGF-J31 and HA can be combined with mechanical stimuli. 
Figure 4-1: Histology and gross morphology 
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Collagen I 
Constructs were treated with hyaluronic acid (HA), TGF-J31, or HA and TGF-J31 . 
Total collagen was stained with Picrosirius Red and GAGs were stained using 
Safrainin-0/fast green. Immunohistochemistry was used to assess the 
abundance and distribution of collagen I and collagen II . Both control and treated 
constructs exhibited uniform distributions of glycosaminoglycans (GAGs), total 
collagen , and collagen II without expression collagen I. Scale bar represents 200 
IJm. 
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Figure 4-2: Compressive stiffness and glycosaminoglycan (GAG) content 
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Constructs were treated with hyaluronic acid (HA), TGF-J31, or HA and TGF-J31 . 
(a) Compressive stiffness was additively increased following combined HA and 
TGF-~1 treatment. (b) Combined HA and TGF-J31 treatment additively increased 
GAG content. Bars labeled with different letters exhibit significant differences (p < 
0.05). 
Figure 4-3: Tensile stiffness and collagen content 
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(a) Tensile stiffness (b) TGF-J31 treatment significantly increased the tensile 
stiffness. Bars labeled with different letters exhibit significant differences (p < 
0.05). 
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Chapter 5: Tensile properties and collagen network 
characterization of connective tissues of the immature 
knee joint* 
Abstract 
Background: The major connective tissues of the knee joint act in concert during 
locomotion to provide joint stability, smooth articulation, shock absorption, and 
distribution of mechanical stresses. These functions are largely conferred by the 
intrinsic material properties of the tissues, which are in turn determined by their 
biochemical composition. A thorough understanding of the structure-function 
relationships of the connective tissues of the immature knee joint is needed in 
order to provide design parameters for efforts in tissue engineering. 
Methodology/Principal findings: The objective of this study was to perform a 
comprehensive characterization of the tensile properties, collagen content, and 
pyridinoline crosslink abundance of condylar cartilage, patellar cartilage, medial 
and lateral menisci, cranial and caudal cruciate ligaments (analogous to anterior 
and posterior cruciate ligaments in humans, respectively), medial and lateral 
collateralligamen1ts, and patellar ligament from immature bovine calves. Tensile 
stiffness and strength were greatest in the menisci and patellar ligament, and 
lowest in the hyaline cartilages and cruciate ligaments; these tensile results were 
reflected in the results for collagen content. Pyridinoline crosslinks were found in 
• Eleswarapu SV,* Responte DJ,* Athanasiou KA. Interplay of collagen content and crosslinking 
with tensile mechanics of musculoskeletal tissues of the immature bovine joint. PLoS ONE 
(accepted) 
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every tissue despite the relative immaturity of the joints, and significant 
differences were observed among tissues. 
Conclusions/Significance: Results from this investigation reinforce the interplay of 
tissue biomechanics and biochemical content and provide preliminary design 
parameters for future efforts concerned with connective tissue engineering for 
joint repair. 
Introduction 
The major connective tissues of the knee joint act in concert during locomotion to 
provide joint stability, smooth articulation, shock absorption, and distribution of 
mechanical stresses. 194-196 These functions are largely conferred by the intrinsic 
material properties of the tissues, which are in turn determined by their 
biochemical compositions. Based on structure-function relationships, each 
connective tissue of the knee joint can be conceptualized along a continuum from 
hyaline to fibrocartilaginous to fibrous (Figure 1 ). These tissues have received 
considerable attention in both basic science and clinical literature, but much work 
remains to be done to elucidate the contributions of particular biochemical 
components to important mechanical parameters, especially with respect to 
applications in tissue engineering. Approaches in tissue engineering are guided 
heavily by the interplay of native tissue structures and their corresponding 
functional correlates. To better understand these relationships, this study 
examines the biochemical composition and tensile properties of the major 
connective tissues of the immature bovine knee joint. 
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The knee is a pivotal hinge joint that permits flexion, extension, and limited 
rotation through coordinated action of its hyaline, fibrocartilaginous, and fibrous 
connective tissues. Hyaline cartilage is found at the condylar surfaces of the 
femur and tibia, as well as on the posterior aspect of the patella. Hyaline cartilage 
provides a smooth surface for low-friction gliding of the femoral and tibial 
condyles and the patella during knee flexion and extension. Fibrocartilage 
comprises the medial and lateral menisci, which are crescent-shaped structures 
interposed between the femoral and tibial condyles. The two menisci bear 
dynamic loads applied by the femoral condyles during joint compression and 
relaxation, thereby playing a role in shock absorption and stress distribution over 
the tibial condyles. Fibrous tissue makes up the major ligaments of the knee joint, 
in particular the patellar ligament, the collateral ligaments, and the cruciate 
ligaments. The patellar ligament originates from the apex of the patella and 
inserts at the tibial tuberosity below; together with the tendon of the quadriceps 
femoris, the patellar ligament provides stability to the patella as it glides over the 
patellofemoral groove and femoral condyles. The medial and lateral collateral 
ligaments (MCL and LCL) are extracapsular ligaments that protect the medial 
and lateral sides of the knee from a contralateral outside or inside bending force, 
respectively. The anterior and posterior cruciate ligaments (ACL and PCL) are 
intracapsular ligaments that stabilize the knee during rotation and bending. 
Relative to the femur, the ACL prevents anterior transposition of the tibia, while 
the PCL prevents posterior transposition. Together, these tissues contribute 
significantly to normal knee function. 
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The connective tissues of the knee joint are known to derive their 
mechanical properties from their biochemical compositions, but precise structure-
function relationships remain elusive beyond general notions of the role of the 
extracellular matrix (ECM). Structurally, each of these tissues is hypocellular and 
possesses an ECM rich in collagen, with varying amounts of glycosaminoglycans 
(GAGs). 197•198 In general, collagen is known to be largely responsible for the 
tensile integrity of these tissues, while GAGs, predominant in hyaline cartilage 
and sparse in fibrous tissues, contribute to compressive strength.199 In addition to 
total collagen content, the amount of crosslinking present in the collagen network 
has been shown to play an important role in tissue tensile properties.200 In 
examining tissue tensile properties, two important measures of tensile integrity 
are Young's modulus and ultimate tensile strength (UTS). Young's modulus is a 
measure of a material's tensile stiffness; it is defined as the slope of the linear 
portion of the stress-strain curve describing a material's behavior during uniaxial 
loading in tension. The UTS is the maximum stress a material can withstand and 
is determined as the highest point of the stress-strain curve. Though collagen 
content and crosslinking are known to play a role in tensile mechanics, their 
precise structure-function relationships with respect to Young's modulus and 
UTS remain unclear. In particular, pyridinoline crosslinks have been shown to 
correlate with both tensile strength and stiffness in bovine articular cartilage,49 but 
there is a dearth of literature describing the contribution of pyridinoline crosslinks 
to the mechanical behavior of other bovine joint tissues. 
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In humans, conditions afflicting the connective tissues of the knee, such 
as traumatic injury and osteoarthritis, contribute to substantial healthcare costs 
and work-related disability. The prevalence and severity of these conditions 
result in annual direct costs of $510 billion, which is expected to increase as the 
population ages.201 For arthritis alone, which can arise as a result of injury to any 
of these tissues202, it is projected that 67 million individuals will be diagnosed by 
2030182. Surgical treatments such as total joint replacement are highly invasive, 
require extensive recovery and rehabilitation times, and may often involve costly 
revision surgeries.203 Biological treatments such as autografts and allografts 
present additional challenges such as secondary surgeries, immunogenicity,204 
and limited cell sources. 
The field of tissue engineering aims to improve orthopedic medicine by 
providing functional replacements for damaged or diseased joint tissues. Recent 
tissue engineering efforts have focused on major connective tissues such as 
hyaline cartilage,53•94 meniscus,187•205 tendon,206•207 and ligament.208 Although 
various approaches have been employed to engineer these tissues, it has been 
difficult to reproduce native collagen organization and attain native mechanical 
properties. Various types of mechanical53-55•58 and biochemical33•51 stimuli have 
been studied to improve construct properties, and both scaffold-free94•99•209 and 
scaffold-based90•210 approaches have been investigated for connective tissue 
engineering applications. 
An important consideration in these tissue engineering efforts has been 
the cell source used to produce constructs. Comparisons of cell types have 
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shown that immature cells exhibit increased biosynthesis211 , making them 
promising candidates for tissue engineering. Immature cells have been used to 
produce constructs with clinically relevant dimensions94 and mechanical 
properties on par with native tissue. To make informed cell source choices, it is 
necessary to establish a comprehensive understanding of the physiology of 
immature joint tissues. Moreover, while studies on the knee joint are well 
represented in the literature, it is important to note that much of what is known 
about the structure-function relationships of these tissues comes from 
assessments of adult rather than immature joints, whether human or animal. 
Given the prevalence of knee injuries in the pediatric population212, along with a 
greater push towards using immature tissues as cell sources for tissue 
engineering, a thorough elucidation of the biochemistry of immature knee joint 
tissues, not just adult tissues, is warranted. An understanding of immature joint 
physiology may also yield insight into tissue development by providing a 
reference to which adult tissues can be compared, as well as informing a general 
understanding of factors at play in pediatric joint injury. Additionally, because 
orthopaedic explant and tissue engineering studies are relying more readily on 
bovine tissues, it is imperative that a full assessment of the bovine joint be 
undertaken. 55,94,213-215 
The objective of this study was to perform a comprehensive 
characterization of the tensile properties, collagen content, and pyridinoline 
crosslink abundance of the major connective tissues of the immature bovine 
knee joint. Tissues of interest were femoral condylar and patellar cartilage, 
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medial and lateral menisci, cranial and caudal cruciate ligaments (analogous to 
the ACL and PCL in humans, respectively), medial and lateral collateral 
ligaments, and patellar ligament. It was hypothesized that trends in tensile 
properties would reflect those in collagen content; that tensile properties and 
collagen content would be higher in fibrocartilaginous and ligamentous tissues 
than in hyaline tissues; and that pyridinoline crosslinks would be found in all 
tissues, in spite of the immaturity of the tissues. It was further hypothesized that 
pyridinoline crosslinks would be found to contribute preferentially to Young's 
modulus rather than UTS. Results from this investigation reinforce the interplay 
of tissue biomechanics and biochemical content and provide preliminary design 
parameters for future efforts concerned with connective tissue engineering for 
joint repair. 
Material and methods 
Tissue harvest and specimen preparation. Tissue specimens were harvested 
from the knee joints of 6 one-week-old male bovine calves (Research 87, Boston, 
MA) shortly after slaughter. To normalize variability among animals, each leg 
came from a different animal. Hyaline femoral condylar cartilage (CC), hyaline 
patellar cartilage (PC), medial meniscus (MM), lateral meniscus (LM), cranial 
cruciate ligament (CraCL), caudal cruciate ligament (CauCL), medial collateral 
ligament (MCL), lateral collateral ligament (LCL), and patellar ligament (PL) were 
taken. For CC and PC specimens, the cartilage was separated from subchondral 
bone with a scalpel. For MM and LM specimens, the femoral and tibial surfaces, 
as well as the inner 1/3 and outer 1/3 portions of the annulus, were sliced away, 
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leaving the approximate interior circumferential portion of the specimen for 
assessment. CraCL, CauCL, MCL, LCL, and PL were taken whole from their 
attachments. 
From each freshly harvested specimen, a 3 mm dermal biopsy punch was 
used to obtain samples for histology, quantitative biochemistry, and high 
performance liquid chromatography (HPLC). The remainder of each specimen 
was then prepared for tensile testing. Tensile specimens were stored for a 
maximum of 24 h in phosphate buffered saline with protease inhibitors at 4°C 
and were allowed to equilibrate to room temperature prior to testing. 
Histology. Samples were cryo-embedded and sectioned at 14 IJm. 
Sections were fixed in formalin for 1 0 min and then stained with either picrosirius 
red or safranin 0/fast green as described previously.94 Samples were dehydrated 
in an ascending series of ethanol and mounted with coverslips prior to imaging. 
Quantitative biochemistry. Biochemistry samples were weighed wet, 
frozen, lyophilized for 48 h, and then digested in a phosphate buffer with 
125 IJg/mL papain (Sigma) for 18 h at 65°C. A chloramine-T hydroxyproline 
assay was employed to quantify total collagen content after 2 N NaOH hydrolysis 
for 20 min at 110°C 117 . Total collagen was normalized to tissue wet weight. 
High performance liquid chromatography (HPLC). HPLC was performed 
to quantify the abundance of pyridinoline crosslinks. Samples were weighed wet, 
digested in 800 IJL of 6 N HCI at 1 oooc for 20 h, and then dried using a vacuum 
concentrator. Samples were re-suspended in 50 IJL of an aqueous solution 
containing 10 nmol pyridoxine/ml and 2.4 !Jmol homoarginine/ml and then 
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diluted fivefold with an aqueous solution of 0.5% HFBA acetonitrile in 10% 
acetonitrile. 1 0 J,JL of each sample was injected into a 25 mm C 18 column 
(Shimadzu, Columbia, MD) and eluted using a solvent profile described 
previously.216 To quantify the amount of crosslink in each sample, pyridinoline 
standards (Quidel, San Diego, CA) were employed to create a calibration curve. 
Tensile testing. Each specimen was cut into a dog-bone shape with a 1-
mm-long gauge length. The specimen was photographed alongside a ruler, and 
lmageJ software was used to determine the width and thickness. A uniaxial 
electromechanical materials testing system (lnstron Model 5565, Canton, MA) 
was employed to determine tensile properties with a 50 N (CC and PC only) or 5 
kN load cell (all other tissues). CC and PC specimens were affixed with 
cyanoacrylate glue to paper tabs outside of the gauge length for gripping; all 
other specimens were gripped directly outside of the gauge length. MM and LM 
specimens were tested in the circumferential direction. CraCL, CauCL, MCL, 
LCL, and PL specimens were tested in the longitudinal direction. Tensile tests 
were performed until failure within the gauge length at a strain rate of 1% of the 
gauge length per second. Force-displacement curves were generated, and 
stress-strain curves were calculated by normalizing data to specimen dimension. 
The apparent Young's modulus, a measure of specimen tensile stiffness, was 
determined by least squares fitting of the linear region of the stress-strain curve. 
The ultimate tensile strength (UTS) was determined as the maximum stress 
reached during a test. 
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Statistical analysis. All biochemical, HPLC, and tensile assessments were 
made using n=5-6. To compare among tissues, a single-factor analysis of 
variance was employed, and a Fisher least significant difference post hoc test 
was used when warranted. Significance was defined as p<0.05. 
Results 
Histology. Representative histology for hyaline cartilage, meniscus, and ligament 
are shown in Figure 2. Staining for collagen was observed in all tissues, though 
hyaline cartilage exhibited less extensive collagen staining compared to either 
meniscus or ligament. Extensive staining for GAG was observed in the hyaline 
cartilage specimens, but was not qualitatively observed in meniscus or ligament 
specimens. 
Collagen content. The collagen/wet weight for CC, PC, MM, LM, CraCL, 
CauCL, MCL, LCL, and Pl were 6.7±2.6%, 5.1±1.4%, 22.7±5.3%, 26.7±7.5%, 
4.6±0.9%, 2.8±1.2%, 19.4±4.6%, 20.9±0.3%, and 21.2±3.5%, respectively 
(Figure 3). Fibrocartilage tissues (MM and LM) had the highest collagen content; 
the fibrocartilage tissues averaged together had 4.1x the collagen content in the 
hyaline tissues averaged together and 6. 7x the collagen content in the cruciate 
ligaments averaged together. Among just the fibrous tissues, the collateral 
ligaments (MCL and LCL) and Pl had higher collagen content than the cruciate 
ligaments (CraCL and CauCL); in particular, the collateral ligaments averaged 
together had 5.4x the collagen content in the cruciate ligaments averaged 
together. The cruciate ligaments were not significantly different from the hyaline 
cartilage tissues (CC and PC) in collagen content. 
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Pyridinoline crosslink content. Pyridinoline was resolved as one peak for 
all samples. Pyridinoline normalized to tissue wet weight (pyd/ww) for CC, PC, 
MM, LM, CraCL, CauCL, MCL, LCL, and PL were 0.303±0.101, 0.174±0.049, 
0.498±0.160, 0.534±0.115, 0.374±0.087, 0.565±0.204, 0.414±0.123, 
0.422±0.067, and 0.585±0.069 nmol/mg, respectively (Figure 4a). Pydlww was 
highest in PL, while CauCL, LM, and MM samples trended higher compared to all 
other tissues. The hyaline cartilages (CC and PC) had the lowest pydlww. The 
fibrocartilage tissues averaged together had a pydlww 2.16x the hyaline 
cartilages averaged together, and all of the ligament tissues averaged together 
had a pyd/ww 1.98x the hyaline cartilages averaged together. 
Pyridinoline normalized to collagen content (pyd/col) for CC, PC, MM, LM, 
CraCL, CauCL, MCL, LCL, and PL were 5.69±3.85, 3.68±1.59, 2.28±0.88, 
2.17±0.92, 8.32±2.12, 16.08±4.53, 2.22±0.85, 2.02±0.34, and 2.80±0.42 
nmollmg, respectively (Figure 4b). Statistically, CauCL had the highest pyd/col 
and CraCL the second highest, followed by the hyaline cartilages. The collateral 
and patellar ligaments and both menisci were not statistically different from each 
other and were less than the cruciate ligaments and the hyaline cartilages. 
CauCL had a pyd/col 1.93x CraCL, 3.43x the hyaline cartilages averaged 
together, 7.22x the fibrocartilage tissues averaged together, and 7.59x the 
collateral ligaments averaged together. 
Tensile properties. The Young's moduli for CC, PC, MM, LM, CraCL, 
MCL, LCL, and PL were 8.4±4.1, 4.6±1.8, 25.9±7.0, 21.6±6.2, 2.1±1.0, 11.6±5.9, 
13.2±5.8, 16.9±4.07, 27.5±2.8 MPa, respectively (Figure Sa). The UTS for CC, 
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PC, MM, LM, CraCL, MCL, LCL, and PL were 7.0±2.2, 3.9±0.7, 15.1±4.5, 
24.6±2.0, 1.4±0.6, 7.4±5.9, 10.1±6.4, 14.9±3.9, and 15.7±3.3 MPa, respectively 
(Figure 5b). MM, LM, and PL exhibited significantly higher stiffnesses (Young's 
moduli) and strengths (UTS) compared to the other tissues, while CC, PC, 
CraCL, and CauCL were among the softest and weakest in tensile properties. 
Also of note, among the cruciate ligaments, CauCL was significantly stiffer and 
stronger than CraCL: Young's modulus and UTS for CauCL were both 5.4x 
CraCL. 
Discussion 
This study examined the major connective tissues of the immature bovine knee 
joint, motivated by a need to understand the interplay of biomechanics and 
biochemistry in immature connective tissues, as well as to establish design 
parameters for in vitro tissue engineering efforts. In the present study, differences 
were found across tissue types with respect to histology, collagen content, 
pyridinoline crosslink abundance, and tensile properties. In addition to reinforcing 
orthopaedic structure-function relationships, to our knowledge, this study is the 
first to examine these parameters in a direct head-to-head comparison between 
all of the major connective tissues of the knee, the first to assess pyridinoline 
crosslink abundance in all the tissues of a bovine joint, and the first to report 
results for pyridinoline crosslink abundance that suggest a preferential structure-
function relationship to tensile stiffness rather than strength. 
In the present study, tissues of interest were first examined histologically 
for the presence of collagen and GAGs to infer qualitative structural differences 
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underlying the biomechanical distinctions between these different tissues. 
Meniscus and ligament specimens appeared nearly identical, exhibiting 
extensive staining for collagen with no observable GAG staining (Figure 2). 
Hyaline cartilage, by contrast, exhibited less collagen staining than either 
meniscus or ligament, but also significant GAG staining. These histological 
trends correspond to the notion of knee joint connective tissues spanning a 
continuum between hyaline tissue (high collagen, high GAG) and fibrous tissue 
(high collagen, low GAG) (Figure 1 ). These qualitative histological differences 
relate to the functional roles of these tissues: fibrous tissues (ligaments and 
tendons) and fibrocartilage tissues (menisci) experience tremendous tensile 
stresses during locomotion, while hyaline cartilage experiences a balance of both 
tensile and compressive stresses, though preferentially the latter. 
Tissue tensile properties, especially in connective tissues, are largely 
understood to derive from collagen content, 199 so it was hypothesized that trends 
in tensile properties would reflect trends in collagen content. In this study, 
collagen content was quantified in each tissue and normalized to tissue wet 
weight (Figure 3). It was found that the menisci had the highest collagen content, 
followed by the patellar ligament and the collateral ligaments. Collagen content 
was lowest in the hyaline cartilages and the two cruciate ligaments. As expected, 
the tensile properties (Figure y-5) do appear to reflect the general trends 
observed in collagen content. In particular, it was found that the menisci and 
patellar ligament exhibited significantly higher stiffness (Young's moduli) and 
strength (UTS) values compared to the other tissues, while the hyaline cartilages 
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and the cruciate ligaments were among the softest and weakest in tensile 
properties. 
The differences in tensile properties among the ligament tissues (high in 
patellar ligament, medium in collateral ligaments, and low in cruciate ligaments) 
may reflect the anatomical development of these tissues, since the 
stiffer/stronger tissues are extracapsular ligaments, and the softer/weaker tissues 
are intracapsular ligaments. In particular, the patellar ligament arises from fibers 
of the quadriceps muscle attaching inferiorly to the tibial tuberosity (hence the 
term "patellar tendon" often used interchangeably with patellar ligament, given 
the tendinous origin), the cruciate ligaments arise posteriorly from the articular 
interzone, and the collateral ligaments form independently of the joint capsule 
(LCL) or from mesenchymal condensation in the joint capsule (MCL).217 
Furthermore, of particular interest was the finding that CraCL (analogous to the 
ACL in humans) is significantly softer and weaker than CauCL (analogous to the 
PCL in humans). Clinically, ACL injuries are more commonly diagnosed than 
PCL injuries, both in children and adults; the apparent softness and weakness of 
the CraCL compared to the CauCL supports the idea that the CraCL, and thus 
the ACL in humans, may be more prone to injury. Taken together, the tensile 
data described above contribute important information about the tensile 
properties of immature tissues, especially in light of the increasing incidence of 
knee joint injuries among youths.212 Additionally, these tensile properties may 
serve as important benchmarks to determine success criteria for in vitro 
engineering of the major knee joint connective tissues, all of which play important 
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roles in mechanical function. Tissue engineering efforts aimed at recapitulating 
native tissue structures should strive to reproduce native tissue biomechanical 
properties, as well. 
Crosslink analysis with HPLC showed that the different joint tissues had 
varying pyridinoline abundances that contributed to tensile stiffness. The data 
showed that the hyaline cartilages and the cruciate ligaments exhibited the 
highest pyridinoline levels (Figure 4). Both the patellar ligament and CauCL 
exhibited higher tensile stiffness values that paralleled pyridinoline content but 
not the amount of collagen. Although pyridinoline has been shown to correlate 
with tensile strength and stiffness in bovine articular cartilage,49 this is the first 
study to show that pyridinoline also contributes to the mechanical properties of 
other bovine joint tissues. These results also corroborate structure-function 
relationships in other species. For example, a study of the rat tendon 
demonstrated that pyridinoline was a better indicator of ultimate stress than 
collagen content.218 These structure-function relationships illustrate the 
importance of crosslinking in a variety of joint tissues. 
Pyridinoline content is known to generally increase as tissues matures, but 
this study provides comprehensive, quantitative benchmarks that can be 
compared to adult tissue values. For instance, the observed pyridinoline 
abundances for condylar cartilage and meniscus fibrocartilage are approximately 
50% and 70% of the mature values, respectively.49•219 These pyridinoline results 
can inform future tissue engineering efforts that aim to reproduce the biochemical 
composition of native tissues. Because engineered cartilage has shown less 
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collagen crosslinking than native tissue, strategies such as increasing lysyl 
oxidase expression220 may be needed to increase pyridinoline formation. Other 
stimuli such as TGF-131 have been shown to increase pyridinoline content in 
articular cartilage221 and could potentially be beneficial for enhancing crosslinking 
in engineered tissue as well. Considering the role of pyridinoline in tissue 
mechanics49•50 and the inherently mechanical nature of knee joint connective 
tissues, crosslinking should be a central focus of future tissue engineering 
approaches. 
This study provides comprehensive biochemical and biomechanical data 
describing hyaline, fibrocartilaginous, and fibrous tissues of the immature bovine 
knee joint. These data may serve as important design parameters for future 
efforts in tissue engineering, particularly with respect to pyridinoline crosslink 
abundance. This work also advances an understanding of structure-function 
relationships in immature connective tissues. Future work may expand on this 
study by examining temporal development and maturation of the collagen 
network and tensile properties, or by making direct comparisons in pyridinoline 
crosslink abundance between immature and adult tissues. Finally, an 
assessment of these parameters in disease states such as osteoarthritis or 
traumatic injury models such as ligament rupture may shed light on predisposing 
factors. 
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Figure 5-1: Continuum of knee joint connective tissues. 
Articular Cartilage Meniscus Ligament 
More hyaline Fibrocartilaginous More fibrous 
Based on their structural compositions, the major connective tissues of the knee 
joint can be conceptualized along a continuum from hyaline (condylar and 
patellar cartilage), to fibrocartilaginous (meniscus), to fibrous (ligament). 
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Figure 5-2: Histology of representative joint tissues 
Hyaline Meniscus 
Collagen 
GAG 
Picrosirius red staining for collagen showed that hyaline cartilage, meniscus, and 
ligament all had significant collagen content. The meniscus and ligament 
samples stained more intensely for collagen than hyaline cartilage. Safranin 
0/fast green staining for GAG showed that hyaline cartilage had significant GAG 
content; meniscus and ligament did not exhibit GAG staining. 
Figure 5-3: Collagen content normalized to wet weight 
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Collagen content was significantly higher for menisci, collateral ligaments, and 
patellar ligament. Groups denoted by different letters are significantly different 
{p<O.OS). 
Figure 5-4: Pyridinoline content of joint tissues 
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(a) Pyridinoline normalized to wet weight was highest for menisci, patellar 
ligament, and the caudal cruciate ligament. Crosslink content was lowest for 
patellar cartilage. (b) Pyridinoline normalized to collagen was highest for hyaline 
cartilages and cruciate ligaments. Groups denoted by different letters are 
significantly different {p<0.05). 
Figure 5-5: Tensile properties of joint tissues 
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(a) Young's modulus was highest for the menisci and patellar ligament and 
lowest for the cranial cruciate ligament. (b) Ultimate tensile strength was also 
higher for the patellar ligament and the menisci. Groups denoted by different 
letters are significantly different (p<0.05). 
Chapter 6: Noninvasive evaluation of bioengineered 
articular cartilage using time-resolved fluorescence 
* spectroscopy 
Abstract 
130 
A bimodal technique integrating time-resolved fluorescence spectroscopy (TRFS) and 
ultrasound backscatter microscopy (UBM) was used to evaluate self-assembled 
bioengineered articular cartilage samples. Using a prototype system of combined TRFS 
and UBM, we compared the biochemical changes in cartilage samples treated with three 
types of exogenous agents (collagenase, C-ABC, and ribose) with a control group 
through fluorescence lifetime and spectral measurements. The microstructure and the 
thickness of the engineered cartilage samples were characterized by UBM. The optical 
and ultrasound results were validated against those acquired via conventional 
techniques including collagen and glycosaminoglycan (GAG) quantification and 
mechanical measurement of construct stiffness. Current results have demonstrated that 
a set of optical parameters (e.g., average fluorescence lifetime and decay constants) 
showed significant correlation (p < 0.05) with biochemical and mechanical data, and high 
resolution ultrasound images provided complementary cross-section information of the 
cartilage samples with deeper penetration depth. Therefore, the technique was capable 
of noninvasively evaluating the composition of extracellular matrix and the microstructure 
of engineered tissue, demonstrating great potential as an alternative to traditional 
destructive assays. 
SunY, Responte DJ, Xie H, Liu J, Hu J, Athanasiou KA, Marcu L. Noninvasive evaluation of 
tissue engineered articular cartilage with combined time-resolved fluorescence spectroscopy and 
ultrasonic backscatter microscopy. Tissue Eng Part C (submitted) 
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Introduction 
Self-assembled cartilage: Cartilage degeneration is a serious problem in 
orthopedic medicine and afflicts millions worldwide. For instance, osteoarthritis 
affects an estimated 10% of people over age 60.13 The acellularity and 
avascularity of cartilage contribute to its limited healing capacity, which has 
created a pressing need for novel tissue regeneration strategies. One tissue 
engineering approach, self-assembly, entails culturing chondrocytes at high 
density in agarose molds to produce cartilage constructs with properties 
approaching those of native tissue.94 Several anabolic59·178 and catabolic51 •138 
exogenous agents have been investigated to modulate the matrix composition of 
constructs and subsequently alter their biomechanical and biochemical 
properties. 
Non-invasive evaluation technology for tissue engineering: The success in 
developing a useful engineered tissue construct relies heavily on evaluating its 
structural and biochemical properties both before and after implantation. 
Traditional destructive methods such as biochemistry assays and mechanical 
testing are a clear impediment to such a setting and are highly inefficient in time 
and cost. Destructive measurements are undesirable in tissue engineering 
because cell culturing and differentiation are expensive and time consuming. 
Additionally, conventional methods demonstrate high variability and do not allow 
dynamic measurements that are important for long term tissue studies. Thus, 
there is a clear need for non-invasive, non-destructive tissue characterization 
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methodology that allows ongoing evaluation of tissue during development or 
analysis of matrix modified by exogenous agents. 
Fluorescence based techniques have the potential to measure biochemical 
changes in tissue in relation to clinical diagnosis.222 Auto-fluorescence of 
structural proteins (collagen and elastin), co-enzyme factors (the reduced form of 
nicotinamide adenine dinucleotide, NADH), amino acids (tryptophan, tyrosine), 
lipids and vitamins allow label free compositional analysis of samples. 223 Laser 
induced fluorescence has been widely employed in characterizing skin tumors, 
urinary bladder tumors and head and neck cance~24 and myocardial tissue.225 
However, techniques based on the analysis of intensity and spectral distribution 
of fluorescence are often hampered by challenges in resolving the broad 
emission spectra and spectrally overlapping of the endogenous fluorophores. 
Time-resolved fluorescence spectroscopy (TRFS) techniques take into account 
the decay characteristics of the fluorescence emission thus providing better 
differentiation between fluorophores with overlapping spectra.226•227 Additionally, 
the fluorescence decay characteristics allow description of biological 
microenvironment of the fluorophore. This makes TRFS a more robust method 
for non-destructive tissue analysis. The use of auto-fluorescence in tissue 
engineering, however, is fairly recent. Previous work includes non-invasive in situ 
evaluation of osteogenic differentiation with time-resolved fluorescence 
spectroscopy,228 and TRFS and ultrasound evaluation of cartilage constructs 
cultured in scaffolds.229 Collagen, glycosaminoglycans {GAG), and NADH are 
major endogenous fluorophores of engineered tissue that can be analyzed using 
~~~ ~~~~~~~--------·· 
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fluorescence spectroscopy. Formation or degradation of collagen, collagen 
crosslinks and changes in relative concentration of other fluorophores will change 
the overall tissue fluorescence emission. 
Ultrasound imaging is well recognized as a viable tool for studying the 
structure and morphology of biological tissue.230•231 Moreover, ultrasound 
backscatter microscopy (UBM) that employs high frequencies transducers (>40 
MHz), has been used to characterize atherosclerotic lesions,232 connective tissue 
network233 and collagen fiber distribution in human dermis.234 1t provides a spatial 
resolution of tens of microns and sufficient penetration depth of 5-6 mm. We 
have previously demonstrated the use of UBM in atherosclerotic plaque 
characterization studies.235•236 High frequency ultrasound was also used to 
assess the morphologic acoustic, and mechanical properties of articular 
cartilage. 237 
The overall objective of this study is to evaluate the ability of an experimental 
system combining TRFS and UBM modalities for non-destructive analysis of self-
assembled cartilage constructs properties. Experiments were conducted in 
constructs where the extracellular matrix (ECM) protein is biochemically altered 
in a manner that affect the ECM content as well as the mechanical properties of 
the construct. Specifically, the goals of this study are (1) to determine whether 
changes induced in tissue constructs via a set of anabolic or catabolic agents 
known to affect the ECM composition can be detected using non-destructive 
bimodal TRFS-UBM measurements; and (2) to determine the correlation 
between optical and ultrasonic parameters of the constructs and biochemical, 
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biomechanical properties measured using conventional assays and mechanical 
tests. 
Methods 
Tissue fluorophores: To understand the overall fluorescence emission (intensity, 
peak, emission, decay characteristics or lifetime) originated from the engineered 
cartilage tissue, TRFS measurements were performed in all major intrinsic 
fluorophores within the sample. These included collagen type II (major collagen 
type in week 4 cartilage sample), GAG (providing mechanical integrity to the 
tissue}, aggrecan (backbone of the protein-sugar complex proteoglycan), and 
NADH (expressed in the cells). These measurements served as references. The 
measurements were conducted in pure powder form for collagen, GAG 
(chondroitin sulfate)and aggrecan and in 1 mMPBS solution for NADH. All the 
chemicals were extracted from tissues or cells and purchased from Sigma-
Aldrich. 
Cartilage sample preparation and treatments: Bimodal TRFS and UBM 
measurements were performed on the self-assembled articular cartilage samples 
generated as follows. Chondrocytes were harvested from the patellofemoral 
groove and distal femur of immature bovine legs (Research 87, Boston, MA) and 
isolated as described previously.94 Cells were thawed and seeded in 5 mm 
diameter agarose wells to form constructs. Constructs were cultured at 37°C, 
10% C02 and were fed daily with a chemically-defined medium.94 All exogenous 
agents were administered in chondrogenic media and constructs were cultured at 
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37°C, 10% C02 for the duration of each respective treatment. Chondroitinase-
ABC (C-ABC) treated constructs were each treated with 500 IJI of a 2U/ml C-ABC 
solution for 4 hours. For the collagenase treatment, constructs were exposed to 
0.2% collagenase for 30 min. Ribose treatment was performed for 4 hours at a 
concentration of 30mM.Collagenase is responsible for the degradation of the 
collagen components while C-ABC is effective for GAG digestion resulting in an 
increase of collagen concentration. Ribose can nonspecifically oxidize the 
collagen crosslinks. At 4 weeks, constructs were assessed using non-invasive 
assessments and then processed for biochemical and biomechanical testing. 
The central 3 mm regions of the constructs were used for compressive 
evaluation and the outer ring was used for biochemical assays and tensile 
evaluation. 
TRFS-UBM system and measurements: The hybrid TRFS-UBM system consists 
of four primary modules: TRFS sub-system, UBM sub-system, hybrid probe, and 
control unit (Fig. 1). 
TRFS sub-system: A pulsed nitrogen laser (337 nm, 0.7 ns, 30Hz) provided 
the excitation light through an optical fiber (600 !Jm core diameter, NA = 0.22), 
which was positioned perpendicular to the sample and directed light onto the 
sample. Sample autofluorescence was collected throughthe same fiber and a 
beam splitter, and dispersed by a spectrophotometer after which scattered 
excitation light was removed by the use of a long-pass filter (340 nm). The 
fluorescence signal was detected with a gated multichannel plate photomultiplier 
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tube (MCP-PMT, rise time of 180 ps),and amplified by a wideband preamplifier 
(1.5 GHz bandwidth), recorded by a fast digitizer (2.5GHz bandwidth, 20G 
samples/s). The fluorescence decay pulsesfrom each sample were obtained by 
scanning of the spectrophotometer across a spectral range of 360-600nm (steps 
of 5 nm). The laser output energy was measured at the end of the optical fiber 
and was adjusted to 2 J,JJ/pulse. Measurements were taken from fourlocations on 
each sample, with the probe placed in direct contact with the sample. Reflected 
laser pulses from the sample were measured following the fluorescence 
measurements for the deconvolution of the system response from the 
measurements. 
UBM subsystem:A high-voltage pulser generating a wideband pulse (200V 
peak-to-peak) was used to drive the ultrasound transducer. The received 
radiofrequency (RF) echoes were amplified with a 30 dB low-noise amplifier and 
filtered with a bandpass filter (24-90 MHz). A 12-bit digitizer with a sampling rate 
of 400M samples/s was employed to record the RF. A linear positioning stage (1 
J.Lm positioning resolution) allowed for scanning and forming a UBM image. The 
measurements were conducted with a customized 40MHz press-focused single 
element transducer (aperture size of 3. 75mm, 63% bandwidth, 6mm focal depth) 
made available by the Ultrasonic Transducer Resource Center, University of 
Southern California, Los Angeles, CA. The optical fiber for TRFS measurements 
was inserted in the center channel (0.9 mm diameter) of the transducer. The 
UBM system with this transducer provided an axial and lateral resolution of 30 
and 65J,Jm, respectively. 
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Biochemical, histological, and mechanical testing: For biochemical analysis, 
samples were frozen at -20°C and lyophilized for 48 hours to determine dry 
weights. Lyophilized samples were digested using pepsin-elastase as described 
previously.138 DNA content was determined using PicoGreen®dsDNA Assay Kit 
(Invitrogen, Carlsbad, CA). Sulfated GAG content was assayed using the 
Blyscan Glycosaminoglycan Assay kit (Biocolor) and collagen content was 
quantified using a chloramine-T hydroxyproline assay.117 For histology, samples 
were cryo-embedded and then sectioned at 14 1Jm. Sections were fixed in 
formalin and stained with safranin-0/fast green and picrosirius red. 
Compressive properties were quantified using a creep indentation 
apparatus.119•152A 0.8 mm porous indentation tip was used to apply a tare load of 
0.2 g followed by a test load of 0.7 g. For tensile testing, samples were cut into 
dog-bone shapes and glued to paper tabs for testing. Tensile assessments were 
conducted at a strain rate of 1% of the gauge length per second on a materials 
testing system (lnstron Model 5565, Canton, MA). The slope of the resulting 
stress-strain curve yielded the Young's modulus and the maximum stress was 
reported as the ultimate tensile strength. 
Fluorescence and ultrasonic data processing: Fluorescence system response 
was fully characterized by the shape of its fluorescence decay profile, h(k) for k = 
0 ... K-1 , where k was the index for the (k+1 )th time sampling point with a 
sampling rate of 20 G samples/s(& = 0.05 ns).The fluorescence decay 
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functionh(k) was assumed to follow a bi-exponential (BE) decay model26, 
whereh(k) was a weighted average of two exponential decay functions with two 
time constants, 't1 and 't2 [Equation (1)]: 
fork= 0 ... K -t 
(1) 
a1 and a2were the amplitude of the components at t = 0, and 't1 and 't2 were 
estimated from time-resolved fluorescence responses. However, we must 
emphasize that, with bi-exponential model, we did not implicitly assume that the 
fluorescence system under study was composed of two distinct fluorescent 
species. Rather, the choice of number of exponential decay components was 
merely justified by the goodness of fit. The time constants for the two 
components were considered as averaged time scales for fast components and 
slow components in the fluorescence system respectively. 
The average lifetime can be calculated as Equation (2}, 
at ·Eilk~a<k> 
Tavg = l:k A(k) (2) 
Incidentally, for bi-exponential model with decay profile in (1), Equation (3) gives, 
(3) 
The fractional contribution for each time constant to the average lifetime was 
defined as Equation (4): 
(4) 
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The fluorescence spectrum was obtained by integration of the measured 
fluorescence decay curves over time. The fluorescence spectra were normalized 
by maximum fluorescence intensity along the entire emission wavelength. 
The ultrasound image was formed by subtracting the DC offset from the 
ultrasonic radiofrequency (RF) data, and a band-pass filter with frequency range 
of 24 to 75 MHz was used to remove high frequency noise. The Hilbert transform 
was applied to the filtered RF signals to detect the envelopes, followed by a 
logarithmical compression. The processed data for each line of sight were 
displayed as a gray-scale B-mode ultrasound image showing the reconstruction 
of the cross section of the tissue constructs. 
Statistical and correlation analysis: Six samples were assessed with conventional 
biochemical and biomechanical tests, as well as noninvasive optical and 
ultrasonic measurements for each group. A one-way ANOVA test was used to 
analyze the data and Tukey's post-hoc test was used when warranted. 
Significance was defined as p<O.OS. All the data were presented as mean ± 
standard deviation. Pairwise comparisons were generated between all optical 
and conventional parameters and correlation coefficients with p<O.OS were 
considered significant. Correlation coefficients are reported in the results. 
Results 
TRFS of tissue fluorophores: The fluorescence emission characteristics obtained 
from the major intrinsic fluorophores in cartilage tissue are presented in Fig. 2. 
Collagen showed significantly stronger fluorescence intensity than all other 
140 
fluorescent components (Fig. 2a). While the fluorescence spectral shape of GAG 
(chondroitin sulfate) strongly overlapped (emission peak at -400 nm) that of 
collagen (Fig. 2b), the intensity of GAG was significantly lower by 6.5 times. Both 
aggrecan and NADH had red-shifted emission peaks at -450 nm and -465 nm, 
respectively (Fig. 2b). Collagen exhibited the longest lasting emission among all 
fluorophores as demonstrated by both the average lifetime values (-5.6 ns at 400 
nm) (Fig. 2c) and the slow decay time component 't2 value (-6.7 ns at 400 nm) 
(Fig.2d) that accounted for -80% of the overall decay (Fig. 2e). GAG presented 
also a relative long lasting emission with an average lifetime slightly lower than 
collagen (-4.3 ns at 400 nm) and a slightly different decay dynamics 
characteristics (-5.0 ns't2 and -83% A2). Aggrecan presented a faster decay 
dynamics (-3.1 ns 'taverage. -4.4 ns 't2 and -65% A2at 400 nm) when compared 
with both collagen and GAG. The NADH in free form presented a very fast decay 
dynamics with an average lifetime in sub-nanosecond range (-0.38 ns at 465 
nm) as previously reported. 12 
TRFS of cartilage constructs: The time-resolved fluorescence spectrum of the 
four groups of cartilage samples (control, collagenase, C-ABC, and ribose,) can 
be fully described by various combinations of spectroscopic parameters as a 
function of wavelength (Fig. 3). The cartilage samples treated with collagenase 
had degraded collagen contents and presented a significantly lower intensity by 
33% compared to the control group which showed the highest intensity in the 
400-460 nm spectral range (Fig. 3a). The emission spectra of all groups were 
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largely overlapped (peak at -430 nm), except for the control group that showed a 
slightly blue-shifted peak emission (-415 nm)(Fig. 3b). Major changes of the 
average lifetimes of all the groups occurred at the wavelength band of 400/40 nm 
instead of the fluorescence emission peak of 430 nm. The average lifetimes were 
elevated at 400/40 nm and then decreased when the wavelength increased (Fig. 
3c). The control and C-ABC groups with higher collagen concentration (C-ABC 
deleted GAG therefore increased GAG concentration) exhibited the longer lasting 
emission compared to other groups as demonstrated by the average lifetime 
values of- 2.8 ns(Fig. 3c)and the dynamics characteristics (-3.8 ns 't2 and -70% 
A2)(Fig. 3dand 3e).The samples of the collagenase group with degraded collagen 
contents showed a fast decay dynamics (-2.4 ns'taverage at 400/40 nm, -3.4 ns 
't2,and -65% A2). There was no significant difference for the fast decay 
components 't1 for all the groups obtained from multiexponential deconvolution 
(0.7 ns at 400 nm) (Fig. 3d). The fractional contribution of the slow decay A2 
contributed more to the average lifetime and showed more difference between 
groups (Fig. 3e). 
A set of time-resolved parameters were analyzed statistically for each group 
and summarized in Fig. 4. If the mean value of average lifetimes was calculated 
over the whole wavelength range from 360-600 nm, the lifetime value of the C-
ABC group was significantly longer the lifetime of the control group (Fig. 4a). The 
average lifetime at 400/40 nm (this band was picked at the area with the major 
changes of decay dynamics) of the collagenase group was significantly lower 
than the control and C-ABC group (Fig. 4b) but no significant difference was 
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shown between the C-ABC and control group. Information at longer wavelength 
also helped with differentiation between groups by comparing Fig. 4a and 4b. For 
the slow decay constant -r2 at the wavelength band of 400/40 nm, the -r2 value of 
the constructs treated by C-ABC was significantly increased by 12% than the -r2 
of the collagenase group which related to the increase of the collagen 
concentration (Fig. 4c). The slow decay constant -r2contributed to the overall 
fluorescence emission greater than 60% regardless of the treatments(Fig. 4d). 
The fractional contribution of the slow decay constant A2 of the collagenase also 
showed significantly lower than the control and C-ABC group (Fig. 4d). The 
combination of -r2 and A2resulted in a significant faster decay and shorter average 
lifetime for the collagenase group compared to the control and C-ABC group. 
UBM images of cartilage constructs: UBM images of the cross section of the 
cartilage samples from the four treatment groups are shown in Fig. 5. The 
surface of the sample was well defined with a homogeneous region within the 
margins (Fig. Sa). The thickness of each sample was determined from the top 
and bottom surfaces of the UBM images at ten different locations and the 
average thickness was compared between groups (Fig. 5b). The collagenase 
group was found to have a significantly lower thickness of 0.22±0.02 mm 
compared to the thickness of 0.41±0.04 mm for the control group, decreasing 
46% compared to the thickness of the control group. 
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Histology. Histology results are summarized in Fig. 6. Picrosirius red staining 
showed decreased collagen abundance in collagenase-treated samples, 
whereas the other two treatment groups exhibited similar staining intensities as 
controi(Fig. 6a). Saf-0/fast green stained the control and ribose groups more 
than the collagenase or C-ABC treatment groups(Fig. 6b). Collagenase deleted 
collagen fibers such that GAG compositions were not held in the network and 
were washed out.C-ABC administration resulted in less GAG staining than 
collagenase treatment. 
Biochemical and biomechanical results: Biochemical and biomechanical 
assessments are shown in Fig. 7. Collagen content decreased significantly 
following collagenase treatment and increased significantly for neotissue treated 
with C-ABC (Fig. 7a). Ribose treatment did not statistically alter collagen content. 
GAG abundance decreased for constructs treated with collagenase and C-ABC, 
resulting in GAGNm values of 5.1% and 3.1% for collagenase and C-ABC 
treatments, respectively(Fig. 7b).Ev significantly decreased after collagenase 
treatment. In contrast, tensile strength increased following both C-ABC and 
ribose treatments, increasing by 72% and 49%, respectively(Fig. 7c). 
Compressive stiffness decreased significantly for both collagenase and C-ABC 
treatment groups. Aggregate modulus values were 70 kPa and 36 kPa for the 
collagenase and C-ABC treatment groups, respectively. Ribose treatment did not 
significantly alter the compressive stiffness (Fig. 7d). 
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Correlation with optical, biochemistry, and biomechanical properties: Parameters 
between technologies (optical, biochemistry, and biomechanical methods) with 
high and significant correlation were selected. The time-resolved parameters 
such as't390, 't4so, 'tt-39o, 'tt-4so,showed high correlation (r>0.45) and significant 
correlation with collagen/ww and Young's modulus (Ev). Significant and high 
correlation was observed for collagen/ww with Ev (r-0.67), and collagenlwwwtih 
average lifetime over all the wavelengths (r-0.7) (Fig. Ba). In comparison, 
significant and high correlation was observed for GAG/ww with HA(r-0.67). 
However, no significance was shown between GAG/ww and the average lifetime 
over all the wavelengths (r=-0.35) (Fig. 8b). Correlation analysis was also 
performed for the average lifetime from the wavelength band of 400/40 nm. High 
and significant correlation was observed for collagen/ww and average lifetime at 
400/40 nm with r-0.69 and no significant correlation was observed between 
GAG/ww and the average lifetime at 400/40 nm. 
Discussion 
Biochemical compositions and TRFS results: Given the biochemical content of cartilage 
tissue constructs, the most likely auto-fluorescent biomolecules in these constructs are 
the constituents of the extracellular matrix (collagen type II, crosslinks, and GAGs) and 
the NADH in cells. The fluorescence emission of these biological fluorophores was 
studied (Fig. 2) and found consistent with values in literature.8•27While GAG 
demonstrated a peak fluorescence emission at about 400 nm, similar to emission peak 
of collagen, GAG emission measured in tissue extracts for the same excitation fluence 
rate was found more than six times weaker than that of collagen (Fig. 2a). This 
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suggested that (1) GAG had less contribution to the overall fluorescence emission due to 
the weak emission intensity and (2) the collagen emission characteristics were most 
likely to dominate the whole emission when both collagen and GAG molecules are 
present. The fluorescence spectrum of the aggrecan composition showed an emission 
peak of 450 nm, close to the emission peak of the spectrum of the cartilage sample 
(420-430 nm), demonstrating the contribution of aggrecan to the cartilage 
autofluorescence (Fig. 2a). To our best knowledge, this is the first time to report the 
time-resolved fluorescence spectroscopic data for GAG and aggrecan. 
Current TRFS results obtained for cartilage constructs showed that blue-
shifted increased fluorescence intensity and longer average lifetime values at 
400 nm. In addition, most of the changes of the decay dynamics, such as 't2 and 
A2, happened at -400 nm (Fig. 3). Mature collagen presents a blue-shifted peak 
emission at about 390-400 nm with and a lifetime greater than5 ns. Moreover, 
the TRFS revealed statistically significant decreases in average fluorescence 
lifetime values (400/40 nm) as a function of collagen content, ranging from 2.65 
ns in control samples to 2.37 ns in collagen-depleted samples (Fig. 4b). This was 
further demonstrated by the correlation in Fig. 8 where collagenlww showed 
significant and high correlation with the average lifetime (r=0.7), but the 
correlation between GAG/ww and average lifetime was not significant. Therefore, 
all the results above confirmed that (1) collagen dominated the fluorescence 
emission of cartilage constructs and (2) if collagen contents were increased by 
endogenous agents, fluorescence intensity and average lifetime were both 
increased and the changes occurred at - 400 nm. The emission peak of the 
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spectrum of the cartilage constructs was -430 nm (not 400 nm) due to the 
contribution of aggrecan and NADH. 
Combination of multiple time-resolved fluorescence parameters: Time-resolved 
fluorescence parameters were robust for the characterization of tissue 
fluorescence emission due to the independence of the excitation intensity and 
light excitation-collection geometries. These parameters including the decay 
constants 't1, 't2, fractional contribution A2, and average lifetime at specific 
wavelength bands, allowed full characterization of the fluorescence dynamics 
originated from tissue constructs (Fig. 4). For example, average lifetime gave an 
estimation of the mixture of different biochemical compositions, but the fast and 
slow decay constants and the fractional contribution of each decay constants 
gave a more detailed description of the decay dynamics (Fig. 2, 3, 4). The 
combination of a set of time-resolved parameters provided a more stable and 
sensitive detection of biochemical compositions. 
Potential optical quantification of collagen cross/inks: The crosslinks 3-
hydroxypyridinoline and pyridinoline present a peak fluorescence emission 
around 390nm and are identified as abundant components of cartilage collagen. 
Thus, this crosslink is most likely to dominate the fluorescence of mature 
collagen type II. Crosslink between collagen fibers has an important impact in cell 
and tissue mechanics and tissue engineering. Cartilage specifically forms 
hydroxylysyl and lysylpyridinoline crosslinks that exhibit an emission peak around 
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400nm when excited with 325nm light.238 Our future work is geared towards 
optical characterization of collagen crosslinks using time resolved fluorescence 
spectroscopy. We hope to study collagen gels with controlled crosslink and 
correlate HPLC,216 mechanical and biochemical assay results to fluorescence 
intensity and lifetime results in these gels. Results may shine light upon the 
feasibility of developing a non-invasive optical assay for monitoring cartilage 
development in-vitro by tracking collagen crosslink. 
Possible tissue characterization with UBM RF data: Optical coherence 
tomography (OCT)was used to quantify optical surface reflection and surface 
roughness of articular cartilage,239 providing high resolution images (-10om) but 
limited penetration depth (-1 mm). In clinical study, the modalities for 
osteoarthritis diagnosis include x-ray,240 arthroscopy,241 and magnetic resonance 
imaging (MRI).242 However, all these techniques have some limitations. X-ray 
and arthroscopy are invasive approaches, and MRI is limited by resolution and 
expensive. Here, we determined that UBM measurements successfully 
complemented the optical methods by providing morphological information of the 
cross section of the sample with greater penetration depth. In its current 
configuration, UBM can reach a penetration depth of 5-6mm, which is more than 
1 0 times deeper than attainable for the optical techniques applied here ( <250 
1Jm). The analysis of the ultrasound RF signals facilitates a direct visualization of 
the sample but may also allow for evaluating mechanical information. 243 
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Feasibility of non-invasive evaluation with the combined TRFSIUBM: The tissue 
characterization techniques, TRFS and UBM, successfully detected changes in 
tissue construct composition that correlated strongly with standard biochemical 
and mechanical analysis. The tissue samples with collagenase treatment showed 
significantly shorter lifetime at 400/40 nm compared to other groups since the 
collagen contents were depleted by collagenase (Fig. 4b). C-ABC treatment 
depleted GAG and therefore increased the concentration of collagen, resulting in 
an increase of average lifetime (Fig. 4a). The collagenase group gave the 
weakest fluorescence intensity and also the shortest average lifetime because 
the collagenase not only degraded the collagen network but also decreased the 
GAG content. UBM provided parallel information in terms of the growth of the 
constructs with different types of treatments. The reduced thickness of the 
collagenase group and C-ABC group samples was attributed to the depletion of 
the collagen and GAG respectively (Fig. 5). These observations were validated 
by biochemical results where the collagenlww of the collagenase group was 
lowest among the groups and the GAG/ww was lowest for the C-ABC group (Fig. 
7). In summary, a set of optical parameters (such as average lifetime at specific 
wavelength bands, decay constants, and fractional contribution) could be used to 
infer the biochemical and biomechanical properties of engineered tissues. 
Conclusions 
This paper presented a novel technique to evaluate tissue engineered 
articular cartilage using combined optical and ultrasound techniques. The 
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approach allowed characterizing a cartilage construct's collagen composition and 
structure in a nondestructive manner. Significant and high correlations were 
found between Young's modulus and collagen/ww, as well as aggregate modulus 
and GAG/ww. Moreover, significant and high correlation was observed between 
optical parameters and collagen/ww, but not GAG/ww. Each modality examined 
in this study demonstrated the ability to discriminate between changes in 
constructs treated with exogenous agents. Correlations of optical parameters 
with results from traditional assays demonstrated the potential of this bimodal 
technique in non-invasive evaluation of tissue engineered cartilage. Our future 
work will be focused on using the system to quantitate more subtle changes 
involved in in vitro differentiation such as collagen crosslinks. 
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Figure 6-1: Schematic diagram of the combined TRFS-UBM system. 
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System includes laser source module, TRFS subsystem, UBM subsystem, and 
the combined probe (transducer+fiberoptics). A tissue engineered cartilage 
sample (at t=week 4) is shown. 
Figure 6-2: Fluorescence spectroscopic data. 
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Data were acquired from the major endogenous fluorophores in the cartilage 
samples, including collagen type II, GAG powder, aggrecan, and NADH in cells. 
The time-resolved fluorescence parameters were retrieved with bi-exponential 
deconvolution. (a) Plots of fluorescence spectrum, (b) normalized spectrum, (c) 
average lifetime, (d) fast decay constant -r1 (filled symbols) and slow decay 
constant -r2 (open symbols) for collagen, GAG, and aggrecan(since NADH has 
only one exponential component, NADH was not included here),and (e)the 
fractional contribution of the slow decay component A2. 
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Figure 6-3: Fluorescence spectroscopic data of constructs 
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Fluorescence data were acquired from four groups of cartilage samples with 
different types of treatment (control , collagenase, C-ABC, and ribose). The time-
resolved fluorescence parameters were retrieved with hi-exponential 
deconvolution. (a) Fluorescence emission spectrum, (b) normalized spectrum, (c) 
average lifetime, (d) fast decay constant -r1 (filled symbols) and slow decay 
constant -r2 (open symbols), (e) fractional contribution of the slow decay 
component A2. 
Figure 6-4: Quantification of the time-resolved fluorescence parameters 
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(a) the mean value of the average lifetime from 360 nm to 600 nm, (b) average 
lifetime at 400/40 nm, (c) slow decay constant -r2at 400/40 nm, (d) andfractional 
contribution of the slow decay component A2. 
Figure 6-5: Ultrasound imaging of constructs 
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(a) UBM images of the cartilage samples from the four groups. (b) Thickness 
measurements of samples for each group. 
Figure 6-6: Histology results 
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(a) Picrosirius Red for collagen and (b) Saf-0/fast green for GAG. Both stain 
were positive for control and ribose groups, but C-ABC and collagenase 
treatments decreased GAG staining. Collaganese treatment also decreased 
collagen staining intensity. 
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Figure 6-7: Biochemistry and biomechanics results 
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(a) collagen content and (b) GAGcontent normalized by wet weight of the 
sample. Biomechanical results for (c) Young's modulus and (d) aggregate 
modulus for the four groups. 
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Figure 6-8: Correlation between optical and conventional assessments 
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(a) Correlations between collagen/ww and Ev (Pearson r=0.67, p=0.0003}, 
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Chapter 7: Collagens of articular cartilage: structure, 
function, and importance in tissue engineering* 
Abstract 
158 
Collagen is a crucial matrix component of articular cartilage. Because articular 
cartilage is a load bearing tissue, developing mechanical integrity is a central 
goal of tissue engineering. The significant role of collagen in cartilage 
biomechanics necessitates creating a collagen network in tissue engineered 
constructs. An extensive network of collagen fibrils provides cartilage with 
mechanical integrity, but developing strategies to replicate this collagen network 
remains a challenge for articular cartilage tissue engineering efforts. To study the 
structure and biomechanics of the collagen network, many experimental and 
computational methodologies have been developed. However, despite extensive 
cartilage tissue engineering research, few studies have assessed collagen type, 
crosslinks, or fibril orientation. Further study of the collagen network, both within 
native tissue and engineered neotissue, will enable more robust constructs to be 
developed. This review focuses on the biology and biomechanics of the collagen 
network, relevant experimental methods for assessing the collagen network, and 
articular cartilage tissue engineering studies that have examined collagen. 
Chapter published as Responte OJ, Natoli RM, Athanasiou KA. Collagens of articular cartilage: 
structure, function, and importance in tissue engineering. Critical Reviews in Biomedical 
Engineering. 35(5): 363-411, 2009. 
Motivation 
Articular cartilage 
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Articular cartilage is a hyaline cartilage that lines the articulating surface of bones 
that is devoid of vasculature, nerves, and lymphatics.1 Articular cartilage consists 
of a solid phase and a fluid phase. Water, along with dissolved solutes form the 
fluid phase, accounts for 60-85% of the total cartilage weight.2 The solid phase 
primarily includes collagen, proteoglycans, and chondrocytes. Chondrocytes, the 
only cell type within cartilage, comprise only 1-5% of the tissue by volume.1 
Because cartilage lacks vasculature, chondrocytes receive nutrients by diffusion 
or imbibition and exudation during loading. The organization and presence of 
cells and matrix components exhibit depth-dependence within cartilage. 
Cartilage injury and disease 
The avascular, aneural, alymphatic, and largely acellular nature of cartilage 
hinders tissue repair.9 Cartilage injury produces a mechanically inferior repair 
fibrocartilage,10•11 which prevents recovery of cartilage functionality. In particular, 
increased collagen I and decreased glycosaminoglycan content within 
fibrocartilage alters the tissue's mechanical properties. The repair tissue 
ultimately breaks down, resulting in continual degeneration leading to 
osteoarthritis. 
Osteoarthritis is a significant problem worldwide, especially in developed 
countries, resulting in a great economic burden. In western nations, it is 
estimated that up to 2.5% of the GNP is spent on arthritis,244 and in the United 
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States, expenditures for arthritis and other rheumatic conditions exceeded $320 
billion in 2003.12 It is estimated that 1 0% of the world's population aged 60 years 
or more has osteoarthritis, 13 making it a leading cause of disability.245 
Osteoarthritis is also associated with some of the poorest quality of life issues, 244 
particularly in terms of pain and physical function. The prevalence and severity of 
cartilage degeneration provides a strong impetus for engineering articular 
cartilage. 
Collagen and tissue engineering 
Due to the limited regenerative capacity and physiological importance of articular 
cartilage, damaged or diseased tissue needs to be replaced. Tissue engineering 
has the potential to substantially improve treatment of cartilage defects. The 
hydrated matrix of cartilage, composed primarily of proteoglycans and collagen, 
creates the mechanical integrity of the tissue. The importance of the matrix in 
cartilage biomechanics, and its ability to withstand a demanding mechanical 
environment, necessitates producing a suitable matrix in tissue engineered 
constructs. 
The structure of the collagen network contributes extensively to the 
mechanical integrity of cartilage, particularly to the tensile properties.128 Collagen 
comprises 60-85% of adult articular cartilage by dry weight,2 making it a 
significant component of the extracellular matrix. Several types of collagen form a 
fibrillar network within the tissue. Many experimental methods exist to study the 
composition, structure, and crosslinking of this network. In addition, theoretical 
and computational models have been developed to analyze the role of collagen 
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in articular cartilage biomechanics. Despite extensive research, tissue 
engineered articular cartilage tends to have significantly less collagen than native 
tissue. 246-248 Strategies for improving this shortcoming will be needed to move 
closer to functional tissue engineered cartilage. This review covers the biology 
and mechanics of the collagen network in articular cartilage, pertinent 
experimental methods for studying collagen, and results from articular cartilage 
tissue engineering studies. In doing so, methods and directions for advancing 
engineering of the articular cartilage collagen network are highlighted and 
identified. 
Biology of articular cartilage collagens 
Types of collagen 
Collagen molecules are comprised of three polypeptide chains that form a unique 
triple helical structure. These polypeptides contain high numbers of the repeating 
peptide sequence glycine-X-Y, where X and Y are frequently proline and 
hydroxyproline. This sequence helps stabilize the triple helix structure. 
Additionally, there are two short extrahelical telopeptides on each polypeptide 
chain which have neither the repeating peptide sequence nor a triple helical 
conformation. The most common types of collagen are the fibrillar molecules that 
assemble into fibrils; examples of fibrillar collagens include collagens I, II, and XI. 
The major collagen source within articular cartilage is a heteromer of collagen 
types II, IX, and XI, which is over 90% collagen 11.3•4 This heteromer forms the 
fibrillar network that provides articular cartilage with is tensile strength and 
stiffness. As shown in Fig. 1, these fibrils have a hierarchical organization. 
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Collagen VI is localized around the chondrocytes and contributes to mechanical 
properties of the pericellular matrix, as well as cell signaling. Several types of 
collagen, namely collagens I and X, are rarely expressed in normal articular 
cartilage but are present during development and certain pathologies. The 
following provides a brief synopsis of the collagens commonly studied in articular 
cartilage. 
Collagen II 
Collagen II is only found in articular cartilage and the vitreous humor of the eye, 
and it accounts for the majority of collagen in hyaline cartilage.249 As the 
predominant collagen of the heterofibril, collagen II is a primary indicator of 
hyaline cartilage differentiation. Although collagen II accounts for 75% of fetal 
collagen, as the tissue matures the collagen II proportion increases to 90%.3 
Collagen II has been shown to be expressed at higher levels by proliferating 
human fetal chondrocytes.25° Furthermore, creating transgenic mice that did not 
express collagen II resulted in chondrocyte apoptosis, 251 indicating the necessity 
of collagen II in articular cartilage. 
Collagen IX 
Collagen IX forms covalent links between other collagen IX molecules and also 
crosslinks collagen II molecules as shown in Fig. 18.252 Because collagen IX is 
only found in cartilage and a few other tissues such as the vitreous humor and 
developing cornea,253 it can be used as a marker for cartilage differentiation. The 
upregulation of collagen IX during maturation also suggests it has a role in 
163 
development. 254 In vivo studies have shown that collagen IX plays a structural 
role in the development and integrity of articular cartilage. For instance, collagen 
IX knockout mice displayed irregular integrin immunostaining and abnormal 
columnar arrangement of chondrocytes. However, these developmental 
problems largely attenuated as the mice aged.255 Other in vivo studies have 
shown the roles of collagen IX to include development of the cartilage growth 
plate256 and prevention of multiple epiphyseal dysplasia. 257 
Collagen XI 
Collagen XI is a fibrillar collagen that associates with collagen II. Type XI 
collagen comprises 10% of fetal cartilage collagen, but only 3% of adult tissue.3 
Collagen XI molecules crosslink primarily with other collagen XI molecules within 
the heterofibril.252 Additionally, collagen XI has also been shown to limit 
fibrillogenesis by inhibiting the growth of collagen II fibrils, which could be 
attributed to steric hindrance or interaction with other matrix molecules.258 This 
inhibition has been confirmed in vivo with collagen XI knockout mice that showed 
increased collagen fibril diameters. 259 
Collagen VI 
Collagen VI is localized in the matrix immediately surrounding chondrocytes, a 
region referred to as the pericellular matrix. 260 Type VI collagen contains the 
sequence Arg-Giy-Asp that binds to chondrocyte receptors. 261 It has been 
hypothesized that the close interactions between collagen VI and chondrocytes 
contribute to mechanotransduction,262 so replicating the collagen VI structure 
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may be important for creating an appropriate microenvironment for chondrocytes. 
Moreover, collagen VI mRNA is barely detectable in dedifferentiated 
chondrocytes, but starts to increase only six hours following differentiation. 263 
Development also entails localization of collagen VI in the pericellular region; it is 
more widely distributed throughout the matrix prior to birth.264 Collagen VI 
comprises less than 1% of adult collagen.3 
Collagen I 
Collagen I is produced in many different connective tissues of the body, but it is 
not typically expressed in hyaline articular cartilage. Study of the rabbit knee joint 
has shown that collagen I is expressed at the articular surface early in 
development, but disappears by six weeks after birth.265 However, collagen I is 
abundant in tissues such as ligament, tendon, temporomandibular joint disc, and 
the meniscus. Type I collagen also appears in repair fibrocartilage that fills 
defects in damaged articular cartilage. 266 Because repair cartilage is 
mechanically inferior to native hyaline cartilage, 267 collagen I expression is 
undesirable for tissue engineered articular cartilage. Culturing chondrocytes in 
vitro can result in dedifferentiation and collagen I production. 69•268 Thus, collagen 
I can act as a marker for the differentiation status of chondrocytes for tissue 
engineering procedures. 
Collagen X 
As with collagen I, collagen X is not expressed natively in hyaline cartilage. 
Generally, collagen X is only found near the bone, as immunohistological studies 
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have shown that collagen X is localized in the zone of hypertrophic and calcifying 
cartilage.269 In addition, collagen X is expressed by some cells at the articular 
surface of maturing cartilage264 and in osteoarthritic cartilage. 270•271 Collagen X 
has been shown to be localized at the lower growth plate of both chick embryo272 
and human fetal cartilage. 250 The appearance of collagen X in tissue engineered 
constructs can indicate hypertrophic chondrocytes. 
Collagen cross/inks 
The various types of collagen discussed above interconnect with one another via 
crosslinks. The enzyme lysyl oxidase mediates normal crosslinking273 and can 
form several types of crosslinks, including pyridinoline (Fig. x2-1C) and ketoimine 
linkages. In native articular cartilage, there are significantly more pyridinoline 
than ketoimine crosslinks, with a mean ratio of -12 to 1.274 Crosslinks can also 
be formed non-enzymatically when collagen amines react with sugars to form 
advanced glycation endproducts (AGEs).275 Many different sugars, including 
glucose, ribose, and threose, can play a role in AGE formation. For instance, 
adding ribose increased the formation of AGEs in the matrix of adult bovine 
chondrocytes. 276 In human articular cartilage, the formation of AGEs increases 
with advancing age.277 Increased AGE-mediated crosslinking contributes to 
increasingly stiff, brittle cartilage that may predispose cartilage to degeneration 
and osteoarthritis. 278 
Furthermore, the number and types of crosslinks change as the tissue 
matures. For example, as human cartilage matures, the number of crosslinks 
increases.249•279 Crosslinks increase with age in animal models as well. In bovine 
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explants, the number of collagen crosslinks per wet weight is 730% greater in 
adult cartilage relative to fetal cartilage.49 AGE crosslinks also show maturation 
dependence, increasing linearly with age after reaching maturity.278 After lysyl 
oxidase oxidizes a lysine residue, several intermediate structures form prior to 
forming a pyridinoline crosslink. Comparing the number of pyridinoline crosslinks 
to the number of crosslink intermediates provides one way of assessing tissue 
maturation.274 These results indicate that a tissue engineered construct may 
need the proper proportion of pyridinoline crosslinks to reflect native tissue. 
Crosslinks play several important functional roles in cartilage. In addition 
to effects on tissue mechanics, crosslinks increase collagen retention, which 
could impact cell signaling. Fewer crosslinks can also increase collagen 
susceptibility to proteases. 280 These various functions of crosslinks show the 
necessity of recapitulating suitable crosslinking in tissue engineered constructs. 
Collagen fibril/agenesis 
Fibrillogenesis is a sequential process that begins when individual collagen 
molecules are extruded from chondrocytes. After extrusion, the collagen 
molecules fuse, either laterally or linearly, to form larger fibrils. Initially, this 
process produces small fibrils with uniform diameters that eventually interconnect 
to form fibrils. As the tissue matures, the diameters of the fibrils increase and the 
fibril size becomes less uniform as depicted in Figure x2-2. Throughout this 
process, various mechanisms, such as growth inhibition and fibril degradation 
regulate fibril formation. The growth of fibrils is modulated at fibril interfaces by 
the binding of small proteoglycans. 281 Diffusion limitations can also inhibit fibril 
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growth.282 Additionally, chondrocytes produce collagenases that degrade 
collagen molecules. Various collagenases that chondrocytes produce provide a 
way to finely control collagen degradation.254•283 In particular, cleaving regions 
involved in crosslinking could destabilize fibrils. Modulation of fibril formation and 
degradation of fibrils control the development of the collagen network. 
Ultrastructure of articular cartilage 
Organization of collagen 
Articular cartilage has several structurally distinct regions known as the 
superficial, middle, deep, and calcified zones, and the properties of the collagen 
network vary significantly between zones (Table 1 ). In native tissue, collagen 
concentration is highest in the superficial zone and decreases farther from the 
articular surface,284 yielding an inhomogeneous distribution (Fig. 2). Additionally, 
the organization of the collagen fibrils varies depending on the zone, and was 
first characterized by Benninghoff in 1925.285 The superficial zone has fibrils 
oriented parallel to the articular surface. Beneath the superficial zone lies the 
middle zone that has larger fibrils that form interweaving arches. The deep zone 
contains the largest fibrils, which are oriented perpendicularly to the articular 
surface. The calcified layer contains the transition from the hyaline cartilage into 
the subchondral bone. This zonal variation can be attributed to the force 
distribution that cartilage experiences in vivo, 286•287 yielding an anisotropic 
arrangement in native tissue. Generally, the fibrils have smaller diameters near 
the surface, with a mean fibril diameter of 30-35 nm in the superficial zone and 
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40-80 nm in the deep zone. 147•148 Because collagen largely dictates the tensile 
properties, zonal variation of collagen fibril orientation and collagen content are 
important to consider when evaluating tensile properties of tissue samples. 
Within each zone, several types of matrix exist: the pericellular matrix, the 
interterritorial matrix, and the territorial matrix. The territorial matrix is farthest 
from the chondrocytes and has less aligned collagen fibrils. Closer to the 
chondrocytes, the interterritorial matrix has more oriented collagen fibers with 
larger diameters. The pericellular matrix immediately surrounds the chondrocytes 
and buffers the mechanical forces that the chondrocytes experience.2ss-291 The 
pericellular matrix can also impact cell-cell communication by sequestering 
soluble signaling molecules.292 
Although the zonal organization of cartilage has been identified, 
considerable structural variation exists. Studies have shown differences in 
collagen ultrastructure based on factors like age, anatomical origin of the sample 
(e.g., joint and location within a joint), and variations in individual anatomy and 
physiology_284•293•294 Although collagen organization of the superficial zone is 
widely confirmed, conflicting results pertaining to the intermediate and deep 
zones have been reported. Scanning electron microscopy (SEM) analysis has 
shown that fibrils in the intermediate zone actually form overlapping lamellae 
rather than interweaving arches. 295 Some studies of the deep zone have also 
shown divergences from the classic Benninghoff model of perpendicularly 
oriented fibrils. Traverse fibrils296 and fibrils with random orientations 148 have 
been observed, in addition to the predominant perpendicular arrangement. 
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However, the Benninghoff model characterizes the majority of the fibrils in 
articular cartilage. 
While the Benninghoff model describes collagen orientation through the 
depth of the tissue, split-lines illustrate the collagen orientation in the plane of the 
tissue surface. Pricking cartilage with a pin dipped in ink produces lines that 
correspond to fibril orientation in the superficial zone (Fig. 3). Electron 
microscopy has been used in various studies to show the correspondence 
between split-lines and collagen orientation.296•297 Within areas of cartilage that 
experience the most loading, split-line patterns are highly consistent between 
samples.298 Tensile properties have been shown to correspond to split-lines 
orientation.128•155 Split-lines show the importance of considering the in-plane 
collagen ultrastructure, in addition to the vertical variation. 
Ultrastructure development 
Studies in rabbit knee joints have shown that the organization of collagen 
depends on age, with initial organization in tibial plateau cartilage occurring 
within two weeks after birth. In particular, the orientation of collagen fibrils 
correlates with the acquisition of full mobility.299 As the animal matures, collagen 
fibrils acquire increasingly vertical orientations in deeper layers (Fig. 2), resulting 
in lower tensile strength parallel to the surface. 300 The factors that control 
development of collagen orientation have not been fully elucidated, but 
mechanical loading appears to govern this process. 301 
Mechanical loading on the tissue has been frequently proposed as the 
primary stimulus for collagen orientation.301 Additionally, theoretical modeling of 
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cartilage development based on a loading stimulus reproduces native collagen 
structure. 302 Although the loading hypothesis for ultrastructure development has 
not been fully confirmed, some experimental evidence exists. For instance, 
fibroblast-seeded collagen gels subjected to 2.5% cyclic strain develop fiber 
alignment and mechanical anisotropy.303 Various studies have also shown that 
loading of cartilage lowers the susceptibility of collagen to enzymatic 
degradation.304•305 This selective degradation has been proposed as a 
mechanism underlying mechanical stimulation of collagen orientation, but 
alternate mechanisms could also play a role. 
Collagen interactions with other matrix molecules 
Although the collagen network directly influences the mechanics of cartilage, 
interactions with other components of the matrix are also crucial. Various 
proteoglycans interact with collagen and, in many cases, regulate the assembly 
of fibrils. Reduced aggrecan deposition in mice has been shown to increase fibril 
diameter and alter banding patterns, suggesting interplay between aggrecan and 
collagen.306 Several small proteoglycans including lumican, decorin, and 
fibromodulin also interact with collagen. These interactions can regulate fibril 
diameter, fibril-fibril interactions, and susceptibility to degradation.6 Knocking out 
perlecan, a heparan sulfate proteoglycan, reduced the size and density of 
collagen fibrils. 7•8 This is in contrast to decorin and lumican knockout models, in 
which fibril size is increased. Molecules other than proteoglycans can also 
influence the collagen network. For example, cartilage oligomeric matrix protein 
(COMP) stabilizes fibrils by binding to collagen triple helices. 307•308 The 
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interactions between the collagen and various matrix components play a large 
role in governing the size and stability of collagen fibrils. 
Collagen-cell interactions 
Collagen also interacts directly with chondrocytes to influence cellular function. 
For example, interaction with collagen II increased chondrocyte aggregation and 
reduced the level of chondrocyte apoptosis. 251 In contrast, degrading collagen 
caused 45% of chondrocytes to apoptose; exogenous addition of intact collagen 
back to the culture reversed these apoptosis effects. 309 Similarly, administering 
caspase inhibitors has been shown to mitigate chondrocyte apoptosis induced by 
removal of collagen from the matrix.310 In addition to preventing apoptosis, the 
collagen network influences biosynthesis. For instance, inhibiting collagen 
crosslinking increased collagen levels by 100%, indicating a feedback 
mechanism between the collagen network and chondrocytes. 311 Collagen's 
influence on the survival and biosynthesis of chondrocytes shows the integral 
role of collagen-cell interactions in cartilage physiology. 
Although the cellular interactions with collagen are not fully elucidated, 
many of them have been attributed to integrin-(31 309 and annexin V.312 Annexin V 
has been shown to regulate mineralization of growth plate cartilage; it may have 
a role in pathological mineralization as well. 313 Studies have suggested that 
annexin V influences growth plate chondrocytes by altering calcium transport 
across cell membranes. 314 Knocking out integrins created abnormal chondrocyte 
shape and reduced chondrocyte proliferation by 35%.315 The integrin receptor 
also mediates the differentiation of chondrocytes and appears to be critical for 
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joint development. 316 These various collagen-chondrocyte interactions play a 
critical role in cartilage development and homeostasis. 
Conclusions 
The collagen network of articular cartilage is primarily composed of fibrils of 
collagens II, IX, and XI. In addition to collagen IX crosslinking, enzymatic (lysyl 
oxidase mediated) and non-enzymatic (AGE formation) crosslinks interconnect 
the fibrils. Crosslinks can impact cartilage biomechanics, collagen retention, and 
collagen susceptibility to proteases. As the tissue matures, collagen molecules 
fuse laterally or linearly to form larger fibrils and, ultimately, fibers. Collagen 
exhibits zonal variation within cartilage, both in terms of amount and orientation. 
Additionally, several distinct levels of collagen organization exist around 
chondrocytes with a pericellular matrix, territorial matrix, and interterritorial 
matrix. 
Collagen mechanics: theoretical, computational, and experimental insights 
As discussed above, collagen in native articular cartilage is inhomogeneously 
dispersed and anisotropically arranged. Further, cartilage has been shown to 
possess tension-compression non-linearity121 •317•318 due to the increased stiffness 
of collagen in tension. These features complicate theoretical and computational 
approaches. In this section, we will examine mechanical properties of collagen, 
mechanical models of articular cartilage specifically incorporating features of the 
collagen network, and experimental findings elucidating the varied roles of 
collagen in articular cartilage biomechanics. 
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Fibrillar and molecular stiffness of collagen 
Any effort to incorporate features of the collagen network into mechanical models 
of articular cartilage must be informed by the mechanical properties of collagen 
itself. Researchers have investigated collagen mechanical properties within 
tissue and at the single molecule level. At the single molecule level, material 
properties of collagen type II have been measured using optical tweezers, 
yielding an average persistence length of 11.2 nm.319 Assuming a solid rod with 
circular cross section of diameter d, an estimate of the Young's modulus (Ev) 
from the persistence length (Lp) is given by Ev = (64k8 TLp)/(rrc:f), where ka is 
Boltzmann's constant and T is the temperature. 320 At room temperature (23°C), 
and assuming a diameter of 1 nm, Ev = 0.93 GPa. Other investigators have also 
found the stiffness of the collagen molecule to be in the range of a few GPa by X-
ray diffraction and Brillouin light scattering.321-323 
In an early study on collagenous tissue, Haut and Little324 proposed a 
quasi-linear viscoelastic constitutive equation for collagen fibers from rat tails and 
measured the material properties via tensile stress-relaxation tests. They then 
used the measured material properties to predict the tissue's behavior under 
constant strain-rate, hysteresis loop, and dynamic tests, finding good 
experimental agreement with all but the latter. The value of the material property 
corresponding to the elastic nature of collagen fibers was found to be 11.5 GPa. 
Quasi-linear viscoelasticity of collagen fibers has more recently been examined 
in articular cartilage. Using tensile step-wise stress relaxation testing, the 
instantaneous fibrillar modulus was found to be -2.2 times the relaxed modulus 
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(Ere/axed). the latter of which depended on applied strain (E), as Ere/axed = 0.5 + 
250£ MPa.325 Another study suggests that collagen type II has an elastic modulus 
of 7 GPa. 326 It is important to know the stiffness of collagen fibers for 
implementation in mechanical models of articular cartilage, a topic which we will 
now discuss. 
Theoretical and computational models of articular cartilage 
incorporating the effects of collagen 
Fiber reinforced continuum models 
While there are several ways to incorporate features of the collagen network in 
material models of articular cartilage, fiber reinforced continuum models (Fig. 4A) 
have been the most common approach.127•136•327-341 However, it must be noted 
that the presence of fibers within a composite does not guarantee that the 
mechanical behavior of the bulk material will be different than it is without the 
fibers. As Aspden342•343 points out with respect to cartilage, a collagen fiber must 
exceed a critical aspect ratio to have a sufficient interaction force with the rest of 
the extracellular matrix to effectively transfer stress to the fiber. While collagen 
fibers in native tissue satisfy this aspect ratio, fiber aspect ratio may be an 
important consideration in tissue engineering efforts. 
At the most basic level, fiber reinforced models include fibers distributed 
throughout the solid matrix that are predominantly active in tension (Fig. 48). In 
an early study, Schwartz et al.127 related the stiffness at the continuum level to 
the microstructure of articular cartilage. Their microstructural model consisted of 
bilinear elastic fibers embedded in an elastic matrix. The fibers, representing 
collagen, were given a tensile modulus of 150 MPa and a compressive modulus 
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of 2 MPa. They also allowed the fibers to have random orientation throughout the 
tissue. An interesting finding, which has also borne out in subsequent studies, is 
that re-orientation of the fibers during loading leads to increased stiffness in the 
direction of the applied load and a non-linear tensile stress-strain curve. Elastic 
fibers have also been incorporated into the linear biphasic model118 to overcome 
difficulties the homogeneous biphasic model has in fitting unconfined 
compression experiments.339 It was found that a fiber Young's modulus of 11 
MPa best frt unconfined stress relaxation experiments. Additionally, it was 
discovered that different constituents in the model (e.g., fibers or the matrix) can 
experience substantially different stresses in a region of identical strain. This 
feature is not present in homogeneous models. 
The elastic fiber reinforced biphasic model has been improved upon to 
include cartilage inhomogeneities through the incorporation of depth-dependent 
material properties and anisotropy, by orienting the collagen fibers differently 
through the depth of the tissue. 332 This model was also used to investigate the 
strain-rate dependent stiffness of articular cartilage, which was attributable to 
"self-stiffening" of fibers, with little contribution from the rest of the solid matrix. 344 
In a recent study, the anisotropic nature of the collagen network was also 
accounted for by orienting the fibers according to their zonal structure: parallel to 
the articular surface in the superficial zone, random in the middle zone, and 
perpendicular to the subchondral bone in the deep zone. 338 It was shown that 
deep vertical collagen fibers increase tissue stiffness in the transient period of 
loading, which the authors postulate may be mechano-protective against damage 
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to the underlying bone. Collagen fibers in biphasic fiber reinforced models have 
also been treated as viscoelastic.330•340•341 •345 These studies have also shown that 
collagen network architecture is important in determining the tissue's mechanical 
behavior. One study used sample-specific data for the tissue's composition,330 
demonstrating the degree of specificity that can be incorporated into these 
models. Finally, this line of inquiry has even been extended to include 
hyperelastic fibers in a viscohyperelastic matrix within a biphasic framework, 
thereby creating a model that accounts for the non-linear nature of finite 
deformations. 329 
Other models incorporating features of the collagen network 
Other methods for including aspects of the collagen network into mechanical 
models include transversely isotropic theories, 346•347 conewise linear 
elasticity,318•348 and microstructural models taking into account collagen 
distribution, orientation, or crosslinking.349-351 (Fig. 4A) With respect to articular 
cartilage, planes parallel to the articular surface are the transversely isotropic 
planes. Thus, the tissue's material properties are different perpendicular to the 
surface compared to parallel to the surface. It was demonstrated that a 
transversely isotropic, transversely homogeneous model was able to predict non-
uniform behavior of the tissue, whereas the isotopic homogeneous model could 
not.347 To account for the tension-compression non-linearity of cartilage material 
properties, Soltz and Ateshian318 developed a conewise linear elastic model 
within a biphasic framework. Though developed at the level of an orthotropic 
material, due to experimental considerations, they reduced the model to cubic 
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symmetry. Good agreement was found between theory and experiment for both 
confined and unconfined compression experiments and torsional shear testing. 
On average, articular cartilage was -21 times stiffer in tension than compression. 
In an interesting study, Quinn and Morel351 generated a model for articular 
cartilage mechanics using only one material property, an elastic modulus of 70 
MPa for the collagen fibrils. The rest of the model was generated taking into 
account the molecular orientation and distribution of collagen fibers and their 
interaction with the proteoglycan gel. Scaling up the model allowed prediction of 
continuum level mechanical properties in reasonable agreement with previous 
experimental measurements. The model also predicts novel matrix interactions at 
low compressive strains (-1 %) where current experimental data are limited. 
Lastly, two studies have initiated investigation into connections within the 
collagen network349•350 (e.g., crosslinking), one of which suggests substantial 
differences between collagen modeled as a network than when modeled as 
moving in an affine manner. 
Experimental findings 
Effects of collagen amount. orientation. and intrinsic viscoelasticity on 
tensile properties 
Turning now to predominantly experimental work, as early as 1973 the tensile 
properties of articular cartilage were shown to be related to collagen amount, as 
well as to its anisotropic and inhomogeneous arrangement within the tissue.128 
Specifically, it was shown that cartilage is stiffer in the superficial zone compared 
to deeper zones (Table 1) and also stiffer when pulled parallel to the predominant 
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fiber orientation (determined by split-lines, Fig. 3) compared to when pulled 
perpendicularly. Woo et al.155 found similar results to the aforementioned study 
by employing an exponential stress-strain law (equivalent Young's modulus 
ranged 1.65 to 3.5 MPa) as opposed to simply fitting the linear portion of the 
stress-strain curve. Results from both of these studies were additionally related 
to the preferred direction of collagen fibers determined by polarized light 
microscopy or SEM. 
More recently, tension-compression non-linearity (i.e., the disparity 
between tensile and compressive moduli measured in articular cartilage) and 
flow-independent viscoelasticity of the solid matrix (i.e., that part of the viscous 
behavior due solely to the solid matrix and not flow of fluid within the matrix) have 
been examined experimentally.121 ·317•352 Huang and associates121 ·317 employed 
the biphasic-conewise linearly elastic quasi-linear viscoelasticity model (8-CLE-
QL V) during confined and unconfined stress-relaxation compression tests of 
articular cartilage at both slow and fast strain rates, finding an average aggregate 
modulus in tension of 8.8 MPa. The 8-CLE-QLV was able to simultaneously 
describe the tensile and compressive behavior, performing better than the 
preceding biphasic-conewise linear elastic and biphasic poroviscoelastic models 
of articular cartilage. These findings suggest tension-compression non-linearity 
and flow-independent matrix viscoelasticity, both attributable to collagen, are 
important contributors to the transient mechanical behavior of articular cartilage. 
Another study examined the tensile properties as a function of strain rate, finding 
similar Young's moduli and ultimate tensile strengths at 1, 20, and 50% strain s-1, 
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but significantly increased properties at 70% strain s-1. The authors suggest this 
may be a protective mechanism for cartilage to withstand sudden traumatic 
loads.352 
Effects of collagen crosslinking on tensile properties 
While collagen content, anisotropy, and inhomogeneity are important in 
determining cartilage tensile properties, another important aspect is the amount 
of crosslinking present in the collagen network.200 Williamson et al.49•50 studied 
changes in collagen content and pyridinoline crosslinking as a function of age in 
a bovine model and related them to tissue tensile properties. They found that 
both increasing collagen amount and pyridinoline crosslinking correlated with 
increases in equilibrium and dynamic tensile stiffness and tensile strength. As an 
alternative approach, one study inhibited crosslink formation by treatment with J3-
aminopropionitrile (BAPN), an inhibitor of the crosslinking enzyme lysyl oxidase, 
and measured tensile properties. Results showed that treated explants had 
significantly less crosslinking and decreased tensile properties.353 In addition, 
administering sugars exogenously increased the formation of AGEs and, 
subsequently, increased the stiffness of the tissue.276 The biomechanical role of 
AGEs is unclear, if not controversial. Increased AGEs may be a way in which 
cartilage attempts to mitigate the decrease in mechanical properties associated 
with aging or, by causing cartilage to become more brittle, be an explanation for 
why advanced age is a risk factor for the development of osteoarthritis. 
Regardless, these studies, and those mentioned above, underscore the 
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complicated role the collagen network plays with respect to the tensile 
mechanical properties of articular cartilage. 
The role of collagen in compression 
Though it is well accepted that the GAG content of articular cartilage is essential 
for its compressive properties, collagen has also been shown to have a role in 
governing compressive behavior and, interestingly, Poisson's ratio. In articular 
cartilage, the negatively charged GAGs lead to substantial hydration within the 
tissue that induces a swelling pressure able to resist compressive loads. The 
swelling pressure is balanced by tensile forces within the collagen network. 
Kovach and Athanasiou 189 showed that the spatial arrangement of collagen fibers 
is related to the aggregate modulus measured during creep indentation. In 
another study, confined compression was performed to various strain levels in 
the presence of different saline concentrations with the expectation that 
compressions greater than 5% would lead to the full load being borne by the 
proteoglycan osmotic pressure, which would be evidenced by equal stresses in 
the axial and radial directions. Contrary to the authors' expectations the axial and 
radial stresses were not equal, highlighting a role for the collagen network in 
compression.124 It has demonstrated that the function of the stiffness of the 
collagen network is to maintain a high concentration of proteoglycans, which is 
then able to resist compressive forces. 354 Similar to their study of bovine cartilage 
tensile properties, Williamson et al.125 examined compressive properties as a 
function of age. Results showed that the compressive modulus measured in 
confined compression increased 180%, while tissue permeability decreased 
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70%, from fetus to adult. These changes were correlated with increased collagen 
during development, since GAG changes during this period were negligible. 
Finally, Kiviranata et al.355 demonstrated that Poisson's ratio is negatively 
correlated with collagen content (i.e., increased collagen, decreased Poisson's 
ratio) in bovine articular cartilage. An additional unique aspect of this study was 
that collagen content was measured with Fourier transform infrared (FTIR) 
spectroscopy. Further the effect of fiber and proteoglycan moduli on Poisson's 
ratio were parametrically assessed via finite element analysis, showing that the 
fiber modulus had far more of an effect on Poisson's ratio than the proteoglycan 
matrix modulus. 
Conclusions 
In summary, collagen plays an important and varied role in articular 
cartilage biomechanics that has been evidenced experimentally. Further, 
sophisticated theoretical and computational models of collagen's biomechanical 
functions have reproduced experimental findings and have predicted behavior 
that yet remains to be verified. From a basic science standpoint, future models 
should continue to increase in complexity. Special focus should be placed on 
models informed by detailed microstructural analyses that incorporate collagen 
orientations and distributions with molecular physics scaling up to the tissue level 
and models including collagen network crosslinking. This would be a daunting 
challenge. At the same time that more complicated models are developed, from a 
functional tissue engineering approach356 we must recognize that such a level of 
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sophisticated understanding may not be necessary to evaluate whether a 
construct can adequately function in articular cartilage's native mechanical 
environment. Tissue engineers and biomechanicians alike need to continue to 
identify the salient mechanical characteristics of tissues and constructs that are 
necessary for cartilage regeneration and the structure-function relationships 
defining them. Further, standardized testing protocols should be followed so that 
mechanical properties can be compared from one study to another. 
Experiment methods for collagen assessment 
Due to the importance of collagen in cartilage, collagen composition and 
ultrastructure have been examined using various experimental methods. Many of 
these methods have also been used in tissue engineering studies to assess the 
collagen network within neotissue. 
General collagen assessment 
Several methods have been developed to measure collagen in articular cartilage 
without distinguishing among the different types of collagen. Hydroxyproline 
assays quantify the amount of collagen within cartilage based on the fact that 
hydroxyproline residues within biological tissue originate from elastin or collagen. 
Because articular cartilage contains negligible amounts of elastin, the amount of 
hydroxyproline can be used to infer the amount of collagen in the tissue. This 
method entails using chloramine-T to oxidize the hydroxyproline groups. 
Subsequently, adding Ehrlich's reagent (p-dimethyl-aminobenzaldehyde) 
produces a chromophore that can be quantified by assuming that 12.5% of the 
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collagen is hydroxyproline357 or by employing a collagen standard. The 
hydroxyproline content varies by only 0.14% between collagen I and collagen II, 
indicating that either collagen type can be used as a standard.358 
Another common method is collagen staining. Sirius red, dissolved in 
saturated picric acid, is an anionic dye that enables selective staining of collagen. 
When the dye binds to collagen via the dye's sulphonic acid groups, a change in 
birefringence occurs that can be visualized using polarized light microscopy.359 
Other staining protocols can be used as well, such as Gomori or Mallory 
trichromes, osmium tetroxide, periodic acid-Schiff, and Van Gieson. All of these 
methods readily verify the presence of collagen, but do not distinguish among the 
various collagen types. 
Immunohistochemistry (IHC) and enzyme-linked immunosorbent 
assays (ELISAs) 
IHC provides qualitative visualization of specific collagens within cartilage. 
Typically, a primary antibody is used to bind a particular collagen, followed by a 
secondary antibody binding the primary antibody. The secondary antibody can 
be conjugated to enzymes, like horseradish peroxidase or alkaline phosphatase, 
or fluorophores to produce a product that can be visualized. Employing a 
monoclonal antibody rather than a polyclonal antibody can increase the 
specificity of the antibody binding.36° For tissue engineering applications, IHC can 
elucidate the localization of specific collagen types in a construct361 •362 and 
characterize the phenotype of neotissue. 363 
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ELISAs can provide highly specific, quantitative determinations of the 
amount of collagen within a sample.364 ELISAs rely on reporters (e.g., enzymes 
or fluorophores) conjugated to antibodies to produce color that can be quantified. 
For example, indirect ELISAs detect the amount of collagen in a well based on 
the number of primary antibodies that are retained (Fig. 5A). This can be 
disadvantageous if the collagen does not bind strongly to the well plate's surface. 
Sandwich ELISAs determine the quantity of collagen between two antibody 
layers (Fig. 58). The use of two antibodies to bind collagen improves the 
specificity of sandwich ELISAs. Another ELISA variation is the competitive ELISA 
(Fig. 5C), which involves incubating samples with unlabeled antibodies. Then the 
antibodies are added to wells coated with collagen, but antibodies that have 
bound collagen from the sample will not be retained. Thus, higher collagen 
concentrations in the sample produce reduced color. This method can also be 
used for collagens that do not bind to the well. These numerous variations of 
ELISAs provide a versatile array of methods for quantifying collagen. 
The convenience and high sensitivity of ELISAs make them the preferred 
method for quantifying levels of specific collagen types. ELISAs are commonly 
used to determine the proportions of collagens type I and II in cartilaginous 
neotissue. 280•365 The quantitative nature of ELISAs allows collagen levels to be 
statistically compared among treatment groups. 
Electron microscopy 
Electron microscopy can provide high resolution images of collagen fibril 
organization within cartilage. The two most common types are transmission 
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electron microscopy (TEM) and scanning electron microscopy (SEM), both of 
which create images based on detecting emitted electrons. Samples are typically 
stabilized by applying an oxidant (e.g., glutaraldehyde) to crosslink proteins. To 
more easily visualize the fibrils, bound proteoglycans are often removed with a 
short proteolytic digest.366 Subsequently, heavy salts, such as osmium tetroxide 
and uranyl acetate, are applied to create contrast. Next, ethanol is used to 
dehydrate samples prior to embedding and sectioning. Finally, the sample is 
permeated by a resin and then fixed. Analysis of the ultrastructure can be 
performed in several ways. Analyzing cross-sections of tissue can show fibril 
diameters and distributions, while serial sectioning can give information about the 
entire length of the fibril. 367 In embryos, the small size of the fibrils has enabled 
analysis of entire fibrils, elucidating the fibrillogenesis process. 281 
Electron microscopy has the disadvantage of requiring samples to 
undergo substantial preparation prior to assessment, affecting the degree to 
which they retain their original collagen architecture. Common problems include 
structure distortion due to dehydration and loss of GAGs.368 To minimize issues 
associated with chemical fixation, several other fixation methods have been 
developed. Microwave irradiation can be employed more quickly than 
conventional fixation to fix samples while preserving the collagen structure.369 
Additionally, freezing has been used to fix samples while avoiding extensive 
dehydration. Using high pressure or very rapid freezing can mitigate ice crystal 
formation during the freezing process. 368•37° Further, cryoprotectants can be 
added to reduce the formation of ice crystals. These methods provide 
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advantages over the traditional chemical fixation, which ultimately improve the 
accuracy electron microscopy images of collagen network. 
Scanning electron microscopy CSEM) 
SEM detects electrons that are emitted from the sample surface after the primary 
electrons interact with the sample. Various studies have employed SEM to 
examine the orientation and size of collagen fibrils within articular 
cartilage.295•300•366•370•371 SEM has a lower resolution than TEM, but the depth of 
view is much greater. This enables SEM to provide a more three-dimensional 
representation of the collagen network. Cryofracture has been used to section 
the sample in two orthogonal planes and, subsequently, determine more about 
the three-dimensional collagen organization.295 Prior to conducting SEM, 
samples must be coated with a conductive material. This coating, which is 
typically less than 20 nm thick, does not impair visualization of most collagen 
fibrils. 
Transmission electron microscopy CTEM) 
TEM creates images based on electrons that are transmitted through thin 
sections of a sample. The key advantage of TEM is its high resolution. TEM can 
show collagen fibril morphology, fibril orientation, and fibril diameter. 
Furthermore, the high resolution of TEM allows imaging of detailed fibril 
morphology, such as banding patterns of collagen fibrils.372-374 The banding 
patterns indicate how the fibrils have packed together and can vary significantly, 
even within a single fibril. Although banding patterns reveal important structural 
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information, aspects such as collagen quantity and collagen type provide more 
functionally relevant information. Studies have employed TEM to study the 
collagen within cartilage and collagen fibrils grown in vitro to examine fibril 
diameter and pericellular matrix organization (see for example112·375). 
Prior to conducting TEM, samples must be sliced into ultrathin sections 
approximately 50-1 00 nm thick. Because fibril organization is on the order of 
microns, TEM sections can be too thin to show tissue ultrastructure. 
Furthermore, treatment with heavy salts is sometimes applied to create additional 
contrast before microscopy. Lead citrate is commonly employed to stain 
biological samples for TEM (Fig. 6). Like other lead based stains, staining 
intensity is heavily dependent on pH, and the tissue fixation method can also 
impact the staining intensity.376 Because the electron density depends primarily 
on the amount of bound uranyl acetate, the lead is thought to bind mostly to the 
uranyl acetate.377 Additionally, conjugation of antibodies to gold particles can be 
used to visualize specific macromolecule localization. 
Assessing collagen orientation 
Polarized light microscopy 
Polarized light microscopy measures birefringence of the sample to elucidate 
collagen alignment within cartilage. The polarization angle is a widely used 
method for quantifying collagen orientation. Additionally, orientation information 
can be used to infer thickness of the zones within a sample. When light passes 
through cartilage, it interacts with the valence electrons of collagen.378 This 
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creates birefringence that can be detected by a polarized light microscope. In 
general, highly oriented fibers will increase the phase difference between the 
orthogonal components of the light. 379 Collagen orientation is then deduced from 
the directions of the optical axes at maximal birefringence. The optical 
retardance, which is linearly proportional to birefringence, can also be used to 
infer collagen orientation. Thus, larger polarization angles are indicative of the 
superficial zone, while smaller polarization angles are indicative of the deep 
zone. Other factors, including size of the fibrils and the sample's thickness, can 
influence this phase difference. 379 This technique has been used to determine 
collagen fibril orientation in many studies in both native tissue 285•379 and tissue 
engineered constructs.114•380 
Diffusion tensor imaging (DTI) 
Magnetic resonance can also be used to deduce the collagen fibril orientation. In 
particular, diffusion tensor imaging (DTI) has been applied to cartilage 
tissue?93•381 -383 DTI measures the movement of water molecules, which is related 
to constraining forces within the matrix. 293 The collagen distribution within 
cartilage produces an anisotropic constraint on the water, which allows DTI to be 
used to quantify collagen orientation. DTI has been shown to reproduce the 
results of polarized light microscopy,293 suggesting that DTI can provide a viable 
alternative for examining collagen orientation. The non-destructive nature of DTI 
analysis provides a key advantage. Although DTI is a powerful tool, higher costs 
have limited its application in the research setting. 
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Quantifying anisotropy 
Quantifying collagen anisotropy from micrographs can compliment methods like 
polarized light microscopy and DTI. Image analysis can be used to determine 
how fibril orientation varies with respect to depth, which can be used to quantify 
anisotropy of fibrils. For instance, conducting localized vector analysis of electron 
micrographs can quantify fibril anisotropy.384 Additionally, a gradient detection 
algorithm has been employed to quantify orientation in confocal reflectance 
micrographs of collagen gels. 385 Some freely available programs such as 
Continuity (University of California-San Diego) can also be used to determine 
collagen fibril orientation.386 In general, researchers use different computational 
methods to quantify orientation. The lack of a standard methodology for 
determining anisotropy makes it difficult to quantitatively compare the 
orientations between studies. 
Assessing collagen inhomogeneity 
FTIR involves detecting infrared radiation that is transmitted through a sample, 
the results of which can be used to quantify collagen distribution. FTIR is used to 
quantify the collagen content in tissue sections, providing spatial information that 
bulk assays such as hydroxyproline do not. This spatial resolution shows how 
collagen content varies with depth and location in a joint. FTIR has been used for 
examining collagen content in cartilage tissue. 330•355•387•388 The data FTIR 
provides have functional implications, such as a correlation between the fibril 
network modulus and collagen content.330 Similarly, FTIR has been used to show 
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the distribution of collagen in tissue engineered cartilage. 388 The quantification 
and spatial resolution of FTIR makes it a valuable technique for assessing 
collagen orientation. 
Crosslink assessment 
Methods are available to examine collagen crosslinking in articular cartilage. The 
amount of crosslinks can be quantified using high performance liquid 
chromatography (HPLC). Generally, cartilage samples are first hydrolyzed to free 
the crosslink residues. Then the solution is passed through an HPLC column that 
can separate compounds based on factors like charge, size, and polarity. The 
fluorescence of the eluted sample can be used to quantify the number of 
crosslinks by excitation/detection at 295/400 nm for pyridinolines and 328/378 
nm for pentosidines. Additionally, the specific type of pyridinoline link can be 
determined from the elution time at peak absorbance. The high sensitivity of 
HPLC allows detection at the picomolar level.216 More recently, mass 
spectrometry has been applied to yield more detailed information about 
crosslinking chemistry, such as glycosylation state.389 As an indirect measure, 
lysyl oxidase activity can be used to approximate the extent of crosslinking.390•391 
Because pyridinoline crosslinks play an important role in the mechanics of 
cartilage, quantifying them provides a powerful tool for assessing neotissue. 
Conclusions 
A wide variety of methods enable study of the structure and composition of 
collagen within cartilage samples. Techniques like IHC and histological staining 
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can qualitatively verify the presence of collagen, which can be quantified using 
methods such as hydroxyproline assays and ELISAs. Electron microscopy 
provides information about the collagen distribution and orientation, but requires 
extensive sample preparation. For examining collagen orientation, traditional 
polarized light microscopy has been complemented by newer methods such as 
DTI. Additionally, HPLC can quantify the number of crosslinks, providing more 
information about the structure of the collagen network. Collectively, these 
methods can thoroughly characterize collagen within both native tissue and 
engineered cartilage. 
Role of collagen in tissue engineering 
Significance of collagen in tissue engineering 
To produce functional cartilage constructs, tissue engineering efforts will likely 
need to recapitulate the collagen network of native tissue. Because the matrix 
plays an important role in providing mechanical integrity, it is necessary to 
reproduce a collagen network with appropriate composition, orientation, and 
crosslinking. The overabundance of GAGs in tissue engineered cartilage makes 
it particularly important to improve the collagen network.112•141 •392 Despite various 
strategies, including scaffolds, biochemical agents, and mechanical stimulation, 
tissue engineered constructs generally have significantly less collagen than 
native tissue. 109•246-248 This lack of collagen is problematic because it 
compromises the mechanical integrity of the tissue. 
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Collagen scaffolds for tissue engineering 
Collagen has been employed as a biomaterial scaffold to promote cartilage 
engineering due to its natural biocompatibility, porosity, and low immunogenicity. 
Collagen matrices have also been found to have the proper molecular cues to 
stimulate collagen production?0 The prevalence of collagen in the articular 
cartilage matrix makes collagen particularly attractive for cartilage tissue 
engineering applications; however, as with many natural biomaterials, collagen 
poses a risk for pathogen transmission. In particular, concerns have been raised 
about the increased frequency of prion diseases, which may be associated with 
collagen scaffolds. 71 
Despite this concern, several tissue engineering studies have examined 
the potential of collagen scaffolds for articular cartilage tissue engineering. Much 
of this work has examined chondrocytes seeded on collagen scaffolds393 or 
crosslinked collagen sponges. 394 Canine chondrocytes seeded on collagen II 
retained their chondrocytic phenotype more than cells seeded on collagen I, 
which is expected considering the predominance of collagen II in articular 
cartilage. 395 Collagen scaffolds have been shown to increase collagen synthesis 
more than other common biomaterials, such as copolymers of lactic acid and 
glycolic acid?0 To more closely replicate the cartilage matrix, collagen has been 
combined with other matrix molecules (e.g., GAGs).396 In addition to extensive in 
vitro work, various in vivo studies have been conducted with collagen scaffolds, 
including rabbit,397·398 dog, 395•399 and horse400 models. Similar to many other 
tissue engineering strategies, collagen scaffolds promote chondrocyte 
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phenotypes and matrix production without attaining native mechanical properties. 
For example, mesenchymal stem cells seeded on collagen gels implanted in 
rabbit osteochondral defects promoted hyaline cartilage formation, but failed to 
reproduce tissue with native mechanical values. 397•398 Despite extensive 
research, these deficiencies in mechanical properties suggest that other tissue 
engineering strategies will need to be pursued. 
Engineering the collagen network 
Collagen content 
Culture conditions often have a profound impact on collagen production. 
Numerous studies have mechanical stimulation can be used to increase the 
collagen content of neotissue. For example, direct compression53•54193 and 
shear401 have been shown to increase collage deposition. Hydrostatic pressure 
has also been shown to increase collagen gene transcription, 56 collagen 
production,57•58 and construct tensile properties. 59 However, relatively few studies 
have examined the collagen deposition in tissue engineered constructs that have 
been mechanically stimulated. Other conditions, like cell density,365•402 scaffold 
porosity,403 and cell source,404•405 also modulate collagen production. 
Tissue engineering studies have shown localization of collagen VI in the 
pericellular space. Human and bovine articular chondrocytes cultured in vitro 
exhibited chondron structures in regions displaying characteristics of hyaline 
cartilage.406 Furthermore, confocal microscopy has shown that cultured 
chondrocytes sequestered type VI collagen in the pericellular space.407 In self-
assembled constructs, collagen VI localized in the pericellular region within four 
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weeks. 103 Type VI collagen also accumulated uniformly around cells embedded 
in agarose, with the rate of deposition slowing after two weeks. The production of 
the pericellular matrix may actually be excessive in some constructs, as agarose 
embedded chondrocytes have exhibited collagen VI expression levels 400% 
higher than native values.408 
Exogenous application of bioactive agents also can be used to increase 
collagen content. For bovine articular chondrocytes cultured on alginate beads, 
IGF-1 increased collagen gene expression and deposition,41 but it did not impact 
the number of crosslinks.42 Further, TGF-J31 promoted collagen fibril formation409 
and increased the collagen weight fraction.37 Many of the bone morphogenetic 
proteins (BMPs), which are part to the TGF-J3 superfamily, have also been shown 
to promote collagen synthesis. For instance, BMP-234 and BMP-735 have been 
employed to increase collagen deposition. Recently, small proteoglycans in 
tissue engineered constructs have been shown to decrease collagen deposition. 
By knocking out the small leucine-rich proteoglycan lumican, there was increased 
collagen II deposition and increased fibril diameters.374 Similarly, when decorin 
was removed from tissue engineered constructs, increased tensile properties 
indicated a possible alteration of the collagen network. 392 Adding various 
bioactive molecules, individually or in combinations, provides many opportunities 
for altering collagen content. 
Despite many studies that demonstrate the role of growth factors, the 
responses to a growth factor is often difficult to predict. This is particularly true 
with members of the TGF-J3 superfamily, which have been shown to increase or 
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decrease collagen deposition depending on the experimental system.29•37•42-44 In 
addition to the variation in culture systems, the developmental stage of the 
cell,30•45 zone of cell source,41 and the amount of extracellular matrix already 
deposited44 also influence the response to the growth factor. Synergism between 
growth factors can also alter their impact. 39 The complexity of the growth factor 
response makes it difficult to generalize an optimal treatment regimen. 
Cross/inking 
Studies have shown that crosslinks are generally less common in tissue 
engineered constructs than in native tissue. For a six week culture of bovine 
chondrocytes in a rotating bioreactor, the number of crosslinks was only 30% of 
native values.280 Similarly, after four weeks of alginate bead culture, crosslinks 
reached only 22% of native values. 311 The inability to fully produce crosslinks in 
tissue engineered constructs presents a necessary area for improving tissue 
engineering efforts. The number of crosslinks has been found to depend on the 
cell source, with more crosslinks formed in constructs from full thickness cell 
sources compared to middle or deep zone sources.404 
Various small molecules can be employed to modulate collagen 
crosslinking. For example, BAPN inhibits lysyl oxidase, thereby decreasing the 
extent of crosslinking. BAPN treatment of cartilage explants decreased tensile 
integrity, without altering the amounts of collagen or GAGs.353 For bovine 
chondrocytes cultured on alginate beads, administering BAPN reduced the 
amount of collagen near chondrocytes and increased collagen synthesis. 311 In 
another study, chondrocytes seeded on alginate beads and treated with BAPN 
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for the first five weeks of a ten week culture exhibited increased collagen content 
and increased stiffness.113 
In contrast to inhibition, several agents can be added to increase 
crosslinking. Oxidative agents can be used to increase collagen crosslinking, but 
these compounds are not specific like lysyl oxidase. The major disadvantage of 
commonly used crosslinking chemicals (e.g., glutaraldehyde) is cytotoxicity. 
Genipin, an extract from the gardenia plant, has recently been explored as a 
crosslinking agent. Applying genipin to bovine articular cartilage410 and human 
intervertebral discs411 did not increase cytotoxicity. In the intervertebral disc 
study, genipin treatment increased the mean circumferential yield stress and 
ultimate tensile strength by -78%. Alternatively, adding sugars increased 
collagen crosslinking by inducing AGE formation.276•412 Finally, though not in 
cartilage, applying exogenous lysyl oxidase to tissue engineered vascular 
constructs increased their tensile strength and elastic modulus.220 Interestingly, 
collagen crosslinks can also contribute to compressive properties, such that the 
proportion of mature to immature crosslinks correlated with the equilibrium 
modulus in unconfined compression?49 
Network organization 
Engineering the anisotropic distribution of collagen poses another significant 
challenge. As a step forward, radial confinement of self-assembled constructs 
increased collagen organization perpendicular to the articular surface.114 In 
addition to confining constructs, it is possible to control the cell distribution within 
neotissue and, consequently, alter collagen distribution. For example, creating 
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anisotropic pore architecture within a scaffold produced by 30 fiber deposition 
created zonal variation in collagen composition.403 However, this approach 
produced collagen levels an order of magnitude less than native tissue. 
The bacterially-derived enzyme chondroitinase-ABC (C-ABC) has also 
been used to alter the cartilage matrix. C-ABC selectively degrades GAGs,46 
which subsequently reduces stress on the collagen network. Applying C-ABC 
has been shown to increase the tensile properties of cartilage explants.47•413 
Additionally, Natoli et al.392 have used C-ABC to increase tensile properties of 
self-assembled tissue engineered articular cartilage. Treating constructs at both 
two and four weeks resulted in a tensile stiffness of 3.4 MPa at six weeks. 
Treatment with C-ABC also reduced decorin staining, which subsequently 
recovered. Because decorin is known to reduce collagen fibril diameters, C-ABC 
mediated decorin reduction may contribute to increased tensile stiffness. 
Although the mechanism by which it increases tensile properties has not been 
characterized, it is possible that the reduced GAG content promotes crosslinking, 
larger fibril size, or altered fibril orientation. 
V. D. Conclusions 
Reproducing a collagen network in tissue engineered articular cartilage 
constructs with appropriate composition, orientation, and crosslinking has proven 
to be a difficult task. Several strategies, including mechanical stimulation and 
growth factor application, have been employed to alter the collagen composition 
of neotissue with some success. In general, crosslinks are less common in 
engineered neotissue than in native tissue. Although exogenous oxidative agents 
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can increase crosslinking, these crosslinks are not specific like lysyl oxidase 
mediated crosslinking. Ultimately, it will be necessary to develop improved 
methods for engineering network crosslinking and organization before neotissue 
replicates the structure of native cartilage. By further studying the collagen 
network in both native tissue and engineered cartilage, it will be possible to 
improve the quality of tissue engineered constructs. 
Conclusions 
Collagen forms a complex network within articular cartilage. The major 
component is the heterofibril of collagens II, IX, and XI. These fibrils are 
organized inhomogeneously and anisotropically within cartilage and provide 
mechanical integrity to the tissue. Various theoretical and computational models 
of cartilage biomechanics have been developed, but incorporating microstructural 
analyses will help improve these efforts. To better understand factors affecting 
the collagen network, many experimental methods are available. It is possible to 
readily assess the composition, crosslinking, and structure of the collagen 
network. 
Successful articular cartilage tissue engineering will need to produce an 
appropriate collagen network. Studies have shown that tissue engineered 
cartilage generally lacks sufficient collagen, a problem that will need to be 
addressed. Cartilage tissue engineering studies have primarily examined the 
amount of collagen, with fewer studies assessing collagen type, crosslinks, or 
fibril orientation. By overlooking these aspects, many tissue engineering studies 
do not elucidate the mechanisms that underlie observed changes in mechanical 
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integrity. Furthermore, the interactions between collagen, proteoglycans, and 
chondrocytes need to be studied more extensively. Understanding properties and 
interactions of the collagen network will enable more robust constructs to be 
developed, and will subsequently improve the functionality of tissue engineered 
articular cartilage. 
Table 7-1: Collagen fibril characteristics and zonal variation 
Superficial Deep 
Fibril diameter141 ' 14ts 30-35 nm 40-80 nm 
Fibril orientation;t:ts::> Parallel Perpendicular 
Tensile modulus (parallel);.:: 42.2 MPa 2.6 MPa 
Tensile modulus (perpendiculart 15.6 MPa 1.1 MPa 
Confined compressive modulus414•41 ::> 0.27-1.16 MPa 0.71-7.75* 
MPa 
*7.75 MPa measured in region 1250-1500 IJm depth from the surface 
bordering the transition zone to calcified cartilage 
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Figure 7-1: Hierarchical structure of a collagen fiber 
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A) Collagen fiber. A fiber is a collection of many fibrils. B) The collagen II:IX:XI 
heterofibril. The fibril is formed by end-to-end and lateral fusion of collagen 
molecules. Collagen IX forms crosslinks between collagen molecules. C) The 
basic triple helix structure of the collagen type II molecule. Shown out of scale is 
the structure of a pyridinoline crosslink, which interconnects collagen triple 
helices through oxidation of lysine residues by lysyl oxidase. 
Figure 7-2: Schematic representation anisotropic collagen arrangement 
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Immature tissue is composed of randomly oriented fibers with roughly uniform 
size. As the tissue matures, the characteristic collagen orientation begins to 
emerge. Mature tissue has horizontally oriented fibers in the superficial zone, 
randomly oriented fibers in the middle zone, and vertically oriented fibers in the 
deep zone. Mature tissue is also composed of fibers less uniform in size. 
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Figure 7-3: Demonstration of split-lines in articular cartilage 
-
Split-lines show orientation of collagen fibers in the superficial zone. A small 
round pin was dipped in black ink and gently pressed into the tissue. The ink 
stains in direction parallel to collagen fibers. In this picture, split-lines are running 
from upper left to lower right. The image was taken on a Leica MZ6 dissection 
scope at 4X magnification. Scale bar= 1 mm. 
Figure 7-4: Theoretical cartilage mechanics 
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Deformation of a Continuum Element 
with Fibers Active in Tension Only 
Undeformed State 
Applied 
'\:ad 
Deformed State 
Fig 4: A) Hierarchy tree for models of articular cartilage incorporating features of 
the collagen network. The basic model for articular cartilage is the linear biphasic 
theory. As one moves down the branches, the models become more complex. 
Along a branch, each level incorporates all of the features from the models above 
it. The most developed branch is that which treats cartilage as a composite 
reinforced by collagen fibers. B) Representative deformation of a continuum 
element reinforced by collagen fibers active only in tension. An applied load 
causes compression of the continuum element. Members in compression are not 
supported by fibers, and hence their springs have been removed. In the 
deformed state, members in compression deform more than members engaged 
in tension. 
- ------------ - ----------------
Figure 7-5: Types of ELISAs 
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A) Indirect ELISAs detect the presence of sample collagen (dark circle) that is 
coated onto the well. The primary antibody (solid line) binds to the collagen and 
then secondary antibodies (dashed line) bind to the primary antibodies. Finally, 
adding a substrate to activate an enzyme conjugated to the secondary antibody 
will change the color of the solution (indicated by gray shading). B) Sandwich 
ELISAs quantify collagen that is retained upon addition to wells coated with 
collagen antibodies. A secondary antibody is then used to create a "sandwich." 
Using two antibodies increases the specificity of the assay. C) Competitive 
ELISAs entail initially incubating primary antibodies with sample collagen (gray 
circles). Subsequently, samples with more collagen will reduce the amount of 
free primary antibodies that can bind to the collagen on the well plate (dark 
circles). 
206 
Figure 7-6: TEM image of a self-assembled tissue engineered construct 
5,000 X 30,000 X 75,000 X 
- =2J..Lm - = 500nm - = 100 nm 
Chondrocyte Collagen GAGs 
Samples were fixed in paraformaldehyde and then stained with cupromeronic 
blue for glycosaminoglycan (GAG) distribution. Subsequently, samples were 
dehydrated in increasing ethanol concentrations and embedded in LX-112 
medium. After sectioning, samples were stained with uranyl acetate and lead 
citrate and examined in a JEM 1010 transmission electron microscope. Boxes 
indicate the field of view for the image to the right. A) At 5,000X, cells are clearly 
visible within the matrix. B) At higher magnification, the collagen and 
glycosaminoglycans become distinguishable. C) At a magnification of 75,000X, 
glycosaminoglycans and individual collagen fibrils are visible. 
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Chapter 8: Understanding biomechanics-driven 
• * chondrogenesis from embryo to adult 
Abstract 
Biomechanics play a pivotal role in cartilage development, pathophysiology, and 
regeneration. During embryogenesis and cartilage maturation, mechanical stimuli 
promote chondrogenesis and limb formation. Mechanical loading, which has 
been characterized using computer modeling and in vivo studies, is crucial for 
maintaining the phenotype of cartilage. However, abnormal loading can have 
deleterious effects and promote the onset of disease. Informed by the prominent 
effects of biomechanics, mechanical stimuli have been developed to enhance re-
differentiation of chondrocytes and chondroinduction of other cell types, thus 
providing new chondrocyte cell sources. Biomechanical stimuli have been widely 
used to enhance the functional properties of neocartilage. In addition to direct 
mechanical stimulation such as applying hydrostatic pressure or compression, 
chemical equivalents mimic mechanical signaling and offer exciting new methods 
for improving neocartilage. Chemical equivalents also elucidate 
mechanotransduction, which could ultimately improve understanding of cartilage 
development and how chondrocytes respond to mechanical stimuli. Harnessing 
mechanics to improve differentiation, maintenance, and regeneration offers a 
Responte OJ, Lee JK, Hu J, Athanasiou KA. Understanding biomechanics-driven 
chondrogenesis from embryo to adult. PNAS (in preparation) 
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new approach for producing functional neocartilage that could eventually be used 
to treat cartilage degeneration. 
Introduction 
Cartilage lines the articulating surfaces of long bones, functioning in the 
mechanically-demanding environment of the joint space. The extracellular matrix 
of cartilage primarily includes collagen, proteoglycans, and chondrocytes. 
Chondrocytes, the only cell type within cartilage, comprise only 1-5% of the 
tissue by volume.1 Although chondrocytes represent a small fraction of articular 
cartilage, they are crucial because they synthesize the matrix that imparts 
mechanical integrity to the tissue. 
The significance of biomechanical stimuli such as hydrostatic pressure, 
compression, and shear has been well-established for cartilage. Joint loading 
results in direct compression of chondrocytes, which also experience hydrostatic 
pressure due to compression of synovial fluid inside the joint capsule.416 This 
mechanical stimulation produces a signaling cascade, resulting in increased 
gene expression55•56 and protein production.53•54•57•58 Understanding how 
mechanics influence chondrocytes is crucial because the resulting signaling 
cascades can alter matrix production and ultimately influence how well the tissue 
can function in the rigorous joint environment. 
As summarized in Fig. 8-1, biomechanics play a significant role throughout 
an organism's life. Biomechanics contribute to development during 
embryogenesis and cartilage formation, and maintain the chondrocyte phenotype 
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in adult tissues. Alternatively, abnormal loading can promote the onset of 
cartilage degeneration. Informed by these biomechanics studies, various 
mechanical stimuli have been employed to enhance stem cell differentiation and 
the development of more robust regeneration therapies. This perspective article 
highlights the importance of biomechanics in chondrogenesis from the early 
stages of neocartilage formation to maintenance of adult tissue. In particular, it 
will describe the role of biomechanics in cartilage development, maintenance, 
disease, adult cell chondrogenesis, and cartilage regeneration. 
Biomechanics in embryogenesis and fetal development 
Mechanical stimuli during embryonic and fetal development influence cartilage 
differentiation and limb morphogenesis. The mechanical microenvironment acts a 
potent regulator of stem cell fate and contributes to chondrogenesis in the early 
embryo. Biomechanics also plays a key role in skeletogenesis, which begins 
with a cartilage blueprint that is later calcified to become bone via a process 
known as endochondral ossification.417 Immobilization experiments in vivo and 
computer models of development have shown the central role of mechanical 
stimuli in proper cartilage development. 
Stem cells respond to changing mechanical microenvironment 
Much of embryogenesis relies on resident stem cell differentiation into the 
needed cell types; chondrogenesis occurs in the same manner as progenitor 
cells undergo pre-cartilaginous condensation to form tightly packed cellular 
aggregates before differentiating into early chondrocytes.417 The mechanical 
mechanisms of this process are currently unknown, as most studies focus on 
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chemical pathways leading to embryonic cartilage formation. Some groups 
postulate that mechanical forces influence de novo chondrogenesis from early 
stem cells in addition to growth factor gradients; however, this hypothesis is 
difficult to test and current studies utilize in vitro culture platforms or computer 
simulations. Biomechanics have been used to characterize single stem cell 
populations, control differentiation, and further understand development. 
At the single cell level, differentiating stem cells exhibit altered mechanical 
properties. For example, mouse stem cells exhibit increased stiffness after just 6 
days of chemical differentiation, exhibiting up to 3-fold higher stiffness values as 
compared to undifferentiated cells.418 Similarly, cellular biomechanics can be 
employed to evaluate differentiation regimens of embryonic419 and marrow-
derived420 stem cells. Due to the relationship between mechanical properties and 
differentiation, biomechanics could provide a novel method of stem cell 
phenotyping and validation of isolation techniques. 
The control of stem cell fate via substrate mechanics and mechanical 
forces is increasingly being explored as a differentiation strategy. By changing 
the substrate stiffness, researchers can control stem cell lineage commitment. 
Growing embryonic stem cells substrates of various stiffnesses modulated 
differentiation expression421 ·422 and growth rate kinetics.422 Furthermore, applying 
compression enhanced chondrogenesis of progenitor cells, generating 3-fold 
increases in matrix protein synthesis. The demonstrated ability of both substrate 
stiffness and mechanical stimulation to differentiate stem cells suggests that 
biomechanics is a key stimulus during development. 
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Though the mechanisms underlying pre-cartilaginous condensation have 
not been fully elucidated, the differential adhesion hypothesis may offer insight 
into the segregation of cellular sub-populations. Because different stem cell 
lineages exhibit variable stiffness levels and biochemical marker expression, 
differential adhesion could lead stem cells to associate with cells of similar 
lineages. Therefore, pre-cartilaginous condensation may be a result of receptor-
mediated aggregation of mesenchymal progenitor cells expressing the same 
surface receptors. While this hypothesis is untested at the early stages of 
chondrogenesis, the differential adhesion hypothesis allows researchers to 
extrapolate findings from embryonic and mesenchymal stem cell studies to in 
vivo embryonic development. 
Studying chondrogenesis in embryonic stem cells can inform the 
mechanisms of in vivo cartilage development. As depicted in Fig. 2, five 
developmental processes are vital to in vivo chondrogenesis:423 1) cellular 
condensation, 2) chondrocyte differentiation and initial scaffold formation, 3) 
extracellular matrix synthesis, 4) selective cellular death and 5) replacement of 
cartilaginous tissues with bone. Each process necessarily builds upon the prior 
stage; for example, increased deposition of matrix relies on the presence of the 
initial scaffold formed in stage 2. While the suggested progression has been 
studied extensively in vitro, in vivo validation requires further experimentation. 
Stem cell chondrogenesis not only provides a platform for which to study 
embryonic cartilage tissue formation, but proves dependent upon mechanical 
forces as differentiation stimuli. Though mechanical stimuli that have been used 
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experimentally are not guaranteed to be present during in vivo development, 
biomechanics-based studies elucidate various methods with which stem cells 
may be differentiated into a chondrocyte lineage. The consequential responses 
of progenitor cells to changes in their mechanical microenvironment suggest a 
similar pathway in vivo and indicate that biomechanics can in fact influence 
chondrogenesis of stem cells. 
Biomechanics drive skeletogenesis 
Studies of vertebrate limb development reveal that mechanical stimulation 
promotes chondrogenesis. For example, compression triggers chondrogenic 
marker expression-most notably, Sox9, a master gene responsible for 
activating many of the cartilage genes expressed in terminally differentiated 
cells. 424 These results indicate mechanical stimulation is a genetic regulator of 
chondrogenesis. 
Because of the difficulties associated with controlling biomechanics during 
embryogenesis, embryos with impaired limb mobility have been used to 
determine the effects of mechanics on limb development.425•426 Strategies such 
as chemically paralyzing limbs or using animals with skeletal muscle defects 
have been employed to create abnormal joint loading and subsequently disrupt 
skeletogenesis. For instance, immobilization of chick limbs 426 resulted in 
abnormal limb shape and complete failure to form elements of the synovial joint 
such as the knee meniscus. Muscle paralysis has been shown to hinder articular 
cartilage development.427 Immobilization has also been shown to decrease 
matrix production and subsequently reduce mechanical properties of tissues by 
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50%.428 These studies demonstrate that joint mechanics are vital for proper 
cartilage development. 
Computer models corroborate animal studies 
While joint immobilization provides insight into in vivo cartilage development, the 
difficulties associated with this procedure have led to computer modeling of joint 
development. 429 By modeling mechanical stimulation of limb buds, computer 
simulations can define the stages of limb development and chondrogenesis. 
Ultimately, comparing computer models to in vivo studies has shown the 
accuracy of these simulations. 
The modeling approaches to simulate skeletogenesis under mechanical 
stimulation vary widely, incorporating stimuli based on muscle contraction,426 
hydrostatic pressure,430 and shear.430 Intermittent and cyclic hydrostatic pressure 
and strain both help regulate matrix protein synthesis to affect macromolecular 
organization of collagen fibers, which in turn leads to changes in the mechanical 
properties of the tissue.430 When the computer simulation was applied to a 
mesenchymal tissue model, researchers were able to accurately estimate the 
mechanical properties of different cartilage types. These results reveal a 
successful cartilage differentiation algorithm based on mechanical forces 
recapitulative of the native chondrogenic environment. 
Alternatively, computer models predict that intermittent compressive 
hydrostatic pressure inhibits degeneration and ossification of cartilage, 
preventing cartilage from becoming bone; on the other hand, intermittent strain or 
shear stresses accelerate ossification and degeneration.431 •432 Such mechanical 
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forces dictate the progression of what is known as the ossification front, or the 
line at which cartilage begins to calcify, turning into bone; these forces thus work 
to maintain a layer of cartilage of suitable thickness during development. 
Excitingly, the models predict proper limb morphologies progressing through 
specific embryonic development stages. Ultimately, the algorithms can estimate 
an anatomically correct long bone shape based on where cartilage will ossify,433 
indicating the accuracy of the chosen stimulation regimen. 
Despite the successes of modeling techniques in mimicking 
chondrogenesis in vivo and their contributions to understanding skeletogenesis, 
the proposed biomechanics responsible for cartilage formation still require 
validation via animal studies. Animal and computer models must build upon each 
other to provide insight into the effects of mechanical stimulation during in vivo 
chondrogenesis and development of skeletal tissues. 
Maturation of tissue mechanics 
In addition to exploring how mechanics drive chondrogenesis, it is important to 
investigate how these stimuli promote cartilage maturation. Because 
chondrogenesis is a time-dependent process, various groups have investigated 
the effects of prolonged mechanical stimulation on cartilage tissue. As skeletal 
tissues mature, mechanical forces help determine their ultimate tissue strengths. 
These improvements are often a result of increased matrix synthesis during 
growth, or of matrix enhancement via matrix organization. Mechanical stimulation 
thus assists not only in fetal chondrogenesis, but plays a role in cartilage 
maturation as well. 
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To study the in vivo progression of cartilage development, various studies 
have examined tissue mechanics at different maturation stages. For example, 
fetal articular cartilage 20 to 36 weeks old exhibited an age-dependent increase 
in cartilage tissue stiffness.434 These increased mechanical properties paralleled 
biochemical composition: stiffness increased by a factor of 2.5 from age 20 to 36 
weeks and collagen content increased 3-fold. Similarly, comparing the 
mechanical properties of fetal and newborn bovine tissue revealed a correlation 
between tissue strength and specimen age.435 
In addition to altered biomechanical properties during tissue maturation, 
mechanical stimulation also plays a vital role in generating regional variation in 
cartilage. Although fetal cartilage did not demonstrated regional variation, 
newborn and adult cartilage exhibited stronger tissues in regions bearing the 
greatest static or dynamic loads.436 Similarly, the compressive and tensile 
properties of bovine fetal, newborn and adult tissues have been shown to exhibit 
age-dependence and regional variation.437•438 These results suggest that joint 
loading is a potent regulator of chondrogenesis. 
During chondrogenesis, the mechanical properties of cartilage increase in 
response to biomechanical stimuli. Although the mechanisms underlying the 
development of cartilage mechanics have not been fully elucidated, it appears 
that regional variation stems from joint loading. This presents an exciting 
research area for understanding cartilage developing as well as developing 
stimuli to promote in vitro cartilage growth. 
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Summary 
Although the in vivo role of biomechanics during embryogenesis has not been 
fully elucidated, strong evidence exists for biomechanics-driven differentiation 
and chondrogenesis. Beginning at the embryo stage, biomechanics undoubtedly 
influences chondrogenesis as demonstrated by inhibiting embryo movement in 
utero. At this point, the role of biomechanics in embryo and fetal chondrogenesis 
requires more in vivo investigations into the mechanisms and types of 
mechanical stimuli present during differentiation. By understanding the potential 
role of biomechanics from a developmental biology standpoint, researchers may 
design methods to differentiate stem cells exploiting biomechanical stimuli as 
well as better interpret skeletogenesis in vivo. 
Biomechanics promote maintenance of cartilage phenotype 
The effects of mechanics on cartilage maintenance have been assessed using 
theoretical models of load distributions in cartilage and in vivo experiments. The 
identification of prominent biomechanical forces informed the development of in 
vitro biomechanical stimuli to improve cartilage maintenance in vitro. 
Assessing native cartilage mechanical forces 
Modeling studies have been employed to identify the mechanical forces that 
maintain tissue properties. Simulations demonstrate that mechanical forces 
exhibit depth-dependence: forces preserving the upper layers of cartilage are 
inherently different than those sustaining the lower layers; loading disparities lead 
to dissimilar cellular phenotypes.439 Simulations have also been used to model 
the collagen network440 and the pericellular matrix441 to illustrate how the matrix 
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microenvironment is responsible for transducing tissue-level mechanical loading. 
Furthermore, models have delineated how loading promotes matrix protein 
synthesis.442 Modeling thus represents a useful approach for understanding force 
transduction at the cellular and tissue levels. 
In vivo imaging techniques can help elucidate normal loading kinematics. 
For example, two-photon laser microscopy has been used to chondrocyte 
deformation at the single cell level in response to muscle-induced mechanical 
loading443 and tissue level444 during physiological loading. Imaging of articulating 
surfaces indicates that contact kinematics are vital to maintain in order to prevent 
cartilage degeneration.445 Disruption of joint kinematics leads to inappropriate 
contact points between articulating surfaces, which in turn causes cartilage 
degradation at these locations. Imaging methods can thus non-invasively 
examine the normal, in vivo cartilage biomechanics that maintain the mechanical 
properties vital to this load-bearing tissue. 
Mechanical stimulation maintains phenotype 
Both in silica and in vivo work has suggested that biomechanics play a key role in 
cartilage maintenance. To verify the role of mechanics, the effects of substrate 
stiffness, hydrostatic pressure, and compression have examined in vitro. These 
studies have demonstrated how mechanical stimulation can promote a 
chondrocytic phenotype. 
Substrate stiffness 
Though not a traditional form of mechanical stimulation, differences in substrate 
stiffness have been shown to play a biomechanical role in adult chondrogenesis. 
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Chondrocyte phenotype in monolayer culture is best maintained on softer as 
compared to stiffer substrates, validating matrix elasticity as a chondrogenic 
differentiator.446 These results may be used to create scaffolds more similar in 
stiffness to the native chondrocyte microenvironment to actively enhance 
chondrogenesis. Matrix elasticity acts as a potent regulation of chondrogenesis, 
promoting the production of cartilage matrix proteins. 
Hydrostatic pressure 
Hydrostatic pressure has been applied extensively to promote a chondrocytic 
phenotype. Intermittent application of hydrostatic pressure to chondrocytes up-
regulated the expression of genes for cartilage matrix proteins447•448 and 
cytoskeletal elements.449•450 Hydrostatic pressure mechanical stimulation of cells 
in compromised matrices led to further degeneration of the surrounding matrix, 
indicating that hydrostatic pressure affects chondrogenesis best in healthy 
environments. 451 At the cellular level, hydrostatic pressure promotes and 
maintains appropriate expression levels of cartilage genes, which result in the 
synthesis of matrix proteins. These results suggest that hydrostatic pressure 
could promote chondrogenesis in vivo by increasing the synthesis of cartilage 
extracellular matrix components. 
Compression 
Compression has also been shown to have beneficial effects on cartilage 
maintenance. For example, chondrocytes increase biosynthesis under 
physiological levels of dynamic compression, enhancing their cartilage matrix 
protein production.452-454 These effects propagate through the depth of the tissue, 
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with cartilage exhibiting different responses to mechanical loading at various 
depths.415•455 Additionally, studies have demonstrated that passaging cells 
modulates their response to compression, suggesting maturity-dependent 
responses to mechanical loading.456 Other factors such as loading duration442 
and magnitude457 have been shown to alter the response to stimulation, 
indicating that a specific compression regimen needs to be applied to promote 
cartilage maintenance. 
Summary 
Mechanical loading, which has been characterized using computer modeling and 
in vivo studies, plays a pivotal role in maintaining cartilage phenotype. The 
significance of biomechanics spurred the investigation of mechanical stimuli such 
as hydrostatic pressure and compression to enhance in vitro cartilage gene and 
protein expression. 
Loading can promote disease 
Improper loading leads to cartilage degeneration and osteoarthritis 
Although biomechanics can have a beneficial role in maintaining cartilage, 
abnormal loading can promote pathogenesis. Insufficient or excessive 
mechanical stimulation leads to abnormal expression of chondrogenic markers 
and ultimately to undesired changes in cartilage at the tissue level. For instance, 
removing the meniscus increases loading on tibial cartilage.458 Because the tibial 
cartilage cannot sustain the increased contact pressures, cartilage thinning and 
degeneration result.459 Initiation of osteoarthritis need not be traumatic: slight 
220 
changes in the load distribution during trivial activities such as walking may 
initiate early osteoarthritic effects in even healthy knee joints.460 Sudden 
disruptions in joint biomechanics due to ligament or meniscal tear create an 
improper mechanical loading environment that eventually leads to cartilage 
degeneration. Proper biomechanical loading can greatly reduce the risk of 
osteoarthritis and instead promote cartilage maintenance. 
Harnessing biomechanics to promote chondrogenesis of adult cells 
In addition to promoting chondrogenesis during development, various efforts 
have focused on harnessing biomechanics to promote the chondrogenesis of 
adult cells. These efforts aim to combat the deleterious effects of monolayer 
culture and expand the cell sources that can be used for in vitro cartilage 
formation. In particular, biomechanical stimulation has proven to be an exciting 
new strategy for effecting chondroinduction and re-differentiation of 
chondrocytes. 
Mechanical loading effects on adult stem cell migration 
As previously discussed, stem cell condensation and early chondrocyte 
differentiation are hallmarks of embryonic cartilage development; alternatively, 
adult stem cells also exhibit an ability to respond in vivo to heal cartilage defects. 
In addition to chemical factors that promote adult stem cell migration, the 
mechanical microenvironment influences stem cell recruitment. A rabbit study 
exceptionally demonstrated the effects of mechanics by grafting periosteal 
tissue-a source of progenitor cells-in an environment subjected to mechanical 
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loading.461 The loaded environment stimulated in vivo chondrogenesis of stem 
cells present in the periosteum, demonstrating how biomechanics can initiate 
chondro-differentiation. Similarly, simulations of the effects of loading and fluid 
flow predict that joint motion can prompt stem cell release to heal cartilage 
defects.462 These studies illustrate how biomechanics can alter the behavior of 
adult stem cells and thus influence in vivo cartilage regeneration. 
Mechanical stimulation to promote re-differentiation 
De-differentiation of chondrocytes is problematic in monolayer culture, which 
limits the potential for expanding cells and conducting large-scale experiments. 
Chondrocytes exhibit signs of phenotypic loss even after the first passage,69 
which is often manifested by reduced gene and/or protein expression of 
chondrogenic molecules such as collagen II and aggrecan. In addition, 
expansion alters cellular mechanical properties463 and changes the chondrocyte 
response to mechanical stimulation.464 
Mechanical stimulation has demonstrated re-differentiation potential, 
particularly by using hydrostatic pressure. Intermediate hydrostatic pressure 
during re-differentiation increased synthesis of cartilage-specific matrix 
molecules.465 Similarly, applying HP to dedifferentiated chondrocytes in pellet 
culture up-regulated chondrogenic gene expression and matrix production.466 
However, hydrostatic pressure has also been shown to decrease collagen II 
production,467 illustrating that more work needs to be done to understand how 
hydrostatic pressure can be used as a generic re-differentiation agent. 
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Compression has also been used to re-differentiate chondrocytes. 
Applying compression to passaged chondrocytes seeded on a collagen II 
scaffold increased collagen and proteoglycan production.468 Another study 
showed that compression increased GAG production of expanded chondrocytes 
but did not alter collagen II expression.456 The parallel responses of compression 
and hydrostatic pressure indicate that mechanical stimuli can be highly effective 
re-differentiation agents. 
Biomechanics-driven chondroinduction 
Biomechanical stimuli are potent chondroinductive agents for various cell types. 
Applying intermittent HP to murine embryonic fibroblasts resulted in two-fold 
increases in collagen synthesis and GAG production.469 Similarly, HP increased 
chondrogenic gene expression in neonatal human dermal fibroblasts.470 
Mechanical forces have also been postulated to explain chondrogenic gene and 
protein expression observed in smooth muscle cells following atherosclerotic 
calcification.471 Although several studies have shown promising results for using 
HP to promote chondroinduction, the effects of other forms of mechanical 
stimulation need to be investigated. Employing biomechanical stimuli to 
chondroinduce differentiated cells could eventually provide new cell sources to 
supplement stem cell efforts. 
Summary 
Biomechanics have been shown to enhance chondrogenesis of adult stem cells, 
de-differentiated cells, and cells from non-chondrocyte lineages. Thus, 
biomechanical stimuli could be employed to derive chondrocytes from diverse 
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cell populations and thus provide new chondrocyte cell sources. Additional 
refinement of mechanical stimuli for adult cell chondrogenesis will increase the 
availability of cells sources for applications like tissue regeneration. 
Biomechanics drives tissue regeneration 
Biomechanical stimuli have been employed to enhance tissue-level 
chondrogenesis and subsequently promote de novo cartilage formation. Several 
methods of mechanical stimulation including tension, HP, and compression have 
been used to improve the functional properties of neocartilage. In particular, 
research has focused on recapitulating the tensile and compressive properties of 
native cartilage, which could enable neocartilage to function in vivo. Additionally, 
in vivo mechanical stimulation has demonstrated chondrogenic potential. 
Direct mechanical stimulation 
The growing body of working showing the importance of biomechanics in 
cartilage development and maintenance has spurred investigations of in vitro and 
in vivo mechanical stimuli to improve cartilage formation. In particular, HP, direct 
compression, and shear have been examined. 
Hydrostatic pressure 
HP has been applied to various cartilage engineering systems to improve 
neocartilage properties. Studies of chondrocyte-seeded PGA meshes showed 
that HP increase GAG production 10-fold.60•61 However, other work has shown 
that HP increases collagen production but reduces GAG content.57 The 
differences in HP effects could be attributed to different chondrocyte culture 
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techniques, which have been shown to modulate the matrix production resulting 
from HP application. For example, the anabolic response to dynamic hydrostatic 
pressure evident for chondrocytes in pellet culture but not for cells cultured in 
alginate.58 The widespread use of HP to successfully enhance neotissue 
suggests that HP is a potent stimulus for in vitro cartilage formation. 
Despite these promising results, hydrostatic pressure has also been 
shown to be deleterious. In particular, applying hydrostatic pressure above 
physiological levels exhibited harmful effects and led to decreased matrix 
production and increased expression of inflammatory cytokines.62 Cyclic HP at 
physiological levels has also been shown to decrease proteoglycan synthesis.472 
These studies showed the necessity of identifying an appropriate HP stimulation 
regimen to improve neocartilage properties. 
Compression 
Direct compression has also been used to modulate matrix composition and 
concomitantly influence neocartilage properties. Early work with cartilage 
explants demonstrated that compression could act as a catabolic453•473 or 
anabolic452 stimulus. It became clear that dynamic compression was generally 
more beneficial than static regimens, which tended to produce catabolic 
effects.468 More recent efforts, many focusing on tissue engineering applications, 
have shown that direct compression can be used to improve matrix production 
and subsequently improve the functional properties of neocartilage. For example, 
dynamic compression at various frequencies and strain levels has been shown to 
increase matrix deposition.53•54 The beneficial role of dynamic compression and 
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deleterious effects of static compression highlight the importance of selecting an 
appropriate mechanical stimulation regimen. 
Shear 
Although most biomechanical stimulation work has focused on HP and 
compression, shear forces have also been investigated. Treating cartilage 
explants to dynamic shear increased both collagen and proteoglycan 
synthesis.474 Parallel results were observed for neocartilage exposed to shear, 
which showed 40% more collagen and 35% more proteoglycans than static 
controls. Excitingly, this shear application also resulted in a 3-fold increase in 
compressive strength and a 6-fold increase in stiffness.401 Although there has not 
been as much work on the effects of shear, results thus far suggest that further 
investigation is warranted. 
Chemically-induced mechanical stimulation 
In addition to applying mechanical stimulation, exogenous agents that mimic 
mechanotransduction have also been identified. Various mechanisms including 
nuclear deformation,475•476 a5J31 integrin signaling,477 hyperosmolarity,478 and 
strain-dependent ion channel signaling479 have been linked to 
mechanotransduction. Applying exogenous agents such as ionophores and 
hyper-osmotic media that recapitulate these signaling events have been 
employed to enhance cartilage regeneration. 
lon channel modulation 
Exogenous chemicals can be applied to modulate intracellular ion levels, which 
are known to vary following compression, 479 shear, 480•481 and hydrostatic 
- -----------------~------------
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pressure.478•482•483 To recapitulate these signaling events, one study used 
ouabain (Na+/K+-ATPase inhibitor) and ionomycin (a Ca2+ ionophore) or a 
combination of the two agents and demonstrated tensile modulus increases of 
40-95% for cartilage constructs.484 Electromagnetic fields, which can also affect 
ion channels, have been also been applied to increase matrix synthesis.485 
These tissue-level effects suggest that it is possible to apply exogenous agents 
to mimic biomechanical stimulation and subsequently enhance functional tissue-
level properties. 
Osmolarity 
Applying agents that increase osmolarity mimics the hyper-osmotic environment 
that is created when compressive loading forces fluid out of cartilage. 
Hyperosmolarity has been shown to modulate intracellular ion levels,486 
suggesting that it could be employed like ion channel modulators to alter tissue 
properties. Studies with native cartilage have shown that hyper-osmolarity 
influences gene expression.487.488 Although applying hyperosmolarity to tissue 
engineered constructs has not been studied extensively, expanding 
chondrocytes in hypertonic medium enhanced construct mechanical 
properties.489 These promising results indicate that hyper-osmotic environments 
need to be further investigated in context of cartilage regeneration. 
Summary 
Biomechanical stimuli provide many new opportunities for enhancing functional 
properties during de novo cartilage formation. In addition to direct mechanical 
stimulation, mechanical equivalents offer exciting new methods for improving 
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neocartilage properties and developing a better understanding of 
mechanotransduction. Further investigations regarding appropriate stimulation 
regimens will enable mechanical stimuli to become more consistent among 
different studies. 
Future directions 
Biomechanics have been harnessed to improve the study of cartilage 
development, maintenance, and regeneration. Despite exciting recent advances, 
several areas need to be further examined to more fully understand 
biomechanics and develop biomechanics-driven strategies for improving 
cartilage differentiation and regeneration. 
To further develop a biomechanics-driven approach, it will be necessary to 
develop a better understanding of how mechanics drives chondrogenesis. The 
load-bearing environment of cartilage influences chondrocyte differentiation will 
inform stem cell studies that focus on cartilage regeneration. Furthermore, a 
more thorough understanding of embryogenesis could be used to improve 
chondroinduction and re-differentiation methods. Although there is strong 
evidence for biomechanics influencing cartilage development, further in vivo work 
is needed to clarify the role of mechanics in chondrogenesis that occurs in the 
embryo. 
Biomechanical stimuli can be further enhanced by applying them in 
conjunction with other biochemical and mechanical stimuli. Several studies have 
already shown the benefits of a multi-stimulus approach. For example, applying 
TGF-131 in conjunction with HP had an additive effect on the mechanical 
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properties, increasing the compressive stiffness by 164% and the tensile stiffness 
by 231%.59 A similar effect was observed by applying dynamic compression and 
TGF-131 to synergistically increase compressive stiffness by 277%.141 
Additionally, multiple mechanical stimuli could be applied in combination to 
improve cartilage growth. Because cartilage experiences a complex array of 
biomechanical and biochemical signals in the joint space, it could be highly 
advantageous to develop regimens incorporating multiple stimuli. 
An appreciation of the multi-level influence of biomechanics, from cellular 
microenvironment to tissue level, will play a crucial role in cartilage biology and 
engineering. The most successful efforts will mimic the native cartilage 
microenvironment and eventually reproduce the tissue-level biomechanics that 
are crucial for cartilage function. De novo cartilage with the functional properties 
of native tissue could eventually be used to treat cartilage disease and 
degeneration, which would significantly improve the treatment of conditions like 
osteoarthritis. Biomechanics research has helped drive recent developments in 
the field and will continue to be at the frontiers of cartilage biology and 
regeneration. 
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Figure 8-1: Role of biomechanics in chondrogenesis 
Biomechanics plays a key role in cartilage development by promoting 
differentiation of stem cells and limb formation. After cartilage has formed, normal 
mechanical loading is crucial for maintaining cartilage phenotype and prevent 
pathogenesis. Biomechanics can also be applied exogenously to enhance 
neocartilage formation. 
Figure 8-2: Development of cartilage from embryo to fetal stages 
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--
B) Condensation 
Biomechanics ~ 
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A) Mesenchymal progenitor cells migrate from the early mesoderm to sites of 
skeletogenesis and B) undergo pre-cartilaginous condensations by increasing 
expression of cell-cell interaction protein N-cadherin. Compressive forces are 
thought to initiate this process. C) Chondrocyte progenitors begin secreting 
cartilage-specific extracellular matrix and decrease expression of cell-cell 
proteins, thereby increasing their intracellular distance. D) Chondrocyte 
proliferation continues linearly at the subchondral growth front to create the long 
bones while endochondral ossification occurs throughout the juvenile stages to 
transform cartilage into bone. Regions at the long bone ends remain primarily 
composed of chondrocytes. E) Ends of long bones remain capped with a layer 
articular carti lage through adulthood. 
Figure 8-3: Adult cell chondrogenesis 
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Redifferentiate 
Transdifferentiate 
Chondrocyte 
(A) Following monolayer culture, chondrocytes rapidly de-differentiate. 
Biomechanical stimuli such as hydrostatic pressure can be applied to promote re-
differentiation. (B) Mechanical stimulation also can be used to induce 
transdifferentiation into chondrocytes. 
Figure 8-4: Biomechanical stimulation of neocartilage 
Neocartilage 
Mechanical stimuli 
~ ~ / ! 
--+ -/t' 
Chemical equivalents 
Regenerated Tissue 
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Biomechanical stimuli such as compression and hydrostatic pressure can be 
applied to enhance neotissue formation. Analogously, chemical equivalents 
including ionophores and hyperosmotic environments can be applied to mimic 
mechanotransd uction. 
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Conclusions and future directions 
This thesis details work on functional cartilage tissue engineering, investigating 
the mechanisms underlying responses to various exogenous agents. This 
dissertation has examined growth factors, enzymes, and matrix molecules that 
provide simple yet effective methods for improving the functionality of cartilage 
constructs. Chapters 1-2 focus on the novel catabolic agent C-ABC. Work on 
hyaluronic acid (Chapters 3-4) showed how exogenously adding this core matrix 
molecule can enhance tissue-level functional properties. In addition to the central 
work on exogenous agents, various imaging technologies have been investigated 
(Chapter 6, Appendix 4) to expand the assessments available for tissue 
engineering studies. These novel technologies could provide noninvasive 
assessments to complement the destructive tests typically used in tissue 
engineering studies. 
Chondroitinase-ABC 
Work with C-ABC showed that a catabolic agent can be employed to improve the 
tensile properties of constructs. C-ABC cleaves GAGs, resulting in 
polysaccharide chains small enough to diffuse out or tissue of neotissue. 
Although the effects of C-ABC have been shown for explants47 and 
constructs,51 •139 the studies of this dissertation aimed to 1) examine multiple 
treatments to further enhance tensile properties, 2) examine the effects of 
combining C-ABC with TGF-131, and 3) elucidate the mechanism underlying C-
ABC treatment. 
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The first study (Chapter 1) examined the effects of multiple C-ABC 
applications on self-assembled constructs. This study contained both 4 and 6 
week cultures, both of which had C-ABC treatment at 2 weeks, 4 weeks, or 2&4 
weeks. The 4 wk experiment showed increases in tensile properties for the group 
treated at 2 weeks. For the 6 week experiment, the tensile stiffness was 
increased for all C-ABC treatments. The dual 2&4 week treatment enhanced the 
tensile stiffness more so than the individual C-ABC treatments, providing a 
strategy for improving C-ABC treatment regimens. Additionally, by 6 weeks the 
compressive stiffness had returned to control levels despite reduced GAG 
content. These exciting results were investigated in combination with an anabolic 
agent in Chapter 2. 
The second study (Chapter 2) focused on the effects of combining C-ABC 
with TGF-J31. This study produced several novel findings including 1) C-ABC and 
TGF-J31 can be applied to synergistically enhance neotissue, 2) TGF-J31 can be 
applied to aid the recovery of compressive stiffness following C-ABC treatment, 
3) TGF-J31 increases MAPK signaling in self-assembled neocartilage, and 4) C-
ABC treatment results in increased collagen fibril diameter. The increased fibril 
diameter following C-ABC treatment is particularly exciting because it is the first 
demonstration of a potential mechanism for the effects of C-ABC cartilage 
constructs. Because C-ABC and TGF-J31 appear to be acting via distinct 
mechanisms, it makes sense that combining them results in synergistic increases 
in construct properties. 
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Constructs treated with C-ABC and TGF-J31 also exhibited stability and 
maturation in vivo. The improvement of functional construct properties after 4 
weeks of in vivo cultures shows that self-assembled neocartilage has great 
promise for more extensive in vivo work. Although the different responses of 
constructs and native tissue are not yet fully understood, it is possible that the 
higher cellularity of constructs influences their response to in vivo nutrients and 
cytokines. Further investigation could help elucidate the differences in responses 
and also inform future tissue engineering strategies. These exciting in vivo 
results and the promising mechanical properties of constructs post-sacrifice 
suggest that self-assembled constructs should be studied further using cartilage 
defect models. 
These two studies show significant functional results for a relatively new 
agent in tissue engineering. Although many tissue regeneration efforts focus on 
anabolic stimuli, employing a catabolic agent like C-ABC marks a fundamentally 
different strategy. The success of C-ABC is particularly exciting because it 
provides an opportunity synergistically enhance the effects of anabolic agents. 
This was observed in Chapter 2, which illustrated how C-ABC and TGF-J31 had 
different mechanisms of action and in turn explained the synergistic effects 
resulting from applying these agents in combination. 
Hyaluronic acid 
HA work illustrated the ability of HA to improve functional properties of self-
assembled constructs and showed its mechanism of action. Two studies were 
conducted to assess the effects of HA application: an optimization of HA 
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application and investigation of its mechanism of action (Chapter 3) and an 
examination of how exogenous HA influences TGF-~1 signaling (Chapter 4). 
The first study examined the effects of exogenously applying HA on the 
biochemical and biomechanical properties of self-assembled articular cartilage. 
The influence of HA commencement time, concentration, application duration, 
and molecular weight was assessed in three sequential phases. These results 
showed that HA application at seeding was optimal, increasing compressive 
stiffness 1-fold and increasing GAG content by 35%. Furthermore, only higher 
molecular weight HA at a concentration of 1 mg/ml enhanced the compressive 
stiffness and GAG content of constructs. These studies illustrated a promising 
HA application regimen, but the biological and/or biophysical action of HA was 
not yet clear. 
To investigate the mechanism underlying HA treatment, we evaluated the 
gene expression and GAG retention effects of HA application. Because HA 
increased GAG retention in self-assembled cartilage, it could be increasing the 
fixed charge density and thereby increasing water retention in the matrix. This 
water retention could subsequently enable constructs to resist compressive 
loading and explain the observed increased compressive properties. Microarray 
and PCR analyses showed that HA also influenced genetic signaling, up-
regulating 503 genes, including multiple genes associated with TGF-~1 signaling. 
In chapter 4, additive effects of combining HA and TGF-~1 were observed. 
This study demonstrated that HA and TGF-~1 increased the GAG content and 
compressive stiffness of constructs. Additionally, treating with a combination of 
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HA and TGF-J31 further increased the GAG content and compressive properties, 
additively enhancing construct properties. Combined HA and TGF-J31 treatment 
produced neocartilage with a compressive stiffness and GAG content above 
control values by 150% and 65%, respectively. This study demonstrated that HA 
does not interfere with TGF-J31 signaling in self-assembled constructs. The 
additive increases observed with the combination treatment could result from 
increased retention of the GAGs produced due to growth factor application. 
Furthermore, HA could sequester TGF-J31 in the matrix and thereby increase its 
effective dose. 
These studies collectively illustrated how exogenous HA application 
enhances the biochemical and biomechanical properties of cartilage constructs. 
Gene expression and GAG retention studies showed that HA played biological 
and biophysical roles, both of which could contribute to the enhanced construct 
properties. Additionally, the combination of HA and TGF-J31 additively enhanced 
biochemical and biomechanical properties. Results suggested that HA has great 
potential for improving future cartilage regeneration efforts, particularly in cases 
where it is crucial to improve the compressive integrity of the neotissue. 
Optical assessments 
Studies of optical properties provide exciting new optical measurements to our 
conventional assessments that could be used for noninvasive evaluation of 
constructs. Two technologies were investigated for their ability to complement 
conventional biomechanical and biochemical assessments. The first technology 
(Chapter 6) was combination of time-resolved fluorescence spectroscopy (TRFS) 
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and ultrasound backscatter microscopy (UBM). Second harmonic generation 
(SHG) was also investigated to study the organization of the collagen network. 
The effects of matrix composition were examined using TRFS and UBM. 
To alter matrix composition and mechanical properties, cartilage samples were 
treated with collagenase, C-ABC, and ribose. UBM was used to discern 
thicknesses and construct microstructure. Various parameters quantifying 
fluorescence decay such as the average fluorescence lifetime and decay 
constants correlated significantly with biochemical and mechanical data. These 
correlations are exciting because they suggest that noninvasive assessments 
can be used to infer both the biochemical composition and biomechanical 
properties of constructs. Refining the optical signal processing and conducting 
further experiments will enable this technology to be developed as an alternative 
to traditional destructive assays. 
As described in Appendix 4, SHG was used to study zonal variation in 
patellar cartilage. This work showed that SHG can be used to infer functional 
properties of cartilage. In particular, the sizes of disordered regions were strongly 
correlated with tensile strength and stiffness. Although further work will be carried 
out to fully elucidate the SHG signal origin, the strong correlations are exciting for 
the development of an optics-based assessment of mechanical properties. 
Future work focusing on comparing the collagen architecture with SHG data will 
help clarify what aspects of the collagen network contribute to the differences 
observed with SHG. 
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The development of noninvasive technologies that can be used to monitor 
functional construct properties is an exciting step forward for both in vitro and in 
vivo studies. Destructive assays can be time-consuming and require sample loss, 
limiting the number of assays that can be performed. Similarly, destructive in vivo 
assessments require sacrifice of the experimental animal. Nondestructive assays 
could be employed to execute more effective animal studies and eventually be 
used clinically to quantify cartilage degeneration and repair. 
Future directions 
To build upon the current results, there are several main areas of promising 
future work: 1) the mechanisms underlying novel stimuli such as C-ABC and HA 
need to be interrogated in more detail and 2) more extensive in vivo work should 
be undertaken. 
Mechanistic studies should go delve into protein-level interactions in 
addition to the genetic analysis discussed in this work. Because many 
intermediate signaling events such as Smad cascades depend on post-
transcriptional modifications, other analysis modalities will need to be employed 
to gain a full understanding of intracellular cascades. Other time points could also 
be used to observe how signaling cascades develop over time in response to 
stimuli. Additionally, inhibitors of signaling cascades or receptors should be used 
to demonstrate the effects of blocking stimuli. 
Ultimately, in vivo studies will validate the functionality of self-assembly 
and advance the technology. In vivo work should first focus on a small animal 
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model such as rabbit. Because bovine cells are likely to be immunogenic in 
rabbits, it will be necessary to create leporine constructs. The stimuli that have 
been developed in this thesis and in other work can be applied to leporine 
constructs to improve their functionality prior to implantation. These constructs 
can then be implanted in articular cartilage defects to observe their biological 
reactivity, including their immunogenicity and integration with surrounding tissue. 
Post-sacrifice analysis will then illustrate if the constructs have exhibited stability 
in vivo and if they have matured in the in vivo environment. 
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Appendix 1: Genes differentially expressed due to C-
ABC and TGF-P1 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
4.9015756 up 1.0403095 up 1.0091964 down 3643 
3.6445346 down 1.0832741 up 1.0428727 up LOC616969 64283 
3.1834419 up 1.1570461 up 1.048409 down FOSL2 2355 
not found 
2.1836698 up 1.157017 up 1.0712886 down yet 
2.0065997 down 1.2738936 up 1.0725881 up DTYMK 1841 
6.6061444 down 1.076887 up 1.0735799 up TTC36 143941 
2.6536276 down 1.0896107 up 1.079404 up CHST2 9435 
2.4148612 down 1.0546892 up 1.084452 up 80775 
2.3879619 up 1.2759495 down 1.0869504 down 5286 
2.4231634 down 1.1586796 up 1.0901477 up ACOT2 10965 
not found 
2.0777082 down 1.0542128 down 1.1150856 down yet 
2.279873 up 1.1059803 up 1.1289849 up PIM1 5292 
2.3799655 up 1.0623609 down 1.1787587 down ARHGAP21 57584 
2.6392217 up 1.0520011 down 1.1794683 down RALGDS 5900 
3.0405967 down 1.2100194 up 1.1847044 up UCHL1 7345 
not found 
4.7605104 up 1.112944 up 1.2097858 up yet 
not found 
2.662217 up 1.1783559 down 1.2279336 down yet 
2.4334786 down 1.1244112 down 1.2384548 down GNG2 54331 
not found 
3.2531354 up 1.1740832 up 1.2554867 up yet 
2.4242969 up 1.3502362 up 1.3096834 up STK3 6788 
2.9527056 up 1.7144948 up 1.313285 up KRTCAP3 200634 
3.3123212 down 1.5462247 down 1.3376262 down PTPLAD2 401494 
not found 
2.268236 down 1.1770442 down 1.3558139 down yet 
3.3141582 down 1.3444972 down 1.3762094 down GPR143 4935 
2.5297132 up 1.2099886 down 1.3797472 down KCTD7 154881 
4.2787204 up 1.3469323 up 1.3858787 up RIN2 54453 
not found 
2.1111155 down 1.1948843 down 1.401657 down HOXA9 yet 
not found 
2.7156503 down 1.5361385 down 1.4124867 down KCTD1 yet 
2.358832 up 1.4502801 up 1.4246473 up RASSF8 11228 
2.387816 up 1.523363 down 1.4372935 up ARHGAP18 93663 
not found 
2.5910487 up 1.4257276 down 1.4873735 down yet 
2.467413 up 1.2352266 down 1.5830711 down 8844 
2.0980406 down 1.5881585 down 1.6170659 down C25H160R 116028 
not found 
7.710766 up 1.9033235 down 1.6181289 down yet 
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human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
1.2698736 down 2.0545468 up 1.6203291 up APLP2 334 
5.757525 up 1.8390882 up 1.6237885 up RGS1 5996 
3.0886679 up 2.0294733 down 1.6726714 down HRH1 3269 
not found 
2.582046 up 1.6868291 down 1.6947392 down yet 
2.0365717 down 1.7529999 down 1.6969494 down RANGRF 29098 
2.219547 down 1.631639 down 1.6995617 down TP5313 9540 
1.0202878 up 2.083397 up 1.7121162 up GBGT1 26301 
1.4002259 up 2.0009165 up 1.7153105 up CDKL4 344387 
3.8801126 up 1.6483566 up 1.7167046 up TSPAN13 27075 
2.1056504 up 1.6107342 up 1.7170373 up ZBTB43 23099 
not found 
2.2413926 up 1.8650888 up 1.7241894 up yet 
not found 
1.024952 down 2.072654 up 1.7464159 up yet 
not found 
1.0092305 down 2.0025196 up 1.7545491 up LOC78943 yet 
not found 
1.2969291 up 2.0310533 up 1.7622942 up yet 
4.2454605 up 1.9621024 up 1.766288 up NFATC1 4772 
1.1433569 up 3.6961887 up 1.7751596 up TMEM132E 124842 
2.1382291 up 2.0011594 up 1.7756317 up POLR1D 51082 
not found 
2.0853052 down 1.6589415 down 1.7899919 down yet 
not found 
1.150062 down 2.0350637 up 1.8348933 up yet 
1.0250725 down 2.001905 up 1.835938 up LDHA 3939 
1.4449745 down 2.0311692 down 1.8359752 down RGS7 6000 
not found 
2.1381638 down 2.144713 down 1.8460011 down yet 
not found 
9.323849 down 2.2108417 down 1.8572714 down LOC61482 yet 
1.4071224 up 2.072172 up 1.8611709 up SLK 9748 
1.3071691 up 2.0074022 up 1.8707045 up MFSD9 84804 
1.1773912 up 2.1309576 up 1.8789455 up ITPKC 80271 
1.2407342 down 2.1077657 down 1.8814342 down NSMCE1 197370 
1.2495337 down 2.0440948 up 1.8865193 up NFX1 4799 
1.0227376 down 2.1494243 up 1.8979813 up C14H8orf 65265 
2.6292682 up 1.9165483 up 1.9007959 up 734 
1.3519865 down 2.0001912 down 1.901896 down OSBPL1A 114876 
1.4314009 down 2.0958352 up 1.9192401 up NMI 9111 
not found 
2.4341502 down 2.0122235 down 1.9375664 down yet 
not found 
1.0323571 up 2.123672 up 1.9390423 up yet 
1.0499125 down 2.0992274 up 1.9421153 up ANKRD54 129138 
2.328048 up 1.8754404 up 1.9481441 up MAP2K4 6416 
1.0405006 up 2.5238194 down 1.952007 down SCNN1A 6337 
1.1430696 up 2.1898403 up 1.9596405 up ITGA5 3678 
1.6382186 down 2.2766705 up 1.959958 up TMEM120A 83862 
276 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
1.0738645 down 2.0096188 down 1.9619429 down PRKD3 23683 
not found 
1.2716118 up 2.0408506 down 1.9737242 down yet 
not found 
1.211432 up 2.0340095 down 1.9767976 down yet 
1.0987617 down 2.0165653 up 1.9774314 up VAMP3 9341 
not found 
1.5321649 down 2.197055 up 1.9820287 up yet 
1.2326775 up 2.076399 up 1.9825537 up NGRN 51335 
1.1310698 up 2.2471929 up 1.9827988 up TMEM11 8834 
1.393504 up 2.1094813 up 1.9833035 up HIP1R 9026 
1.3772234 up 2.750556 up 1.9931641 up NEK9 91754 
2.0655665 down 1.9641404 down 1.9996179 down MMP23B 8510 
not found 
1.1286536 down 2.1140273 down 2.001297 down yet 
1.7305224 up 2.059546 down 2.0034006 down PFKFB3 5209 
1.1143031 down 2.1261003 up 2.005346 up SLC15A4 121260 
not found 
1.2164307 down 1.8807808 down 2.0129297 down yet 
not found 
1.0950947 down 2.1581628 up 2.0146935 up yet 
not found 
1.0591428 down 2.2286847 up 2.016651 up yet 
not found 
1.0696607 down 2.2311568 up 2.0323944 up yet 
1.2077997 up 1.9493029 up 2.0350845 up PTRH2 51651 
1.1909176 down 2.4998538 down 2.0409586 down TCEA3 6920 
1.418723 up 1.8513179 up 2.045131 up MKI671P 84365 
1.1687165 up 2.281919 up 2.0464835 up TNFAIP1 7126 
2.1767335 down 2.2753336 up 2.0519114 up FANCE 2178 
1.5154134 down 2.342698 down 2.0535254 down KCTD15 79047 
1.3013417 down 2.0903437 up 2.0572288 up PSMA1 5682 
1.2509115 down 2.1306384 up 2.0607917 up SUSD4 55061 
1.3398112 up 2.0590696 up 2.0870898 up MAPK13 5603 
1.2333162 up 1.9579817 down 2.089843 down 166647 
1.8149283 up 1.8621416 up 2.0910833 up DNTTIP2 30836 
1.4322599 up 1.9511508 up 2.0950732 up CCDC85B 11007 
not found 
1.4917597 down 2.078183 down 2.0973306 down yet 
1.3352706 down 2.3142018 up 2.0992513 up TOP3B 8940 
not found 
2.3574698 up 2.2684314 up 2.1005137 up LOC51163 yet 
1.1581705 up 2.9805024 up 2.1018317 up EIF3F 8665 
not found 
1.0776464 down 1.9401795 up 2.1043231 up yet 
1.040704 up 2.7067525 up 2.1134758 up JAKMIP2 9832 
1.0742064 up 2.234418 up 2.1181145 up SRRT 51593 
not found 
1.2016991 up 2.0137947 down 2.1242156 down yet 
1.1035868 up 1.9920549 up 2.1312492 up C10H15or 81556 
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C-ABC TGF TGF+C-ABC Gene Symbol Entrez 10 
1.3504026 down 2.3870413 up 2.1348176 up TAF6L 10629 
not found 
1.0354674 down 2.1626034 down 2.1394618 down yet 
1.1814162 up 1.936651 up 2.1424315 up LBH 81606 
1.7910793 up 2.8944652 up 2.145998 up RBM22 none 
not found 
1.1020904 down 2.182597 down 2.1535091 down yet 
1.2573025 up 2.2952964 up 2.1557317 up UBTF 7343 
1.6107242 down 2.0605295 down 2.1561933 down IRAK4 51135 
1.1718096 up 1.989224 up 2.1562097 up UNC50 25972 
not found 
1.1752428 up 1.8163778 up 2.1567411 up yet 
3.720657 up 2.3451266 down 2.158956 down ANKRD37 353322 
1.4689589 down 1.8643689 down 2.1594906 down ARHGAP22 58504 
1.5320667 down 2.3976977 down 2.162716 down ZNF32 7580 
not found 
1.1348641 up 1.900795 down 2.1676471 down yet 
1.2183964 up 2.6208737 up 2.1683164 up PROSC 11212 
1.0139945 up 1.2217233 up 2.1712306 up ZBTB5 9925 
not found 
1.8697323 up 1.9139298 down 2.1714013 down yet 
2.3177526 down 2.1790917 up 2.1714835 up FAM129A 116496 
1.2596956 up 2.040952 up 2.1776123 up PSMD6 9861 
not found 
4.4040995 up 2.698971 up 2.1849384 up yet 
1.1091124 up 2.755864 up 2.1876853 up KCNQ3 3786 
1.1108452 down 1.8541149 down 2.1916778 down CDH3 1001 
1.247224 up 1.8590497 up 2.1929138 up MED6 10001 
1.0792893 down 2.1201332 down 2.1968975 down USP9X 8239 
1.4857253 down 2.307843 up 2.1983004 up PRDX1 5052 
1.3454791 down 2.5601377 up 2.2024953 up TXNRD3 none 
1.2006079 up 2.1285164 up 2.2036312 up GMDS 2762 
1.6278675 up 2.2468617 up 2.2109077 up KCTD5 54442 
not found 
1.0236837 up 2.345092 up 2.213217 up TBRG1 yet 
1.3195492 down 2.413385 up 2.2148957 up SPON2 10417 
1.0124848 down 2.6112764 up 2.2171817 up SENP3 26168 
1.0042065 down 3.643015 up 2.2183323 up PKP3 11187 
1.0647688 up 2.5935724 up 2.2218354 up LRP8 7804 
2.1008217 up 2.1386085 up 2.2220256 up RASA2 5922 
1.1704376 up 2.1556697 down 2.2249506 down HSD17B4 3295 
not found 
1.421185 down 2.2234964 down 2.2294497 down yet 
2.0027559 down 2.3694777 down 2.2298656 down ACSL5 51703 
1.2272127 up 2.3513403 up 2.2434998 up ARHGAP26 23092 
not found 
1.237074 up 2.3626919 up 2.2449124 up FKBPL yet 
1.187632 down 2.412843 up 2.246164 up POLR2J 5439 
1.3133228 down 2.6611476 up 2.2491248 up CHST11 50515 
1.1123184 up 2.1273403 down 2.2499003 down NDRG2 57447 
278 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
1.6664172 up 2.0305965 down 2.2512445 down GAS7 8522 
not found 
1.2076786 down 1.9183267 down 2.2528334 down yet 
1.9293876 down 2.868439 up 2.2531333 up ACSL6 23305 
1.2083362 up 2.3684509 up 2.2559464 up C3orf39 84892 
3.1715612 down 2.0669487 down 2.273674 down APOA1 335 
not found 
1.3563006 down 2.1789138 down 2.2765071 down yet 
not found 
1.983315 down 2.1077878 down 2.290807 down yet 
1.1988106 down 2.0368447 down 2.2932296 down ZNF532 55205 
not found 
1.1084356 up 2.0968473 down 2.301958 down yet 
not found 
1.1583425 down 2.0097072 down 2.3033688 down yet 
1.6714807 down 2.493926 down 2.3035157 down TSPYL4 23270 
1.6101749 down 2.249273 down 2.3050134 down MFAP2 4237 
1.5907756 up 2.599245 up 2.3092244 up GRB7 2886 
1.1435785 down 2.403123 down 2.3113093 down ME1 4199 
1.1424454 down 2.3281274 up 2.3193634 up FUS 2521 
not found 
1.0652771 up 2.7198768 down 2.3200746 down yet 
1.466776 down 2.066089 down 2.3275898 down IGF2 3481 
not found 
2.0526717 up 1.9885459 up 2.3343098 up yet 
1.6415204 up 2.7670908 up 2.3359704 up DIP2B 57609 
1.5068405 up 1.9112371 up 2.339905 up MKNK1 8569 
4.050903 up 2.019834 up 2.3420155 up GPR68 8111 
not found 
1.5015069 up 2.4098008 up 2.3474042 up yet 
1.2888963 down 2.6330204 down 2.3665276 down MST4 51765 
1.325751 down 2.8618252 up 2.367214 up ABHD11 83451 
1.1913924 down 2.159122 down 2.371023 down TGFB3 7043 
not found 
1.1673371 down 2.7237163 up 2.3724535 up yet 
1.0959351 down 2.4473052 up 2.3756042 up MRPL49 740 
1.7554717 up 2.4641943 up 2.3825464 up CAMLG 819 
1.4979506 up 1.6284522 up 2.3890631 up C16H10RF 163859 
not found 
1.2022715 up 2.349902 up 2.3895886 up yet 
2.2395308 down 2.0342534 down 2.3904939 down MAP1A 4130 
2.2410932 down 2.3798542 down 2.396234 down NFU1 27247 
1.3692697 up 2.5838375 up 2.397329 up TCF7 6932 
1.5048778 up 2.3840442 up 2.4006138 up PRKRIP1 79706 
2.440888 up 2.631391 up 2.401925 up DSE 29940 
not found 
1.1371698 up 2.791733 up 2.4048095 up LOC53959 yet 
not found 
1.3634651 down 2.3212967 down 2.4176514 down yet 
1.1879445 up 2.7448325 up 2.4245808 up MORG1 84292 
1.2968701 down 4.152734 down 2.4260643 down not found 
279 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
1.0358844 down 2.714399 up 2.4266007 up STIP1 10963 
not found 
1.3946375 down 1.8743402 down 2.428181 down yet 
1.8104963 up 2.3121433 up 2.4382339 up PIGA 5277 
not found 
1.0195549 up 2.5296292 up 2.4404163 up yet 
not found 
1.6490428 down 2.0890446 down 2.442919 down LOC508015 yet 
1.159661 down 2.5762708 up 2.4484603 up PSM014 10213 
1.0735195 up 3.1131701 up 2.4570093 up PITPNB 23760 
not found 
2.139502 up 2.5500758 up 2.459456 up yet 
1.0252186 down 2.7415202 up 2.462911 up HABP4 22927 
2.8784652 up 2.3323138 down 2.463459 down LOXL4 84171 
1.2541357 up 2.1639345 down 2.466271 down CACNB3 784 
1.1140985 down 2.2701235 down 2.4694157 down SOC3 9672 
not found 
1.0175054 up 2.3264687 up 2.4744303 up SQROL yet 
not found 
1.3039547 up 2.2647321 up 2.474709 up TSNAX yet 
not found 
1.3295789 down 2.4397235 down 2.4864612 down yet 
not found 
1.0303869 up 2.224381 up 2.4884584 up UBE2B_HU yet 
not found 
1.0699071 down 2.549118 up 2.5044029 up yet 
not found 
1.7097763 up 2.7502174 up 2.504579 up NKRF yet 
not found 
1.0934718 up 2.0537937 down 2.509598 down yet 
1.2798603 down 2.488982 down 2.5096436 down EFEMP2 30008 
not found 
1.462542 up 2.2302551 up 2.509902 up yet 
not found 
1.4102297 down 2.368238 down 2.5104382 down yet 
1.8860523 down 2.301686 down 2.515596 down 0082 1643 
1.9958661 down 2.5939136 down 2.517772 down CYP39A1 51302 
1.4564852 up 2.3977807 up 2.5205498 up TP53111 9537 
1.6225696 down 2.3281386 down 2.521655 down SFXN3 81855 
1.7482036 up 2.4404957 up 2.5248542 up OYRK3 8444 
2.604903 up 2.1666887 up 2.526468 up B3GNT2 10678 
1.0994741 down 2.7208567 up 2.5270915 up NOP16 51491 
not found 
2.5654593 up 2.8330016 up 2.5312576 up OUSP4 yet 
not found 
2.614989 up 2.673643 up 2.5323186 up LOC10014 yet 
not found 
1.4692864 down 2.4125311 down 2.5383263 down yet 
not found 
1.6253155 up 2.3957942 up 2.5389605 up yet 
1.2440169 up 2.2418215 down 2.542093 down not found 
280 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
not found 
2.8180707 up 2.4757597 up 2.5472147 up BOLA-N yet 
1.554106 up 3.1221828 up 2.5490866 up SF1 7536 
not found 
1.2014999 up 2.377746 up 2.5501838 up yet 
1.1850991 down 2.4115653 up 2.5508053 up SCG2 7857 
not found 
2.5096455 down 2.7947512 down 2.5534146 down yet 
1.0291198 down 2.3924696 up 2.5582092 up PQBP1 10084 
1.0707166 up 3.5939844 up 2.5619557 up MAPK81P1 9479 
not found 
1.9345593 down 2.5022843 down 2.5671625 down yet 
1.0097018 up 3.4857788 up 2.5749109 up SLURP1 57152 
1.5591538 down 2.4215734 down 2.5838223 down PIGP 51227 
1.4093169 down 2.4127426 down 2.5900342 down GATSL3 652968 
not found 
1.635167 up 2.7409897 up 2.5924506 up yet 
1.4496231 down 2.632667 up 2.5938132 up PPCDC 60490 
2.263011 up 2.5612733 down 2.5994782 down SLC6A14 11254 
1.3240415 down 2.4586844 down 2.601335 down RBPJ 3516 
1.5491153 up 2.6138058 up 2.601829 up TBP 6908 
1.3224908 down 2.6829712 down 2.603372 down FAM115A 9747 
1.1594895 down 2.4480958 down 2.6036885 down EXT2 2132 
2.2393806 down 2.3935761 down 2.6096923 down FBLN5 10516 
1.0423334 up 2.1849225 down 2.6122794 down PLCE1 51196 
5.663506 up 3.2219908 up 2.6155717 up JUNB 3726 
1.5142583 down 2.400985 down 2.619251 down MANSC1 54682 
not found 
2.5881414 down 2.646018 down 2.6223853 down yet 
not found 
1.183004 down 2.866338 up 2.6293645 up yet 
not found 
2.3786123 up 3.038464 up 2.6338377 up yet 
1.1524073 down 3.2378407 down 2.6398067 down MAP3K5 4217 
1.1724197 up 2.9055235 up 2.6400616 up DDX56 54606 
not found 
1.1775446 up 2.444821 up 2.641342 up yet 
1.5756801 down 1.5146326 up 2.6491396 up MYLK 4638 
2.7845385 down 2.0308828 down 2.6581671 down none 
1.0313165 up 2.7671804 up 2.6607559 up ORMDL1 94101 
1.4024034 down 3.5309722 down 2.6627097 down MST4 51765 
1.5705991 up 2.5405223 up 2.6711872 up RCHY1 25898 
1.7289288 down 3.4107652 up 2.6752129 up TLR7 51284 
not found 
1.0109245 up 2.1241984 down 2.6764119 down yet 
not found 
1.3193097 up 2.5928278 up 2.6771662 up yet 
2.4477792 up 2.715759 up 2.6785057 up UBE2H 7328 
1.0173111 down 2.5759518 up 2.6803572 up SLC25A22 79751 
1.5228544 up 2.642589 down 2.6840947 down TGFBR2 7048 
281 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
1.3494971 down 3.7625754 up 2.6852372 up POP1 10940 
6.373607 down 2.8433473 down 2.6898022 down AKAP3 10566 
1.6902938 down 2.5423536 down 2.6914165 down MAGEF1 64110 
1.0047361 up 2.6946597 up 2.6975718 up RBM4 5936 
1.7289723 up 2.8540814 down 2.7044663 down LM07 4008 
3.1186552 down 2.030994 down 2.7063782 down SLC6A12 none 
1.2040496 down 2.5671792 down 2.7094786 down DNMBP 23268 
1.355325 up 2.7185903 up 2.712614 up TJP3 27134 
1.3613573 down 2.7948723 down 2.7362437 down IFIT5 24138 
not found 
1.282987 down 2.4781709 down 2.7433863 down yet 
not found 
1.0528868 up 2.5878441 down 2.7464004 down yet 
1.9344132 up 2.7409682 up 2.7514856 up TOE1 114034 
1.0029378 down 2.8847094 up 2.7527537 up ABCF2 10061 
1.3745375 up 3.1808543 up 2.7566466 up MYL4 4635 
1.154493 down 2.6143477 up 2.7582977 up NUP85 79902 
1.0466037 down 2.592014 up 2.7614913 up E2F4 1874 
2.013666 down 2.7902744 down 2.7779233 down TTC8 123016 
2.3016937 up 3.1157095 up 2.7814727 up 79798 
1.8480738 down 2.5820956 up 2.7965033 up PAK1 5058 
2.0749416 down 2.8537126 down 2.7976227 down EFCAB1 79645 
1.2918354 down 2.533671 down 2.8065743 down CUEDC1 404093 
13.1872425 down 2.9083717 up 2.8098698 up CATHL1 820 
not found 
1.1082803 down 2.3069777 down 2.8119843 down yet 
2.2801986 up 2.7725427 up 2.818499 up C4orf32 132720 
1.1350935 up 2.2597258 up 2.8472166 up SESN2 83667 
1.7060609 down 3.1293845 down 2.851912 down LOC53021 167359 
not found 
1.3757409 down 2.935798 down 2.8675966 down yet 
1.2092056 up 2.6850197 up 2.875018 up GAL3ST3 89792 
1.5593632 up 3.4776094 up 2.892076 up CCDC151 115948 
1.0475821 up 2.7861416 down 2.8952677 down EFNA1 1942 
1.1225343 down 3.1325798 down 2.903698 down LOC50955 388341 
1.3213458 up 3.3391654 up 2.905848 up CASK 8573 
1.1071916 up 3.2307189 up 2.9065025 up SLC37A1 54020 
1.0503942 up 2.8001566 up 2.9106617 up PAQR9 344838 
not found 
2.2527761 up 1.3579719 up 2.9245694 up UTP3 yet 
1.535865 down 2.2419598 down 2.9345944 down GPR173 54328 
1.6872048 down 2.650158 down 2.9383204 down TCEA2 6919 
1.0935609 down 2.8823385 up 2.9410617 up SNRPC 6631 
1.2729754 down 2.610434 up 2.949077 up EIF2S1 1965 
2.0206134 down 3.5530193 down 2.9522688 down S100A9 6280 
6.786773 up 3.1627035 down 2.9544806 down PTGES 9536 
1.0572647 down 2.9063723 down 2.9753795 down ENOSF1 55556 
2.498345 down 3.2950635 down 2.9778662 down TPD52L1 7164 
not found 
1.2944517 up 3.3113568 down 2.9912195 down yet 
282 
human 
C-ABC TGF TGF+C-ABC Gene Symbol EntreziD 
not found 
1.0171213 up 3.2197945 up 2.9967856 up yet 
1.5222762 down 3.0872855 up 3.0034716 up GSR 2936 
1.0645467 up 2.7449343 down 3.0099277 down ADAMTSL2 9719 
1.706997 up 3.1029277 up 3.0253143 up RPAIN 84268 
not found 
1.6436144 up 2.0103576 down 3.040507 down yet 
1.1470275 up 3.4615738 up 3.0425148 up MRAS 22808 
not found 
3.5998442 up 2.8440244 up 3.0439718 up yet 
1.1392188 down 2.2549202 down 3.0514061 down IGF2R 3482 
1.4400855 down 3.2597315 down 3.0540686 down TST none 
not found 
2.507685 up 3.9714868 up 3.058635 up yet 
1.3162374 up 3.2813785 up 3.0649276 up CDA 978 
3.8624952 up 3.0706077 up 3.067854 up SGK1 6446 
not found 
2.9732668 up 2.7706516 up 3.069435 up PGF yet 
1.0536393 down 2.0542078 up 3.0862892 up SAR1B 51128 
4.9132676 up 2.9648468 up 3.0945923 up THSD1 55901 
not found 
4.0812416 up 3.6961637 up 3.1038983 up yet 
not found 
1.3582988 up 3.6137476 up 3.105273 up CAMTA1 yet 
1.3374321 up 3.1069398 up 3.1126585 up RCAN3 11123 
1.9302014 up 2.7011766 up 3.1227937 up ECT2 1894 
1.277453 up 4.5986457 up 3.1354046 up CHD4 1108 
1.0947918 down 3.1505322 down 3.140971 down B3GNT9 84752 
1.3665565 down 5.327489 up 3.1469862 up 57642 
1.2931242 up 3.4445279 down 3.1717286 down RRAGD 58528 
1.3956175 up 3.793012 up 3.1770632 up CHRNA10 57053 
2.4026654 up 3.2321677 up 3.185317 up SIK1 150094 
1.1569903 up 2.2829976 up 3.1931899 up FGF18 8817 
1.0169852 down 3.0644739 up 3.1999838 up 338657 
not found 
1.0385623 down 3.7386317 up 3.211961 up yet 
1.5516782 up 3.3334298 up 3.2521477 up ITFG2 55846 
1.3989775 up 6.4452868 up 3.2603595 up LOC524694 27143 
not found 
1.2289053 down 4.745711 down 3.2741516 down yet 
not found 
1.7656565 up 3.5877528 up 3.2772574 up yet 
3.7852402 up 5.4661636 up 3.288583 up PTPN7 5778 
1.9406823 up 3.091763 up 3.332797 up TP531NP1 94241 
1.2557672 down 2.944683 up 3.3520975 up KCNK7 10089 
2.3748977 up 3.5875654 up 3.355734 up BCAS2 10286 
not found 
1.0748934 up 4.468307 up 3.3586102 up yet 
1.8905472 down 3.1622655 up 3.3615441 up FGF13 2258 
1.1949329 up 3.1581414 up 3.3630111 up DOHH 83475 
283 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
1.4712131 up 2.6368139 up 3.3699903 up KLHL25 64410 
not found 
1.3863946 down 3.0862787 down 3.3881478 down yet 
1.0113295 down 4.38441 up 3.4156332 up MMP15 4324 
3.0386994 up 4.453125 up 3.4237907 up CLDN4 1364 
1.3633215 down 2.3601031 down 3.4488301 down Z8T878 51043 
1.3675708 up 4.3549075 up 3.4526787 up LOC539609 27094 
1.3138007 up 4.783742 up 3.4533546 up LOC530472 none 
1.1928498 down 3.4320154 up 3.4598837 up PC8D1 5092 
1.3604134 up 3.6046312 up 3.4746754 up NXF1 10482 
not found 
1.2611979 down 3.5325148 down 3.484802 down yet 
1.4051749 up 2.4342942 up 3.4989543 up COL6A1 1291 
1.5068434 up 3.6751702 up 3.504516 up 8os taur 1647 
1.1356875 up 1.5575407 up 3.5317233 up 8854 585 
not found 
4.5004563 down 3.4371061 down 3.5323806 down yet 
1.7576377 up 3.5629237 up 3.5352762 up 3858 
2.5327806 down 2.7785249 down 3.5367632 down ODZ4 26011 
1.1524539 down 3.0343683 down 3.5384545 down TCFL5 none 
not found 
1.227667 up 7.536936 up 3.5389214 up yet 
2.4536686 down 2.8981876 down 3.5426679 down ZNF84 7637 
1.9237865 down 3.6975787 down 3.5562801 down CDK5RAP2 55755 
not found 
1.3766019 up 4.556256 up 3.5660882 up yet 
1.4182881 up 3.948201 up 3.579726 up MDM2 4193 
not found 
1.1013724 down 4.147421 up 3.579798 up yet 
not found 
2.8802633 up 3.115038 up 3.5823262 up RA8GAP1L yet 
not found 
1.3597994 down 7.7407527 down 3.5831466 down yet 
1.4700658 down 3.2448008 down 3.583776 down PGC 5225 
1.1288188 down 3.756585 down 3.5913644 down VAV3 10451 
1.3032715 down 3.1553357 down 3.591542 down PDGFRA 5156 
1.6562916 down 3.9022677 up 3.6143284 up NFE2L3 9603 
1.3294446 down 3.6400201 down 3.6248896 down PLCE1 51196 
not found 
1.1746292 up 3.8721755 down 3.6365178 down yet 
1.3390449 up 2.9708447 up 3.6368892 up SLC25A4 291 
2.2384346 up 2.7726078 up 3.6373808 up LT8P2 4053 
1.1689352 down 4.977705 up 3.6405952 up RECQL4 9401 
not found 
3.9253683 down 2.7055082 down 3.6548493 down yet 
2.6867158 down 3.068712 down 3.659204 down MS4A88 83661 
not found 
1.9606739 up 3.634362 up 3.6592324 up CENPE yet 
1.0533085 up 3.3435814 down 3.6673074 down OGT 8473 
284 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
1.2163312 up 3.8034656 up 3.6704507 up 5599 
2.0842566 up 4.010074 up 3.6773603 up GPR162 27239 
not found 
1.8353796 down 4.171599 down 3.6793618 down yet 
1.202141 up 3.2885532 down 3.6869571 down KCNMA1 3778 
not found 
1.1202505 up 3.7255461 up 3.7556872 up yet 
not found 
2.496803 up 4.0607533 up 3.778193 up yet 
not found 
1.0896423 up 3.5714028 down 3.7990608 down yet 
not found 
1.7271354 down 3.3532825 down 3.7997644 down LOC61679 yet 
not found 
1.218612 up 3.2031016 up 3.8003051 up yet 
1.6619626 down 4.020443 down 3.840271 down NFIA 4774 
1.2962128 up 4.6099606 up 3.8869188 up 5800 
1.0279901 up 2.9200935 up 3.8933516 up SYT5 6861 
1.0204479 up 4.1571374 down 3.8955693 down SERPINA1 5265 
2.1014924 up 4.5720778 up 3.8988805 up MAPK81P1 9479 
not found 
4.7588577 up 4.2980046 up 3.9095008 up yet 
not found 
6.046609 up 5.6565204 up 3.9210854 up yet 
1.0881543 up 3.573831 up 3.9213157 up BIRC5 332 
1.957142 up 4.627286 up 3.9304435 up HSPH1 10808 
1.8017187 up 3.712933 up 3.9455285 up ST8SIA1 6489 
2.286553 up 4.157042 up 3.952745 up MAP2K3 5606 
not found 
3.020998 up 3.5885441 up 3.9717622 up yet 
not found 
1.6557907 down 3.3278458 down 3.9726975 down yet 
1.0571743 down 3.2556405 down 3.9744673 down RASL11B 65997 
1.4000032 down 4.0416183 down 3.992534 down GAB1 2549 
1.6490785 up 3.7360551 up 3.9938915 up SLBP 7884 
1.3654764 down 3.7851398 down 4.000058 down LHFPL2 10184 
1.7718093 down 3.5993505 down 4.0290613 down SLC11A2 4891 
1.4164734 up 2.8061097 up 4.0875387 up EIF3J 8669 
not found 
1.2698401 up 4.2409053 up 4.0974293 up LOC10017 yet 
1.6646079 down 3.2310705 down 4.123896 down PLCE1 51196 
2.6102667 up 4.0230417 up 4.1342745 up FGF2 2247 
3.7997396 up 4.232461 up 4.140013 up TGIF1 7050 
1.2529715 up 4.437685 up 4.143091 up C18H19or 56006 
5.165703 up 3.3635867 up 4.151217 up SLC30A1 7779 
1.9410077 up 4.181233 up 4.1861644 up CD68 968 
4.4187393 up 3.8408976 up 4.2083244 up ADRB2 154 
1.740131 up 4.459207 up 4.2338185 up IGFBP3 3486 
2.2762842 up 5.037452 up 4.235868 up SNAPC5 10302 
1.1398602 up 3.4486198 up 4.266538 up PAQR5 54852 
285 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
2.0842047 down 4.0483055 down 4.3020124 down SIRT3 23410 
1.6240525 up 2.655072 up 4.3388515 up BAMBI 25805 
4.8896613 up 5.301905 up 4.3499055 up ITPRIP 85450 
2.5629761 down 4.7870603 up 4.3512645 up E2F1 1869 
not found 
1.1740124 up 4.397139 up 4.3740897 up RASSF7 yet 
not found 
1.9269323 up 5.240814 up 4.3747835 up yet 
2.3885117 down 5.515665 up 4.435285 up EPHB2 2048 
1.3626428 up 4.3493433 up 4.438893 up TUBB2C 10383 
2.2283068 up 4.2495008 up 4.4941034 up SMURF2 64750 
not found 
1.3726611 up 4.358388 up 4.5205503 up yet 
1.2354732 down 4.480074 down 4.556166 down FKBP10 60681 
1.0638231 down 3.9097722 down 4.5729413 down THBS4 7060 
1.0729396 down 3.3754218 up 4.6012373 up LAMB3 3914 
1.9845389 up 5.6068325 up 4.6203957 up NLRP6 171389 
not found 
1.164265 down 4.371583 down 4.622005 down yet 
2.6785371 up 4.6505103 up 4.623603 up LAPTM5 7805 
not found 
1.0287519 down 4.5528507 up 4.642802 up LOC614669 yet 
2.729713 up 4.3826413 up 4.675583 up IFRD1 3475 
not found 
1.0471861 up 5.164725 down 4.689234 down AE000785 yet 
1.6632512 down 6.3105545 up 4.7116714 up GCG 2641 
4.2411284 up 4.8122106 up 4.715147 up TGIF1 7050 
1.1412283 down 5.330548 down 4.7217956 down STAC2 342667 
1.9117992 down 3.727457 up 4.7292776 up PROC 5624 
3.0934255 down 4.0913544 down 4.7333097 down PLCD4 84812 
not found 
1.2288761 up 5.8435264 up 4.778885 up yet 
not found 
1.4417832 up 5.475371 up 4.797967 up yet 
1.270624 up 5.051258 up 4.81373 up ISYNA1 51477 
not found 
1.0829424 down 4.1570663 down 4.832486 down yet 
1.461919 down 3.9084842 down 4.882957 down GLB1L 79411 
not found 
4.789552 up 4.8926497 down 4.883491 down yet 
1.0164498 up 4.9275756 down 4.8889756 down ADCY2 108 
1.364317 up 5.110558 up 4.962964 up RASL10A 10633 
1.0930865 up 4.5320354 up 4.97764 up COL11A1 1301 
not found 
1.3672736 down 4.580678 down 5.0668054 down yet 
1.8264153 up 5.364406 up 5.0857797 up ZNF750 79755 
1.1656871 up 3.9557645 down 5.1523824 down PIK3R1 5295 
2.1955793 down 4.564729 down 5.212081 down GLI3 2737 
1.9992377 down 4.6247163 down 5.282652 down LOC61596 54586 
2.1434767 up 6.298757 up 5.2909393 up CENPK 64105 
286 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
3.4820526 up 6.0919657 up 5.2952433 up ST3GAL1 6482 
1.3976505 up 6.2721977 up 5.312982 up ITPKA 3706 
not found 
1.0248469 up 4.3529677 down 5.3608384 down yet 
2.8549964 up 3.983416 down 5.3677125 down 117248 
1.8706241 up 5.150632 up 5.3787465 up MAP3K6 9064 
1.3521882 down 5.1360292 up 5.419618 up GDAP1 54332 
1.0010103 down 6.392243 up 5.4676433 up CCNF 899 
2.6401532 down 5.407202 down 5.5548897 down ANXA9 8416 
2.4861133 down 5.3150907 down 5.566002 down CXHXORF4 139212 
not found 
1.1142812 down 4.9383082 down 5.5839243 down COL12A1 yet 
not found 
1.1703227 down 2.9916117 up 5.590863 up yet 
1.0097867 up 4.137005 down 5.5976205 down DMTF1 9988 
1.8540739 up 5.7503858 up 5.619072 up CCRN4L 25819 
1.5729865 down 5.5316615 down 5.6230764 down SOX8 30812 
1.0823025 down 6.1471324 down 5.6307416 down SPON1 10418 
1.216774 down 6.4675226 up 5.6735997 up RAB26 25837 
not found 
1.5211424 up 4.5794306 down 5.6925807 down yet 
not found 
1.6992375 down 5.707675 down 5.708976 down yet 
1.5896442 down 5.785146 down 5.7421412 down CARD11 84433 
1.3628274 down 4.9254174 down 5.747124 down MAN1C1 57134 
not found 
1.496253 up 7.00452 up 5.756747 up yet 
2.6251798 up 5.4166007 up 5.7742596 up PREX2 80243 
1.0676433 down 5.453607 down 5.774538 down NRP2 8828 
11.911834 up 6.3820887 up 5.7745657 up HSPB3 8988 
2.4760218 up 6.4447756 up 5.8937426 up B3GNT8 374907 
2.3303094 down 6.4225683 up 5.903876 up C1QL1 10882 
1.2621373 down 6.329532 down 5.939477 down TGFBR3 7049 
not found 
1.1253759 up 4.683143 down 5.9859614 down ATP8 yet 
1.2587955 down 4.525118 down 6.1018987 down ACAN 176 
1.5425686 down 6.121172 down 6.102947 down CERCAM 51148 
1.6502489 down 7.7599626 down 6.125916 down IFI16 3428 
1.0770255 up 6.8752613 up 6.171526 up PBX4 80714 
1.5191065 down 5.947346 down 6.182932 down MAPRE2 10982 
not found 
2.2492502 down 7.0700274 down 6.2494655 down yet 
1.509992 down 5.932147 down 6.2814765 down SLC22A16 85413 
not found 
1.3065306 up 6.914314 up 6.300955 up yet 
2.3967214 up 5.667539 up 6.3117166 up RPAP2 79871 
1.0272484 up 7.340063 up 6.3768024 up GPR84 53831 
1.0182298 up 6.680339 up 6.4098535 up ACBD7 414149 
1.0750619 up 5.4539695 up 6.4963174 up DGAT2 84649 
1.4345999 down 6.8017325 down 6.666559 down NFIB none 
- --------~~--~~--~-------
287 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
1.0613542 up 6.043587 up 6.7314095 up ARHGAP25 9938 
2.656527 down 5.855164 up 6.815524 up COL 16A1 1307 
2.423109 down 6.603288 down 6.864555 down none 
not found 
2.8553715 up 5.4450817 up 6.875869 up yet 
1.4276327 up 6.8605084 up 6.9169607 up TXNRD1 7296 
not found 
1.1884139 up 7.1678576 up 6.924168 up yet 
1.339659 up 5.3308806 down 6.9609904 down ND1 none 
not found 
2.1115835 up 6.5890865 up 6.978598 up TGFB1 yet 
2.0876596 up 7.1473007 up 7.1031647 up RHOV 171177 
1.925435 down 9.264734 down 7.1560636 down TOX 9760 
1.0947837 down 4.831062 up 7.1669006 up NAAA 27163 
1.6026946 up 7.901762 up 7.194202 up HIST1H2B 8341 
4.321536 down 4.7767816 down 7.237031 down CLDN7 1366 
1.7858223 up 6.7679176 up 7.290616 up MC1R 4157 
2.1776254 up 6.943243 up 7.3371177 up RCAN1 none 
not found 
1.0391849 down 6.6171727 down 7.376043 down yet 
2.3996716 down 8.731816 down 7.565273 down EFEMP1 2202 
3.3997722 up 6.3904243 up 7.650434 up DLL4 54567 
1.2581141 down 7.554394 down 7.665854 down PAK3 5063 
not found 
2.0074582 down 4.7893553 down 7.6852756 down yet 
3.0413463 up 5.994275 up 7.7264347 up SH203C 10044 
1.3183197 down 7.8271756 down 7.772719 down LPL 4023 
2.3215787 up 6.8984423 up 7.8038197 up GRASP 160622 
not found 
1.4535302 down 8.752241 down 7.8567166 down yet 
2.2111766 up 7.3043013 up 7.8745756 up 54498 
2.9922938 down 6.8156004 down 7.9079084 down PLA2R1 22925 
3.0914476 down 9.382526 down 7.9236627 down BC02 83875 
1.5611192 up 7.189873 up 7.953059 up TAGAP 117289 
1.7863861 down 7.717103 down 7.985852 down PDGFRL 5157 
2.8927777 down 8.827048 down 7.9895835 down TMEM90B 79953 
not found 
1.6419544 down 5.7487564 down 8.044555 down PRM1 yet 
not found 
2.4081178 up 9.032786 up 8.093484 up yet 
not found 
1.3162274 up 6.1380715 down 8.205122 down yet 
1.7994679 up 5.189304 up 8.308894 up IL 1RL2 8808 
1.617134 up 13.119147 up 8.333474 up GPR157 80045 
not found 
1.0232939 up 8.354948 up 8.4446535 up yet 
not found 
2.351486 up 8.171648 up 8.600302 up BCL2L11 yet 
1.7203656 up 9.01704 up 8.613381 up CSPG5 10675 
1.5222696 up 8.563685 up 8.62703 up GALNT10 55568 
288 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
not found 
1.3917518 up 17.978193 up 8.650253 up yet 
not found 
1.2889426 down 7.1168013 up 8.721611 up PKIB yet 
1.7753866 down 9.410274 down 8.999549 down RARRES2 5919 
1.3187244 up 12.304173 up 9.019645 up NRIP3 56675 
3.4757938 up 11.500069 up 9.18707 up GPRC5A 9052 
2.1551843 down 3.9088671 down 9.321633 down 4916 
1.2822757 down 10.945822 down 9.322531 down MGST2 4258 
1.4115542 up 5.744077 up 9.538851 up IFIT1 3434 
not found 
1.0953921 up 8.811695 down 9.5760565 down yet 
1.1747012 up 10.436025 up 9.619276 up CAMKV 79012 
1.0909197 down 10.134245 down 9.697239 down F2R 2149 
1.8988444 down 9.545914 down 9.808312 down CSGALNACT1 55790 
not found 
1.6676607 up 6.395044 up 9.811101 up yet 
not found 
2.5430977 up 11.966972 down 9.839919 down yet 
not found 
3.049745 up 5.7851386 up 9.871931 up yet 
2.0109463 up 10.407687 up 9.883663 up PTPRE 5791 
4.813546 up 9.947744 up 9.915726 up CYB561 1534 
not found 
1.3469199 down 9.004676 down 9.928766 down yet 
not found 
1.27794 up 8.5754795 up 9.971019 up PKIB yet 
not found 
1.0478247 down 8.820894 down 10.017535 down yet 
not found 
2.4757378 down 8.444028 down 10.0971365 down yet 
not found 
2.8092756 up 9.679538 up 10.103738 up yet 
not found 
6.4416122 down 8.997313 down 10.13726 down yet 
1.4920088 up 12.448486 down 10.2072525 down KCNJ8 3764 
2.9075103 up 12.186936 up 10.707724 up CCL2 6347 
not found 
2.320356 up 9.1362505 up 10.969729 up LOC618708 yet 
2.7346618 down 8.217133 down 11.137622 down FNDC1 84624 
1.6005067 down 11.540692 down 11.320967 down PPAP2B 8613 
1.3304777 up 12.310799 down 11.403743 down SFRP4 6424 
1.2384831 down 11.372253 up 11.687462 up TNFSF13B 10673 
1.8963207 down 13.417542 up 11.729195 up KCNT1 57582 
1.7423487 down 11.902527 down 11.771932 down VCAM1 7412 
3.1124148 down 10.969009 down 11.791678 down ANG 283 
not found 
1.6451237 up 6.4411683 up 11.823164 up yet 
2.7262433 up 14.978828 up 12.104685 up GPRC5A 9052 
1.9152048 down 9.218979 down 12.283286 down RGS13 6003 
1.5072047 down 18.381298 down 13.045399 down AHSG 197 
289 
human 
C-ABC TGF TGF+C-ABC Gene Symbol Entrez ID 
not found 
3.8262036 down 12.315087 down 13.118096 down yet 
2.4884028 up 12.445648 down 13.333374 down S100G 795 
1.1474786 up 10.34427 down 13.355462 down COX2 1E+08 
not found 
1.1668326 up 14.866286 up 13.496918 up yet 
1.561023 up 14.027843 up 13.526388 up MFSD6L 162387 
1.0734468 down 14.366854 up 13.690345 up PTPN5 84867 
4.673984 down 12.437477 up 13.702984 up ISG15 9636 
1.0847207 down 18.470402 up 14.063114 up GABRD 2563 
1.3595139 down 24.168238 down 14.214198 down B3GALNT1 8706 
2.598093 down 14.822899 up 14.308889 up SCRG1 11341 
1.0337337 up 12.657353 down 15.119983 down CYTB none 
not found 
2.1291625 down 14.424986 down 15.519769 down yet 
1.4537166 up 19.05149 up 15.597991 up CHRNA7 1139 
not found 
1.2402269 up 13.38799 down 16.26207 down yet 
not found 
2.100859 up 13.997187 down 16.314499 down yet 
3.1339912 up 16.463484 up 16.576937 up RND1 27289 
not found 
6.498768 up 20.344517 up 17.134975 up yet 
not found 
1.3483279 up 19.872509 down 17.372868 down yet 
not found 
5.1296496 up 14.10521 up 17.49387 up yet 
1.6714151 up 16.939123 up 18.354124 up GDF15 9518 
1.1749309 down 22.828346 down 18.70133 down KCNE4 23704 
not found 
1.6558633 up 18.469852 up 19.298754 up yet 
not found 
1.3066667 up 19.889647 up 20.065443 up yet 
10.870654 down 10.452961 down 22.452724 down COLEC11 78989 
not found 
1.6208721 down 22.71264 down 23.228792 down yet 
1.3580009 down 26.60113 up 25.921827 up PRSS16 10279 
1.7512186 down 27.468958 up 28.13812 up COL28A1 340267 
not found 
1.3670394 up 30.50448 up 30.372225 up yet 
not found 
5.3727684 down 34.30109 down 32.708134 down ITGBL1 yet 
not found 
2.6015403 down 37.863586 down 32.954426 down yet 
2.3243833 up 30.317844 up 33.40616 up FAM83D 81610 
7.1131577 down 39.74648 down 39.027416 down COL1A2 1278 
not found 
3.1975613 up 36.345272 up 39.221916 up KCNN4 yet 
2.6915343 up 37.401512 up 41.044163 up KRT13 3860 
9.393338 down 48.18166 down 44.74362 down COL1A1 1277 
27.317495 up 45.60362 up 47.97852 up FOSL1 8061 
10.196195 up 
1.2307239 up 
1.3520703 up 
74.78285 up 
157.54912 up 
221.1537 up 
72.677376 up 
171.10565 up 
208.04163 up 
GJB3 
DRD2 
290 
2707 
4741 
1813 
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Appendix 2: Genes differentially expressed due to 
hyaluronic acid 
Gene FC Regulation Gene FC Regulation 
EFEMP2 3.114134 up RARRES2 5.336247 up 
CCDC64B 3.123814 up MYC 5.342393 up 
VAMP2 3.127333 up TMEM130 5.350016 up 
ATP6VOC 3.166901 up ST3GAL3 5.362597 up 
SH3GL1 3.172893 up FBLN7 5.3653 up 
AHCY 3.173209 up ANKRD9 5.406378 up 
PER2 3.181076 up SPLUNC2B 5.456031 up 
VILL 3.183418 up CCNL1 5.45869 up 
SLA 3.190728 up NOV 5.469276 up 
APBA3 3.193908 up STAR 5.484474 up 
ITPKC 3.212448 up CATHL1 5.495899 up 
MYOD1 3.214046 up DNM1 5.504668 up 
TMEM201 3.215399 up SDC4 5.522861 up 
MY09B 3.220082 up SMOC2 5.530566 up 
TRIM15 3.226252 up DLK1 5.534524 up 
PHLDA2 3.243244 up GADD45B 5.546174 up 
LOC615935 3.243289 up LOC528939 5.557385 up 
NOM02 3.260491 up CYTL1 5.569976 up 
SLC12A9 3.285481 up LOC510193 5.58086 up 
PHF13 3.296038 up CATHL1 5.581614 up 
LIPG 3.316718 up OLFM1 5.584549 up 
MMP2 3.316891 up RHOU 5.594534 up 
LOC781123 3.326981 up ZFP36L1 5.596132 up 
AGTR1 3.336225 up SYTL2 5.608112 up 
IGHMBP2 3.350734 up RAB9A 5.630354 up 
LOC506470 3.351745 up PFKFB3 5.638695 up 
COL3A1 3.354212 up RHOV 5.661543 up 
LAPTM5 3.368565 up CD1A 5.662686 up 
PTMS 3.372933 up LOC781311 6.407356 up 
LOC788112 3.383465 up FOS 6.424679 up 
NEPN 3.397535 up IL1RAP 6.437739 up 
CEBPD 3.398838 up GOS2 6.49481 up 
MXRA8 3.405266 up HSPA1A 6.595901 up 
COL3A1 3.415606 up CABP2 6.608299 up 
LOC615291 3.432834 up DYRK3 6.608676 up 
DLK1 3.433493 up Pl3 6.610308 up 
KIF3C 3.434818 up NPEPPS 6.636694 up 
ANGPTL6 3.438558 up ARRDC2 6.665806 up 
DNM1 3.440338 up APOBEC3B 6.671162 up 
SLC38A3 3.45249 up IVNS1ABP 6.713525 up 
TCN2 3.455155 up GEM 6.7734 up 
ZNF358 3.462085 up RAB15 6.782245 up 
RNF19B 3.477796 up INHBA 6.820276 up 
292 
Gene FC Regulation Gene FC Regulation 
SERPING1 3.478325 up THBS4 6.82103 up 
TRMT61A 3.486873 up COL 16A1 6.87392 up 
FERMT1 3.49078 up GPR182 6.875762 up 
KDM5C 3.495404 up BHLHE41 6.879804 up 
GTLF3B 3.513406 up LOC100297155 6.888501 up 
NDUFA6 3.514897 up GOS2 6.940129 up 
TSTA3 3.515673 up SOCS1 6.945253 up 
KLK9 3.524472 up ATP2A2 6.972224 up 
BUB1B 3.893257 up DYRK3 6.975043 up 
NOS2 3.896367 up TRIM2 7.032845 up 
FAM174B 3.896538 up F3 7.040987 up 
8901 3.900384 up CECR1 7.070349 up 
MARCKSL1 3.90271 up CPZ 7.084812 up 
C1R 3.904908 up HIST1H2BN 7.102291 up 
RGP1 3.909194 up CCK 7.166775 up 
IFT80 3.913821 up HSPC159 7.18218 up 
MY019 3.925459 up TPPP3 7.255092 up 
ENHO 3.92661 up FBLN7 7.269387 up 
COBL 3.927865 up DEGS2 7.325464 up 
LOC787788 3.937935 up NFKBIA 7.335706 up 
TOP1 3.94752 up OXT 7.382643 up 
SLC41A3 3.953745 up JUN 7.484951 up 
GPR56 3.96527 up PARD6B 7.575008 up 
UBAP1 3.972372 up IRF1 7.692354 up 
TCF7 3.980768 up TMEM49 7.749526 up 
DUSP1 3.984211 up CSRNP1 7.806801 up 
AQP4 3.984848 up SF3B3 7.878956 up 
PDLIM7 3.999578 up TPPP3 7.889803 up 
INHBA 4.003334 up ELF1 7.897074 up 
SUPT3H 4.016495 up HSPA1A 7.914533 up 
C1S 4.03461 up ZFP36 7.924141 up 
FOXL2 4.037437 up C28H100RF10 7.985926 up 
CFB 4.038267 up TMEM158 8.056785 up 
LDOC1 4.050761 up CCL5 8.094933 up 
TNFRSF18 4.055958 up TMEM49 8.124417 up 
FNDC5 4.056771 up ANKRD37 8.155333 up 
ITGA7 4.065326 up IL6 13.90824 up 
CITED2 4.074863 up HSPA6 14.39829 up 
LOC618617 4.076769 up NFIL3 14.71455 up 
PFAS 4.08242 up LOC790889 14.87002 up 
CCNI 4.090396 up IGFBP3 14.95146 up 
FAM174B 4.097991 up MT3 15.10529 up 
CAMK1D 4.104024 up CCL5 15.24592 up 
NOV 4.118534 up PLAT 15.63222 up 
HIST1H1D 4.119286 up NFIL3 15.63792 up 
DLK1 4.126021 up MT3 15.91723 up 
CSNK1E 4.131059 up CXCR7 16.1135 up 
EVL 4.132863 up CCL5 16.22842 up 
GGT7 4.13391 up MMP3 18.71563 up 
293 
Gene FC Regulation Gene FC Regulation 
NPDC1 4.134587 up PIM1 18.72436 up 
NOS2 4.137818 up MMP3 19.93427 up 
VNN1 4.142443 up NOS2 21.78343 up 
CPXM1 4.143405 up IER3 21.81434 up 
BAMBI 4.145873 up IER3 22.12448 up 
RCN1 4.158174 up MMP3 22.7386 up 
WAC 4.165419 up MMP3 24.5752 up 
CD40 4.173619 up DRD1 29.05235 up 
ARRDC2 4.182496 up MMP1 34.83856 up 
ZVG11B 4.188269 up CSF3 51.37992 up 
NOM02 4.516851 up MMP1 97.79984 up 
ZFP36L1 4.520244 up MMP1 104.4976 up 
CMTM8 4.521695 up FABP4 82.27321 down 
RCN1 4.541266 up LOC527068 17.42143 down 
MUSTN1 4.551707 up AKR1C4 9.713958 down 
SMOC2 4.561538 up C28H100RF116 8.687338 down 
LBP 4.57437 up 101 8.5725 down 
VPREB3 4.588874 up C29H 11 orf54 7.879276 down 
CASK 4.60929 up LYRM7 7.264526 down 
LOC531776 4.615991 up ACADM 7.052514 down 
PCDH1 4.616793 up FAIM 6.664464 down 
RYBP 4.618319 up LIG4 6.540285 down 
EPAS1 4.62966 up CETN3 6.322228 down 
CITED2 4.629825 up LOC519309 6.302485 down 
TMEM98 4.636385 up GTF2H2 6.264545 down 
MAML3 4.639368 up LY96 6.248935 down 
MEG3 4.643378 up PUS10 6.221768 down 
DPF1 4.646753 up CCDC90B 6.197324 down 
TUBA1C 4.646847 up PPIL5 6.150221 down 
OSGIN1 4.65273 up CDC25A 6.135601 down 
HEXA 4.66391 up CCBL2 6.053514 down 
102 4.671534 up ACOT13 5.892866 down 
ACTL6B 4.672018 up CRYZL1 5.864327 down 
S1PR5 4.68331 up ACADM 5.690349 down 
TCP11 4.686401 up COX2 5.621278 down 
C1orf35 4.700328 up ZNF570 5.470599 down 
AHSG 4.704005 up NLK 5.445201 down 
CHI3L1 4.70421 up SLC30A6 5.346192 down 
SOCS1 4.707557 up PIN4 5.282741 down 
PRMT8 4.711311 up MGC140340 5.227598 down 
NUAK2 4.753817 up HOC 5.215012 down 
ZNF667 4.75695 up CISD1 5.212131 down 
OTUD1 4.772456 up FGL2 5.201345 down 
COL9A2 4.772885 up DUSP19 5.183243 down 
E2F4 4.776411 up ACADM 5.164629 down 
ALOX12B 4.805715 up TTC35 5.159855 down 
HAGHL 4.827222 up ERGIC2 5.132423 down 
AHSG 4.828063 up SCP2 5.120106 down 
LECT1 4.885042 up CISD1 5.018009 down 
294 
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GALNT13 4.89353 up PAAF1 4.950032 down 
CPXM1 4.908038 up COL 1A1 4.917915 down 
THBS1 4.929988 up HIBCH 4.888956 down 
HOMER2 4.93372 up LOC617365 4.861082 down 
LOC786034 4.938739 up ZNF45 4.843883 down 
EPHB2 4.947095 up TERF1 4.785919 down 
NEUROG1 4.948686 up MANF 4.773417 down 
RCN1 4.956459 up ALDH381 4.758535 down 
SLC5A5 4.956598 up HOPX 4.739635 down 
OR4N5 4.959062 up GPR89 4.734633 down 
CNKSR1 4.961392 up FAM33A 4.702982 down 
C1S 4.970248 up C9H60RF203 4.673188 down 
SYT5 5.671103 up LOC790576 4.670548 down 
INTS5 5.683684 up FAM55C 4.657504 down 
ARRDC2 5.684059 up PDSS2 3.989857 down 
RALGDS 5.738509 up MON1A 3.989083 down 
TAP1 5.742827 up MRPS14 3.988718 down 
MRC2 5.749599 up JKAMP 3.983036 down 
PDK4 5.768647 up HSBP1 3.958594 down 
DYRK3 5.772271 up NDUFAF2 3.958105 down 
NFKBIA 5.792005 up C23H6orf129 3.957848 down 
LOC100139238 5.800545 up COPB2 3.946307 down 
CTSC 5.804622 up SNAP23 3.94504 down 
LTBP3 5.832209 up SEC22A 3.944591 down 
LRRC32 5.840722 up TAF12 3.929604 down 
0103 5.842606 up HSBP1 3.925867 down 
MSRA 5.846904 up ACAT1 3.909122 down 
RARRES2 5.857441 up TMC01 3.908627 down 
CCK 5.859914 up ASF1A 3.899491 down 
TFPI2 5.860603 up MGC148355 3.891568 down 
BHLHE41 5.86465 up PEX3 3.88103 down 
PACSIN2 5.910937 up SEC22B 3.857293 down 
KRT19 5.948271 up C10H140RF169 3.856819 down 
ABCA3 6.003136 up ZNF679 3.849454 down 
SERPINA3 6.004657 up DECR1 3.847653 down 
ZNF282 6.033475 up ISOC2 3.844383 down 
LOC526547 6.053746 up INVS 3.842454 down 
VIT 6.055173 up LOC618360 3.827295 down 
HIST2H2AC 6.060773 up NUDT18 3.821577 down 
CD79A 6.064678 up NUDCD2 3.809828 down 
LTBP3 6.070079 up F2RL2 3.803153 down 
SNN 6.074573 up MR1 3.79494 down 
MSRA 6.080097 up LIN7C 3.777147 down 
ADRB2 6.101583 up DEM1 3.75459 down 
CNGB1 6.113863 up COL1A1 3.754417 down 
FKBP2 6.128055 up OLD 3.752985 down 
IGFBP3 6.153936 up EXOSC6 3.74926 down 
SPRY1 6.159435 up FKBP3 3.739859 down 
TFPI2 6.163176 up RMI2 3.737547 down 
295 
Gene FC Regulation Gene FC Regulation 
CSNK1E 6.192606 up IFT80 3.727095 down 
LOC784866 6.193188 up C17H120RF65 3.719115 down 
C2CD4B 6.210067 up COG4 3.699608 down 
SIK1 6.210187 up WDR89 3.697491 down 
SOX14 6.234561 up ECHDC1 3.697172 down 
HKDC1 6.237713 up IKBIP 3.697029 down 
LOC789453 6.239328 up TRIM38 3.693888 down 
NFKBIA 6.256089 up TAF12 3.690125 down 
EAF1 6.303177 up LOC790145 3.689718 down 
CA2 6.350652 up ALG8 3.68716 down 
NPDC1 6.36291 up ORC4 3.683722 down 
C17H12orf43 6.375712 up PTX3 3.677576 down 
NFKBIA 6.376849 up NQ01 3.664299 down 
MYBPH 6.388492 up WDR61 3.658443 down 
THBS2 8.217781 up ZNF212 3.648185 down 
WC1.3 8.248548 up SLC35B3 3.645502 down 
HSPA1A 8.267817 up RPAP3 3.348476 down 
SLC18A1 8.329465 up DNAJC19 3.336782 down 
TRIB1 8.369038 up BCAP29 3.332476 down 
PABPN1 8.436981 up MLF11P 3.329613 down 
ARIH1 8.469493 up FASTKD2 3.327411 down 
DOK5 8.470063 up C8H9orf82 3.326499 down 
ISG15 8.633556 up DAD1 3.314407 down 
CAMK2N2 8.646427 up LOC509351 3.312666 down 
PENK 8.702706 up CCBL2 3.303083 down 
COR06 8.728603 up M6PR 3.301267 down 
COCH 8.931233 up CNPY2 3.293272 down 
VIPR2 9.0446 up 51008 3.291978 down 
TXNIP 9.055558 up NEDD8 3.285314 down 
BHLHE40 9.059837 up ORC4 3.279729 down 
DUSP2 9.085271 up SPIN2 3.278208 down 
F3 9.112331 up IGFBP6 3.269127 down 
MGC128424 9.394942 up MOBKL2C 3.266382 down 
DNAJB1 9.412842 up COMMD5 3.265207 down 
GPR143 9.441118 up SEC24A 3.259661 down 
IGFBP3 9.745452 up USP3 3.25718 down 
NFIL3 9.751995 up MEGF10 3.248936 down 
ABCC5 9.770067 up TXN 3.248487 down 
SLC6A12 10.05488 up SEC24A 3.247972 down 
HSPA1A 10.18999 up PDCD10 3.235048 down 
CD83 10.21416 up SCFD1 3.23246 down 
JUN 10.31015 up C19H17orf59 3.229274 down 
PPP1R15A 10.45808 up NDUFA12 3.227958 down 
ANKRD37 10.53529 up VRK1 3.227353 down 
FOXC2 10.56122 up RP2 3.22672 down 
PIM1 10.79375 up SRBD1 3.223807 down 
LOC781225 10.82594 up DHRS7B 3.22126 down 
KLF6 11.10566 up HIBCH 3.218236 down 
HIST3H2A 11.25192 up OSTM1 3.211916 down 
296 
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ATF3 11.5361 up MAGED2 3.203118 down 
SIRPB1 11.95384 up NUP37 3.202151 down 
EDN2 11.99311 up ANXA4 3.197249 down 
NR1D1 12.19705 up ZNF583 3.197115 down 
TTLL1 12.25681 up LOC507750 3.192091 down 
IL6 12.29486 up AP3M1 3.183748 down 
TMEM201 12.40948 up C29H11orf54 3.182208 down 
TTLL1 12.59335 up HSDL2 3.181174 down 
CXCR7 12.68297 up NUP35 3.174443 down 
ABCA3 12.72033 up TM4SF18 3.160268 down 
LOC539246 13.12961 up NSUN3 3.159656 down 
HIST3H2A 13.13226 up GOSR2 3.159473 down 
PPP1R15A 13.21102 up ANAPC13 3.156304 down 
CHAD 13.41516 up OSGEPL1 3.143615 down 
HHAT 13.78577 up BNIP1 3.142914 down 
UNC5B 13.89304 up NEDD8 3.138902 down 
TNIP2 3.005433 up MTRF1 3.132261 down 
FBXW11 3.005953 up FMC1 3.131933 down 
THRAP3 3.00726 up PIGV 4.656295 down 
NUCB1 3.013866 up NUDT12 4.641157 down 
ARG2 3.025374 up C24H 18orf19 4.610604 down 
BGN 3.035267 up FAM33A 4.590575 down 
CLU 3.050675 up TTC35 4.5864 down 
LOC514257 3.057187 up DIXDC1 4.583977 down 
TMEM2 3.059981 up IFT81 4.56812 down 
MMP2 3.065241 up ELP3 4.552411 down 
CELF1 3.069309 up ZFYVE19 4.548154 down 
ACOT11 3.075295 up GEMIN6 4.537964 down 
PMP22 3.08949 up UGP2 4.500171 down 
PTGDS 3.099971 up LOC100139010 4.481614 down 
CTU1 3.114043 up BDH2 4.437852 down 
OSBPL10 3.527234 up FAM33A 4.411434 down 
FES 3.533298 up GOSR1 4.411247 down 
ZFP36L1 3.53613 up HOPX 4.404112 down 
ACOT11 3.547875 up IFT74 4.401402 down 
PELI1 3.550364 up LOC790145 4.397867 down 
LOC100139804 3.557612 up MRPL1 4.379288 down 
MT1A 3.564599 up RPS19BP1 4.358896 down 
IFT80 3.568703 up ORCS 4.358825 down 
TMEM37 3.569978 up TMEM69 4.358188 down 
SEMA4A 3.57003 up CDC26 4.324949 down 
DYRK1B 3.574329 up NSUN3 4.296114 down 
NECAP1 3.576426 up MED7 4.292007 down 
TRIB2 3.577234 up XRCC4 4.257215 down 
COL9A2 3.583751 up ATG7 4.251924 down 
ZFP36L1 3.586739 up CCBL2 4.251091 down 
CHI3L1 3.59329 up LRRC8E 4.246186 down 
FBXL2 3.601454 up DAD1 4.233543 down 
PID1 3.603112 up MRPL13 4.21195 down 
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AEBP1 3.605375 up SMARCA4 4.192433 down 
CRTC2 3.632599 up CHCHD7 4.183427 down 
LOC521525 3.633227 up C23H60RF47 4.166932 down 
EVL 3.642021 up C8H90RF85 4.148521 down 
MXRA8 3.647827 up ACTR6 4.146216 down 
KCNJ9 3.651811 up LOC790576 4.142726 down 
MT2A 3.660033 up NPM3 4.141362 down 
SDC4 3.668364 up NDUFC1 4.135549 down 
IFT80 3.676864 up ACAT1 4.132094 down 
TNFRSF6B 3.689817 up DECR1 4.091567 down 
C20orf111 3.690375 up ANXA1 4.090646 down 
ECRG4 3.694305 up SERPINI1 4.089996 down 
TGM2 3.701644 up PPP2R3C 4.079665 down 
TMEM55B 3.701872 up PTX3 4.07661 down 
SRSF1 3.70805 up TXNDC9 4.075418 down 
RASSF8 3.724096 up C23H6orf129 4.069323 down 
SDC4 3.739374 up MED7 4.054468 down 
BGN 3.741939 up ZUFSP 4.0383 down 
SHISA2 3.747012 up CUL7 4.033473 down 
LOC785034 3.774395 up ADAL 4.003998 down 
C2CD4B 3.794694 up VCAM1 3.634909 down 
NOXA1 3.798554 up BDH2 3.622305 down 
PITPNM1 3.817486 up NUDCD1 3.618385 down 
GAL 3.820223 up LNPEP 3.600666 down 
MGC152278 3.823275 up MGC157372 3.599697 down 
LOC514257 3.8261 up CCDC56 3.597535 down 
CERCAM 3.828667 up CETN3 3.591166 down 
CKB 3.828687 up OLD 3.58827 down 
TMEM132A 3.839545 up LSM3 3.585655 down 
SERPINE2 3.84178 up COL1A1 3.582285 down 
PAOX 3.848381 up ERGIC2 3.581946 down 
LTBP3 3.866936 up TTC5 3.581138 down 
GPRC5A 3.887951 up BDH2 3.576943 down 
PGF 4.194395 up NPM3 3.57642 down 
HSPA1A 4.198737 up TMEM128 3.572492 down 
MGC127492 4.201395 up C16H1orf93 3.568938 down 
ACTC1 4.208372 up PDHX 3.565717 down 
PDK4 4.210336 up DIXDC1 3.554141 down 
LOC618633 4.212641 up ZNF189 3.55031 down 
STRC 4.215305 up TPRKB 3.540622 down 
PAOX 4.216295 up MRPL47 3.537328 down 
SERPING1 4.229056 up US01 3.52868 down 
CAMK1D 4.23078 up CCDC86 3.521197 down 
LECT1 4.236096 up WDR61 3.513664 down 
LGALS9 4.236411 up C16H1orf156 3.507061 down 
PAK4 4.241145 up C9H60RF203 3.507011 down 
YOD1 4.245889 up CNPY2 3.506887 down 
ANKRD9 4.251147 up SEC62 3.490794 down 
TLE1 4.254692 up JKAMP 3.483456 down 
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PREX1 4.254959 up TXNDC9 3.481243 down 
EXOC3L2 4.259448 up ITGB1BP1 3.474314 down 
THBS3 4.260544 up PSMA4 3.470595 down 
C1S 4.27444 up RWDD2A 3.426783 down 
CEBPB 4.27594 up NUP37 3.42411 down 
MPPED2 4.276982 up GIN1 3.418056 down 
ELF3 4.287345 up GPX8 3.415606 down 
SMOC2 4.294398 up HRSP12 3.404223 down 
CKB 4.295063 up ZNF521 3.394173 down 
102 4.307009 up COMMD6 3.392332 down 
LOC787315 4.312689 up PPWD1 3.386303 down 
CFB 4.316038 up TM2D1 3.383726 down 
SOC 52 4.319769 up ZNF187 3.380747 down 
RMND5A 4.326815 up JKAMP 3.378612 down 
MFAP2 4.334281 up DCTN5 3.378608 down 
SOCS1 4.352686 up CPNE8 3.367283 down 
NUAK2 4.362635 up FARSB 3.366696 down 
LOC539596 4.366135 up MRPL22 3.361334 down 
ZFP36L1 4.382076 up VCAM1 3.359486 down 
AHSG 4.389936 up INSIG2 3.355151 down 
NCF1 4.403068 up C16H1orf156 3.354657 down 
RAB15 4.41229 up NDUFS4 3.352199 down 
WWTR1 4.412438 up CCDC56 3.126912 down 
ACTC1 4.412507 up NIF3L1 3.124021 down 
GADD45B 4.420004 up LYPLAL1 3.118687 down 
FOXJ1 4.423711 up RPL7L 1 3.116196 down 
CPXM2 4.439729 up ARV1 3.114181 down 
RHOS 4.448938 up WRN 3.109585 down 
COL2A1 4.471056 up ISOC2 3.103268 down 
DDX3X 4.473314 up ARV1 3.103001 down 
IFI6 4.477788 up POT1 3.100881 down 
NPPC 4.488915 up NIPSNAP1 3.093173 down 
PMEPA1 4.502809 up OSTF1 3.081111 down 
PPP6R3 4.504335 up CCDC132 3.077971 down 
Pl3 4.515165 up LINS 3.077036 down 
DUSP10 4.995005 up ZNF830 3.074852 down 
COL11A2 5.007313 up ACTR2 3.072552 down 
EPYC 5.00984 up NDUFA2 3.072021 down 
ACSM2A 5.021521 up CCL25 3.071394 down 
HIST1H1D 5.032537 up ALG10 3.070998 down 
DPF1 5.076459 up ALG11 3.066288 down 
LOC616942 5.079365 up AASDH 3.05837 down 
CD40 5.089731 up GGPS1 3.056568 down 
CLK3 5.124697 up CCDC90B 3.056387 down 
CFB 5.142702 up ZNF323 3.053176 down 
NOV 5.150844 up NFU1 3.051242 down 
LOC614284 5.157355 up TRMT5 3.050756 down 
FUBP1 5.175399 up C17H120RF65 3.045974 down 
TIMP3 5.176029 up MED6 3.045792 down 
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BHLHE40 5.177926 up C11H20RF7 3.043979 down 
PABPN1 5.187668 up GTF2H3 3.041368 down 
OLFM1 5.195365 up COL16A1 3.040849 down 
PPP2CA 5.205952 up PAAF1 3.031732 down 
PAOX 5.223555 up ZNF266 3.017759 down 
C3 5.22476 up COQ7 3.011555 down 
COL18A1 5.254467 up ISOC2 3.004399 down 
PPM1M 5.310961 up C12H13orf27 3.003012 down 
FOSS 5.322266 up ORMDL2 3.0002 down 
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Appendix 3: HPLC for pyridinoline quantification 
General methodology 
An HPLC protocol was developed to quantify pyridinoline and pentosidine 
crosslinks based on a protocol reported previsouly.216 Samples were digested in 
200 IJL of 6N HCI at 1 oooc for 20h on a heating block and then using a vacuum 
concentrator. For native cartilage samples with masses of approximately 20mg, 
samples were re-suspended in 1 OOIJL of an aqueous solution containing 1 0 nmol 
pyridoxine/ml and 2.4 1Jmol homoarginine/ml and then diluted fivefold with an 
aqueous solution of 0.5% HFBA acetonitrile in 10% acetonitrile. 10 IJL of each 
sample was injected into the reverse phase column and eluted using a solvent 
profile described previously.216 To use less tissue or to assay samples with lower 
crosslink densities, it is possible to use larger injection volumes and/or smaller 
resuspension volumes. 
Pyridinoline detection 
Initially, various emission wavelengths were scanned to ensure that pyridinoline 
signal was maximized, showing that maximum emission at approximately 400 
nm. Both immature and mature bovine cartilage was used as positive controls 
because they are known to produce crosslinks. 
Pyridinoline eluted between 5-1 0 minutes, yielding chromatograms as 
shown in Fig. A3-2. To validate the pyridinoline peak, samples were spike and 
areas were computed (Fig. A3-3), showing that the target peak was indeed 
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pyridinoline. Variation in elution was probably due to differences in HFBA and/or 
HCI concentrations. Based on the work of Bank et. a/,216 it is known that even 
0.01% variation in HFBA concentration can alter elution profiles. This shows the 
importance of careful solvent preparation for this method. 
Pentosidine detection 
Pentosidine detection could be employed to quantify crosslinks induced by ribose 
treatment or to evaluate the formation of advanced glycation end products in 
native tissue. A pentosidine standard was also purchased and assayed based on 
the ability of the Banks protocol to detect pyridinoline and pentosidine in a single 
HPLC run. Standards were eluting at 20 minutes. Because we primarily tested 
immature tissue, pentosidine was not assessed in most samples. However, uture 
work with different exogenous stimuli or different native tissue sources could 
benefit from pentosidine quantification. 
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Figure A3-1: Emission wavelength spectrum for pyridinoline detection. 
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(a) Emission spectrum of mature bovine cartilage based on 295 nm excitation. 
(b) Emission spectrum of immature bovine cartilage based on 295 nm excitation. 
They-axis is fluorescence intensity based on HPLC elution. Both immature and 
mature bovine cartilage exhibited maximum emission at approximately 400 nm, 
so this emission wavelength was carried forward. 
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Figure A3-2: Representative chromatogram of native tissue 
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Species with low binding affinities typically elute within the first 1-2 minutes. The 
internal standard (pyridoxine, marked as A) also eluted during the first several 
minutes. Pyridinoline (peak B) eluted at 5-10 minutes; its elution time could vary 
depending on solvent composition. The peak shows pyridinoline from articular 
cartilage. 
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Figure A3-3: Validation of pyridinoline standard 
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To validate the observed peaks, a sample was spiked with a standard. The 
construct area, pyridinoline (PYD) area, spiked sample area are shown. The 
theoretical area sum (construct area + PYD area) corresponds with the area of 
the spiked sample, suggesting that the samples contained pyridinoline. 
305 
Figure A3-4: Pentosidine detection with HPLC 
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In addition detecting pyridinoline, the HPLC protocol is capable of quantifying the 
amount of pentosidine. This crosslink elutes later, at approximately 20 min, so 
there is not overlap with any pyridinoline peaks in the same run. Thus, 
pentosidine and pyridinoline can be detected during a single HPLC run. 
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Appendix 4: Nonlinear optical analysis of patella 
Introduction 
Cartilage has a zonal collagen organization that has been characterized for the 
different layers of cartilage. The superficial zone, which is closest to the 
articulating surface, has collagen aligned parallel to the surface. Collagen 
abundance is also highest in the 
superficial zone. 284 The deep zone, which is near the calcified bone, has fibrils 
oriented perpendicularly to the surface. The middle zone of cartilage has 
intermediate organization of fibrils rather than exhibiting dominant parallel or 
perpendicular alignment. 
Collagen organization has practical importance because it influences 
tissue mechanics, which are crucial for normal cartilage function. For instance, 
split-line orientation has been shown to dictate tensile properties.128•155 The 
effects of orientation can be dramatic: the tensile modulus is 42.2 MPa when 
tested parallel to the collagen orientation but only 15.6 MPa when tested 
perpendicularly.2 One of the major challenges in biomechanics has been 
rigorously quantifying the orientation, which is often assessed using indirect 
methods such as split lines. Quantifying collagen organization could enable 
better elucidation of structure-function relationships and provide a method for 
evaluating the quality of tissue engineered cartilage. 
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Various methods have been employed to quantify collagen organization. 
Polarized light microscopy can be used to observe organization because 
collagen is birefringent. In general, highly oriented fibers will increase the phase 
difference between the orthogonal components of the light. 379 Diffusion tensor 
imaging (DTI) has also been used to examine orientation.293•381 -383 DTI is based 
on quantifying water molecule movement, which can be quantified using DTI. 
Collagen anisotropy can alter water movement such that DTI can differentiate 
matrix organization.293 Although polarized light microscopy is widely used and 
DTI is quantitative, a prevalent, quantitative technique has not yet emeraged. 
SHG provides a uniquely specific method of examining collagen 
organization in tissues and has been extensively employed to study collagen in 
cartilage. Collagen organization was first studied using SHG analysis of the 
tendon490 and various other tissues including fascia, cornea, and cartilage have 
been extensively characterized.491 •492 It has been shown that nonlinear optical 
properties of articular cartilage exhibit depth-dependence.492 However, how SHG 
properties relate to biomechanical properties, which are crucial to cartilage 
function, has not been clearly delineated. 
This study evaluated the relationships among biochemical, biomechanical, 
and nonlinear optical properties of patella cartilage. Different zones of immature 
and mature patella were examined to observe any potential effects of maturation. 
This work tested the hypotheses that 1) biochemical, biomechanical, and 
nonlinear optical properties vary depending on depth and 2) optical properties 
can be used to infer biochemical and biomechanical properties. 
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Methods 
Tissue acquisition/sectioning 
Full thickness cartilage was removed with a 4 mm biopsy punch from [region] 
immature and mature patella. Immature (4 week old) bovine patellae were 
purchased from Research 87. Mature bovine patellae, from steers approximately 
one year old, were acquired from the UC Davis Meat Lab. Immature patella 
samples were tested in three different zones (Fig. A4-1). Mature patella samples 
were tested in two different zones due to the reduced thickness of cartilage. Split 
lines were employed to assess collagen orientation prior to removing. 
Biochemistry 
Following freezing -20°C, each sample was lyophilized to enable dry weight 
determination. Each sample was digested using papain for 18h.187 To assess 
collagen abundances, samples were assayed using a chloramine-T 
hydroxyproline assay.117 
Tensile testing 
Prior to conducting tensile tests, samples were cut into dog-bone shapes and 
glued to paper tabs for gripping.122 lmageJ was used to examine the width, 
gauge length, and thickness of samples. All tensile tests were conducted to 
failure by pulling at a strain rate of 1% of the gauge length per second. Tensile 
tests were conducted on a materials testing system (lnstron Model 5565). The 
-------------
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maximum stress was reported as the ultimate tensile strength (UTS). The 
Young's modulus (Ev) was determined by computing the slope of the linear 
region of the stress-strain curves. 
SHG data collection 
In order to obtain scans from a similar region of each section, a punch was used 
to remove a circular section from an opaque cloth. The hole was centered over 
the circular section, so that no samples edges were included in the scan. 
Samples varied considerably in SHG intensity. Initial scans were performed on a 
500 x 500 1-1m region with 5 1-1m steps to ensure that a representative region of 
the tissue was being examined. The final scan was performed on a 200 x 200 1-1m 
region using 0.5 1-1m steps. The optical set up and method for data acquisition 
has been described in detail in earlier papers. An algorithm for assessing 
disorder in fibrillar collagens has been described in detail in an earlier paper: 
disorder is expressed as the percent of maximum disorder possible. The original 
algorithm has since been extended; several additional methods are now included 
for analyzing parameters potentially related to structural disorder: these include 
calculation of local director angles, calculation deviation from the director, as well 
as parameters related to liquid crystal structure. In addition, the distribution of 
peak angles were assessed for the presence of multiple Gaussian distributions, 
using probability density plots. Finally, the size of the largest fibril within the scan 
region was determined during the analysis of disorder: a ''fibril" was defined by 
the presence of at least three lines of pixels varying less than 5% in orientation 
310 
with no breaks. Although this procedure may underestimate the true size of fibrils 
since they are known to be interwoven, this calculation provides a uniquely useful 
way of assessing another aspect of cartilage structure. 
Results 
Tensile properties and collagen content varied significantly depending on zone. 
The UTS was 12.2±3.7 and 21.8±6.5 MPa for the lower and upper zones, 
respectively. Similarly, the tensile stiffness was 21.8±6.5 and 46.5±20.7 MPa for 
the lower and upper zones, respectively. Collagen content was highest in the 
upper zone and lowest in the deeper zone, exhibiting respective values of 
12.8±2.2% and 7.5±0.6'% for the lower and upper zones, respectively. Col/dw 
was not significantly different among the various zones. Similarly, both tensile 
strength and stiffness were highest in the upper zone and lowest in the lower 
zone. 
For SHG, at least three scans were performed on each sample. The 
standard disorder parameter was based on a nearest-neighbor analysis designed 
for application to fibrillar collagen and has been described in detail previously.493 
The alternative disorder parameter was based on the degree to which a given 
pixel deviates from the neighborhood director with respect to orientation, and was 
expressed in degrees. The size of the ordered area within the scanned region 
was defined as the length over which at least 3 parallel lines of pixels extended 
with less than 10% change in orientation. 
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SHG scans showed clear differences among zones as summarized in 
Figure 4. Quiver diagrams of fibril orientation (Fig. A4-4A, Fig. A4-4C) were 
represented in histograms of the fibril orientation distribution (Fig. A4-4B, Fig. A4-
4D). Interestingly, the histograms revealed 2 distinct organization populations in 
the upper zone. In contrast, the lower zone did not display preferential 
organization. This suggested that the upper zone had two ordered populations 
whereas the deeper zone did not exhibit ordered regions. 
Analyses of ordered region size and disorder percentage were examined 
to observe relationships with biomechanical properties. The ordered region size 
was generally greater in the upper zone, which had an area size almost 5 times 
greater than the lower zone (Fig. A4-5A). Ordered region size was correlated 
with both tensile stiffness and tensile strength (Fig. A4-5C, A4-5D). Although the 
disorder parameter exhibited a trend that was inversely related to biomechanical 
properties (Fig. 4-58), the correlation were not significant. The disorder 
parameter was, however, significantly correlated with zone, with the highest level 
of disorder associated with lower zone and the least disorder in upper zone. 
Correlation analysis of all the parameters confirms that the disordered region size 
was most strongly correlated with Young's Modulus and UTS. 
Discussion 
This study confirmed the hypothesis that SHG can be used to infer functional 
properties of cartilage. The core novelty of this work is the use of SHG to 
quantitatively assess biomechanical properties of the patella. 
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The finding that the disordered region size was strongly correlated with 
Young's Modulus and UTS is particularly exciting because it provides a new 
method of assessing mechanical properties. Because biomechanical tests are 
destructive, time-consuming, and require special equipment, developing an SHG 
methodology could be enormously useful. The core question is what exact matrix 
components or organization SHG is measuring to infer mechanical properties. 
Further work will be carried out to understand the basis of SHG differences in the 
patella, which could be used to further understand the collagen architectures and 
develop SHG as a novel testing modality. 
The next step towards understanding the basis of the SHG results will be 
differentiating the effects of collagen abundance and collagen organization. 
Although biochemistry assays can be employed to quantify the amount of 
collagen, it will also be necessary to quantify the collagen organization. SEM or 
TEM could potentially be employed to more rigorously compare collagen 
orientation and SHG parameters. Conducting SEM in conjunction with collagen 
quantification will develop the SHG technology platform. 
One of they key limitations of this work was the lack on knowledge 
concerning the collagen architecture of the immature patella. Attempts to discern 
split lines were unsuccessful, suggesting that the collagen may not yet be 
oriented in the superficial zone. Future work with mature patella will help confirm 
any results seen in this experiment and also provide a system with more well-
document collagen organization. Additionally, the mature samples will provide 
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information regarding how biomechanical, optical, and biochemical properties 
change during maturation. 
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Figure A4-1: Patella sectioning schematic 
Upper ~----- ~-- SHG (40 Jlm) 
>< ~-Tensile (200 Jlm) 
Middle ~- Biochemistry (200 Jlm) 
>< 
Lower 
Patella samples were removed with biopsy punches and then sectioned parallel 
to the surface to evaluate three different zones. From each zone, a 40 IJm slice 
was placed on a slide and evaluated using SHG. 200 1Jm slices were used for 
biochemistry and mechanical assays. 
Figure A4-2: Zonal variation of tensile stiffness and tensile strength. 
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Tensile stiffness and strength were highest for the upper zone and lowest for the 
lower zone. Bars labeled with different letters exhibit significant differences (p < 
0.05). 
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Figure A4-3: Zonal variation of collagen content. 
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Collagen content was highest for the upper zone and lowest for the lower zone. 
The middle zone had intermediate collagen content. Bars labeled with different 
letters exhibit significant differences (p < 0.05). 
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Figure A4-4: SHG evaluation of upper and lower zones 
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(A) Quiver map of collagen order in upper zone. (B) Histogram of counts for 
different orientation angles in upper zone illustrates two distinct populations 
around 20° and 70°. (C) Quiver map of collagen order in lower zone. (D) 
Histogram of counts for different orientation angles in lower zone illustrates lack 
of distinct populations. 
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Figure A4-5: Relationship between SHG parameters and mechanics 
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(A) Ordered region size of three zones. (B) Disorder quantification of three 
zones. (C) Significant correlation between the tensile stiffness and organized 
region size. (D) Significant correlation between the tensile stiffness and 
organized region size. 
